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English abstract 
For dairy cows, the transition from late pregnancy to early lactation is characterized by dramatic changes 
in endocrine status, nutrient utilization as well as tissue metabolism. Specific metabolic processes, e.g., 
in adipose tissue (AT) thereby contribute to the physiological adaptation to the increased nutrient 
demands imposed by the onset of lactation. Even though AT is known to be a major site for regulating 
glucose and lipid metabolism, its role in systemic protein and amino acid metabolism in dairy cows is 
not clear. The branched-chain amino acids (BCAA) are taken up by the mammary gland in excess and 
are greatly used for the synthesis of (milk) protein as well as the supply of metabolic intermediates and 
energy. Their cellular transport and break-down are highly regulated key processes, involving the 
interaction of several metabolic tissues, one of them possibly AT. Yet, studies on the BCAA transporters 
or degrading enzymes in ruminant tissues are sparse. Thus, one aim of the present thesis was to 
characterize the potential capacity of bovine AT (along with liver, skeletal muscle and mammary gland) 
for BCAA metabolism during late gestation and early lactation by analyzing the tissue abundance (and 
activity) of the most relevant BCAA transporters and catabolic enzymes as well as the concentration of 
circulating BCAA on selected time points before and after parturition. Moreover, as high BCAA levels 
have been linked with obesity and certain metabolic dysfunctions such as impaired insulin sensitivity in 
mammals, we further aimed to investigate the effect of over-conditioning at calving on the 
aforementioned variables of BCAA metabolism. Overall, AT consistently had the greatest mRNA 
abundance of the BCAA transporters and the BCAA transaminating enzyme, branched-chain 
aminotransferase 2 (BCAT2) when compared to most other tissues, but expressed a rather low oxidative 
capacity for BCAA (more specifically their keto acids), indicating that AT could be an important site of 
BCAA uptake and initial degradation in dairy cows. Together with the marginal hepatic mRNA 
abundance of BCAA transporters and BCAT2 and the high mRNA and protein abundance as well as 
activity of the subsequent oxidative enzyme in liver, the branched-chain α-keto acid dehydrogenase, it 
seems that BCAA are only degraded in the liver after being deaminated in peripheral tissues, most likely 
AT. Furthermore, we detected a decrease in circulating BCAA levels around parturition in our studies, 
which was associated with the reduced feed intake during this time. Both observations were more 
pronounced for cows that were over-conditioned at calving. Interestingly, despite the lower feed intake, 
those cows appeared to have a greater ability than normal-conditioned cows to irreversibly catabolize 
BCAA in AT, especially before parturition. It is likely that, due to a nutrient oversupply, the over-
conditioned cows were in a more anabolic situation during late pregnancy and might have used BCAA 
metabolites in addition to glycolytic metabolites for synthesizing even more body fat. The present thesis 
thus provides information about a possible anaplerotic link between BCAA and lipid metabolism in AT 
of over-conditioned dairy cows and might serve as basis for further studies investigating the role of AT 
in systemic protein and AA metabolism in cattle during different physiological and pathophysiological 
conditions. 
  
German abstract 
Der Übergang von der späten Trächtigkeit zur frühen Laktation ist bei Milchkühen mit drastischen 
Veränderungen des endokrinen Status, der Nährstoffverwertung sowie des Gewebestoffwechsels 
verbunden. Spezielle Stoffwechselprozesse, beispielsweise im Fettgewebe (AT), tragen dabei zur 
physiologischen Anpassung an den durch die einsetzende Laktation erhöhten Nährstoffbedarf bei. 
Obwohl die regulativen Funktionen des AT im Glukose- und Lipidstoffwechsel bereits bekannt sind, 
weiß man bisher wenig über dessen Rolle im systemischen Protein- und Aminosäurestoffwechsel bei 
Milchkühen. Die verzweigtkettigen Aminosäuren (branched-chain amino acids, BCAA) werden im 
Übermaß von der Milchdrüse aufgenommen und dort verstärkt für die Synthese von (Milch-) Protein 
sowie für die Zufuhr von Stoffwechselintermediaten und Energie verwendet. Der zelluläre Transport 
und der Abbau der BCAA sind intensiv regulierte Kernprozesse, welche die Interaktion verschiedener 
metabolischer Gewebe, darunter möglicherweise auch AT, erfordern. Bislang gibt es jedoch nur wenige 
Studien, in welchen die BCAA-Transporter oder die BCAA-abbauenden Enzyme auf Gewebeebene bei 
Wiederkäuern untersucht worden sind. Demzufolge war ein Ziel dieser Arbeit die potenzielle Kapazität 
von bovinem AT (neben Leber, Skelettmuskulatur und Euter) für den BCAA-Stoffwechsel während der 
späten Trächtigkeit und frühen Laktation zu charakterisieren. Dies erfolgte durch Analyse der 
Gewebeexpression (und -aktivität) der relevantesten BCAA-Transporter und katabolen Enzyme sowie 
durch Messung der BCAA-Konzentration in der Zirkulation an ausgewählten Zeitpunkten vor sowie 
nach der Kalbung. Ferner, da erhöhte BCAA-Konzentrationen in Verbindung mit Übergewicht und 
gewissen metabolischen Dysfunktionen wie beispielsweise einer verschlechterten Insulinsensitivität bei 
Säugetieren stehen könnten, war es ein weiteres Ziel, den Einfluss von Überkonditionierung zum 
Zeitpunkt der Kalbung auf die zuvor genannten Parameter des BCAA-Stoffwechsels zu untersuchen. 
Fettgewebe wies generell die höchste mRNA-Expression der BCAA-Transporter und des BCAA-
transaminierenden Enzyms branched-chain aminotransferase 2 (BCAT2) im Vergleich zu den meisten 
anderen Geweben auf, jedoch zeigte es eine recht geringe oxidative Kapazität für die BCAA (genauer 
deren Ketosäuren). Dies deutet darauf hin, dass AT von großer Bedeutung für die Aufnahme und den 
initialen Abbau von BCAA bei Milchkühen sein könnte. Zusammen mit der geringen hepatischen 
mRNA-Expression der BCAA-Transporter und der BCAT2 sowie der erhöhten mRNA- und 
Proteinexpression und Aktivität des nachfolgenden oxidativen Enzyms, der branched-chain α-keto acid 
dehydrogenase, in der Leber, weist dies darauf hin, dass BCAA nur in der Leber abgebaut werden 
können nachdem sie in peripheren Geweben, höchstwahrscheinlich dem AT, deaminiert wurden. Des 
Weiteren wurde in den dargestellten Studien eine Verringerung der BCAA-Konzentrationen zum 
Zeitpunkt der Kalbung festgestellt, welche mit der zeitgleich reduzierten Futteraufnahme assoziiert 
wurde. Diese Beobachtungen waren bei Kühen, welche zum Zeitpunkt der Kalbung überkonditioniert 
waren, deutlicher ausgeprägt. Interessanterweise schienen diese Tiere, trotz der geringeren 
Futteraufnahme, ein höheres Vermögen zu besitzen, BCAA irreversibel im AT zu katabolisieren als 
normalkonditionierte Kühe. Dies traf insbesondere für die Zeit vor der Kalbung zu. Es ist denkbar, dass 
  
sich die überkonditionierten Kühe während der späten Trächtigkeit, aufgrund eines 
Nährstoffüberangebots, in einer mehr anabolen Stoffwechselsituation befanden und demnach zusätzlich 
zu glykolytischen Stoffwechselprodukten ebenfalls BCAA-Metabolite für den Aufbau von weiterem 
AT nutzen konnten. Die vorliegenden Ergebnisse zeigen somit eine mögliche anaplerotische 
Verbindung zwischen BCAA- und Lipidstoffwechsel im AT überkonditionierter Milchkühe auf. 
Folglich dient diese Arbeit als essentielle Grundlage weiterer Untersuchungen, um die Funktionen des 
AT im systemischen Protein- und Aminosäurestoffwechsel bei Kühen in verschiedenen physiologischen 
und pathophysiologischen Stadien zu erforschen. 
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Introduction 1 
 
1 Introduction 
Sustainable safeguarding of animal performance and animal health continue to present 
challenges in modern agricultural systems. Through genetic selection as well as improved 
nutrition and management, the milk yield of German Holstein cows has increased almost 
threefold over the last decades (Breves, 2007). However, such high demands on the animals’ 
metabolism are often accompanied by metabolic disorders, such as milk fever, ketosis, retained 
placenta, and displaced abomasum as well as reduced fertility, lameness and various infectious 
diseases, all of which may impact the efficiency of milk production and consequently, may lead 
to a shorter productive life span of high-yielding dairy cows (Goff and Horst, 1997; Sordillo et 
al., 2009). 
The majority of these health problems occurs during the periparturient period (3 weeks 
before to 3 weeks after parturition; Grummer, 1995), making it one of the most critical times 
during a dairy cow’s life. A profound knowledge of the complex physiological and 
pathophysiological processes emerging around this time is a prerequisite for finding any 
strategies which may help improve the cow’s health while securing high productivity. 
 
1.1 Dairy cow metabolism during the transition from late gestation to early lactation 
During late pregnancy and early lactation, the nutrient demands imposed on the maternal 
organism increase substantially and rapidly as a result of (1) the growing fetus and (2) the 
production of colostrum and milk. Fetal development, i.e., the development of the fetus itself, 
fetal membranes and supplementary tissues (Bell, 1995), reaches exponential growth during the 
last weeks of pregnancy (Ferrell et al., 1976). Concomitantly, the alveolar system of the 
mammary gland (MG) is growing notably as well (Ingvartsen, 2006). At the expense of other 
metabolic functions, different, mostly evolutionary based, regulatory processes thereby ensure 
absolute metabolic priority for the support of pregnancy and lactation (Bauman and Currie, 
1980). However, the sudden increase in nutrient requirements cannot be compensated by feed 
intake alone. This is aggravated by the fact that specific metabolic and endocrine changes 
around parturition usually lead to a decrease in voluntary feed consumption, which only slowly 
increases again after calving, and, thus, insufficient nutrient intake may often be the case 
(Grummer, 1995; Allen et al., 2005). With the onset of lactation, the animals enter an inevitable 
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state of negative nutrient balance (NNB) and systemic adaptations to NNB occur in e.g., adipose 
tissue (AT), liver, skeletal muscle, gut and MG, necessitating their metabolic regulation and 
coordination (Drackley, 1999; Herdt, 2000). In order to meet the nutrient requirements cows 
have to mobilize body reserves mainly from AT and muscle (Plaizier et al., 2000; Kuhla et al., 
2011). Even though this situation is quite common for mammals, the severity and persistency 
of NNB as well as the manifestation of tissue mobilization in high-yielding dairy cows are all 
exceptional. Exemplary reports have shown a range of 19 to 54 kg of fat, and up to 21 kg of 
muscle protein being lost during early lactation (Komaragiri and Erdman, 1997; Chibisa et al., 
2008). In terms of quantity, the ability to use protein is therefore restricted. Also, protein 
mobilization may only last until 5 weeks (wk) of lactation, whereas utilization of body fat can 
occur at least until 12 wk after calving (Komaragiri and Erdman, 1997). However, according to 
van der Drift et al. (2012), muscle protein mobilization may already occur before parturition 
and thus, in advance of fat mobilization. 
Another notable metabolic adaptation to preserve sufficient nutrients for fetal growth and 
development as well as milk production is a decrease of insulin sensitivity (IS) in peripheral 
tissues during late pregnancy and early lactation (Bell and Bauman, 1997), oftentimes leading 
to an insulin-resistant state (Chagas et al., 2009). Consequently, reduced IS further shifts 
metabolic processes in AT and muscle (which are usually insulin-sensitive) away from 
maintenance or anabolism towards catabolism. Moreover, peripheral glucose utilization is 
reduced, facilitating a direct nutrient flow to the MG, which in lactating mammals is largely 
insulin-independent (Bell and Bauman, 1997). As only restricted amounts of glucose are 
available as energy source for peripheral tissues, alternative fuels are needed to maintain the 
physiological function of these tissues. 
During fat mobilization (lipolysis), fatty acids from AT are released into the circulation as 
non-esterified fatty acids (NEFA), which can then be used as a source of energy by different 
tissues, such as liver and muscle, or be used as precursors for the synthesis of milk fat in the 
MG (Palmquist et al., 1969; Herdt, 2000). Albeit, the capacity of the liver for full NEFA 
oxidation is limited, resulting in either the storage of excess NEFA as triglycerides (“fatty liver 
syndrome”) or in incomplete NEFA oxidation, which in turn is linked to an elevated synthesis 
of ketone bodies, i.e., ß-hydroxybutyrate (BHB), acetone and acetoacetate (Adewuyi et al., 
2005). High blood concentrations of both NEFA and BHB in dairy cows may thereby indicate 
an excess of NNB (McArt et al., 2013), associated with a higher incidence of metabolic 
disorders like fatty liver and ketosis as well as generally impaired immune functions (Drackley, 
1999; Herdt, 2000).  
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In skeletal muscle, as the major protein reserve, increased proteolysis leads to the 
mobilization of amino acids (AA), which, depending on the type of AA, may be directed 
towards milk protein synthesis, direct oxidation, hepatic gluconeogenesis or ketogenesis (Kuhla 
et al., 2011; Mann et al., 2016). However, resulting from both elevated nutrient demands and 
concurrently reduced nutrient intake, general postpartal AA imbalances (Doepel et al., 2002; 
Kuhla et al., 2011) or even deficits in individual circulating AA (Meijer et al., 1995) may occur 
and thus, limit (milk) protein synthesis (Kuhla et al., 2011). In addition, tissue energy 
metabolism as well as the immune system may be affected by impaired nitrogen retention: For 
example, low concentrations of essential AA (EAA) in the circulation can lead to general 
decreases in splanchnic tissue proliferation (Gibb et al., 1992; Larsen et al., 2014) and also to 
reduced lymphocyte proliferation and antibody production, compromising both the innate as 
well as the acquired immune defense (Li et al., 2007). 
 
1.1.1 Effect of body condition on the metabolic status of dairy cows 
The body condition score (BCS) of a dairy cow is used to assess the animal’s proportion of 
body fat [specifically subcutaneous AT (scAT)] and is an important management tool employed 
by animal scientists and producers, providing a gross but reasonably accurate measure of the 
energy status (Roche et al., 2009). Even though the scale may differ between countries, low 
values always signify emaciation whereas high values equate to obesity. Besides factors such 
as diet, milk yield and parity, BCS at calving largely affects the extent and rate of peripartum 
tissue mobilization (Komaragiri et al., 1998). Compared with thinner animals (mean calving 
BCS of 2.5; 5-point scale), cows that are over-conditioned (mean calving BCS of 4.0) and, thus, 
have more tissue reserves to rely on, experience greater losses in body condition as well as body 
weight (Treacher et al., 1986; Pires et al., 2013). At parturition, there is a negative association 
between BCS and dry matter intake (DMI; Hayirli et al., 2002; Matthews et al., 2012), as over-
conditioned cows usually expressing a more pronounced and prolonged decline in DMI, have 
to face a deeper NNB (Hayirli et al., 2002), a more rapid and excessive lipolysis as well as a 
greater release of NEFA into the circulation than cows in moderate or lean condition (Dann et 
al., 2006; Pires et al., 2013). However, it has also been reported that over-conditioned cows 
(mean BCS of 4 at dry-off) lose more muscle fiber area after parturition than thin cows (mean 
BCS of 2.5 at dry-off), indicating a greater mobilization of body protein as well as fat (Reid et 
al., 1986). In view of a positive correlation found between muscle diameter and BCS 
(Kokkonen et al., 2005), BCS not only covers the assessment of fat depots, but may also assess 
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protein reserves in muscles located under the skin, where body condition is scored; a change in 
either or both factors may therefore affect BCS (Reid et al., 1986; Kokkonen et al., 2005). 
It is well documented that due to the more excessive tissue mobilization, cows calving with 
a high BCS bear a greater risk of developing metabolic disorders and other health issues, which 
may compromise productivity (Gearhart et al., 1990; Bobe et al., 2004; Drackley et al., 2005; 
Ingvartsen, 2006). Enhanced insulin resistance (IR), a state in which physiological 
concentrations of insulin induce a decreased biological response in insulin-sensitive tissues 
(Kahn, 1978), is commonly observed during late gestation and early lactation, especially in 
over-conditioned cows, and seems to be related to these dysfunctions (Hayirli, 2006). Even 
though IR is a multi-factorial phenomenon, hyperlipidemia appears to play an important role in 
the development of IR, as elevated NEFA levels may compromise insulin-stimulated glucose 
clearance and disturb intracellular insulin-signaling pathways in liver and peripheral tissues 
(Hayirli, 2006; Pires et al., 2007). 
Furthermore, over-conditioned cows having greater BCS losses, are more prone to oxidative 
stress due to an overproduction of reactive oxygen metabolites and concurrently low levels of 
neutralizing antioxidants (Bernabucci et al., 2005). The possible damage of lipids and other 
macromolecules resulting from this imbalance can lead to alterations of the plasma membrane 
and other cellular compartments (Toyokuni, 1999). As a consequence, vital physiological and 
metabolic functions in the body may be impaired (Bernabucci et al., 2005) and higher 
incidences of various pathologies are likely (Gröhn et al., 1989). 
Yet, the association between some production and health variables, such as milk yield or 
certain diseases, and BCS is non-linear (Roche et al., 2009). Accordingly, a relatively low 
calving BCS (<3.0) may also have detrimental effects especially regarding fertility, e.g., delays 
in the resumption of estrus cycles, reduced pregnancy odds and a higher risk for uterine 
infections and retained placenta (Hoedemaker et al., 2009; Roche et al., 2009; Roche et al., 
2013), partly due to a lower quality of oocytes (Snijders et al., 2000) and general 
immunosuppression (LeBlanc, 2008), respectively. An optimum calving BCS is therefore 
recommended to be around 3.0 to 3.25 (Roche et al., 2009). 
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1.2 Dietary supplementation with conjugated linoleic acids 
An optimal supply in nutrients is essential for high-yielding dairy cows ensuring high milk 
yields and concomitantly good animal health. Research from the last decades has shown that 
an adequate and optimized diet (according to the respective performance level) during late 
gestation and early lactation can alleviate the risks for the occurrence of production diseases 
shortly after calving (Overton and Waldron, 2004; Ingvartsen, 2006). Using feed additives can 
support the metabolic adaptations of the bovine organism to the changing nutrient demands 
during this period. Among the different nutritional supplements, the dietary use of fatty acids, 
such as conjugated linoleic acids (CLA), may be one possibility to improve animal health in 
transition cows (Esposito et al., 2014). The CLA are octadecadienoic acids (C18), which exist 
as different isomers. Most studies have focused on the cis-9, trans-11 and the trans-10, cis-12 
isomers. Feeding these isomers in a rumen-protected form mainly decreases milk fat secretion 
in dairy cows (Baumgard et al., 2000; Bernal-Santos et al., 2003; Castañeda-Gutiérrez et al., 
2007). As the synthesis of milk fat requires over one-half of the energy needed for total milk 
production (Bauman et al., 2011), a reduction of milk fat synthesis can lower the caloric demand 
of milk production (De Veth et al., 2004) and thus, may alleviate metabolic stress. Yet, other 
reported effects of CLA which may possibly improve animal health and performance such as 
decreased NEFA and BHB, increased DMI or improved energy balance have not been 
consistently observed (Baumgard et al., 2001; Bernal-Santos et al., 2003; Pappritz et al., 2011; 
Esposito et al., 2013; 2014). 
 
1.3 Branched-chain amino acid (BCAA) metabolism 
Leucine, isoleucine and valine are collectively known as the branched-chain AA (BCAA) 
based on the structural similarity of their side chains (Figure 1). As they can only be synthesized 
by bacteria, plants and fungi, the BCAA are considered EAA for mammals. Almost always, the 
relative molar abundance is 2.2:1.0:1.6 leucine:isoleucine:valine, reflecting the linked nature of 
their synthesis and degradation (Neinast et al., 2019). Both isoleucine and valine are synthesized 
by the same enzymes, whereas leucine derives from α-ketoisovaleric acid, the transamination 
precursor of valine (Figure 2). The carbon chain of valine (and leucine) thereby originates from 
the readily available pyruvate, and isoleucine carbons derive from threonine, a relatively rare 
AA.  
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Figure 1. Chemical structure of the three branched-chain amino acids (adapted from ChemgaPedia; 
http://www.chemgapedia.de/). 
 
 
 
Figure 2. The synthesis of the branched-chain amino acids (BCAA) occurs in plants, bacteria and 
fungi. Abbreviations: AHAS, acetohydroxyacid synthase; α-KIC, α-ketoisocaproic acid; α-KIV, α-
ketoisovaleric acid; α-KMV, α-ketomethylvaleric acid; BCAT, branched-chain aminotransferase; 
DHAD, dihydroxyacid dehydratase; IPMDH, isopropylmalate dehydrogenase; IPMI, isopropylmalate 
isomerase; IPMS, isopropylmalate synthase; KARI, ketol-acid reductoisomerase. Modified from 
Neinast et al. (2019). 
 
 
Leucine Isoleucine Valine
BCAA synthesis
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The BCAA comprise around 35% of the EAA in muscle proteins (Harper et al., 1984) and 
50% of the EAA in milk proteins (Mackle et al., 1999). Apart from being building blocks for 
proteins, BCAA are also important precursors for the synthesis of non-essential AA (NEAA), 
such as glutamine and alanine, as well as substrates for energy and other metabolic 
intermediates. 
Additionally, in recent years, BCAA have emerged as signaling molecules, which may 
modulate the growth and metabolism of an organism. In particular leucine has been shown to 
independently regulate protein synthesis both in vitro and in vivo, e.g., in mammalian skeletal 
muscle (Lynch et al., 2002a; Suryawan et al., 2012), AT (Lynch et al., 2002a), liver (Lynch et 
al., 2002a; Wilson et al., 2011) and MG (Toerien et al., 2010; Appuhamy et al., 2012) via 
activation of the mechanistic target of rapamycin complex 1 (mTORC1) pathway. The 
mTORC1 is an evolutionary conserved ubiquitous serine/threonine-specific protein kinase 
complex, which can also be activated by growth factors like insulin and insulin-like growth 
factor 1 as well as intracellular energy (Laplante and Sabatini, 2009). Under sufficient AA 
availability, mTORC1 stimulates both the initiation and elongation of mRNA translation, and, 
thus, positively controls protein synthesis (Wang and Proud, 2006). Further, mTORC1 also 
increases the general cellular capacity for translation by enhancing ribosomal biogenesis and, 
consequently, ribosome numbers (Dodd and Tee, 2012).  
Upon high AA levels, mTORC1, usually located in the cytoplasm, is translocated to the 
lysosomes through a group of small guanosine triphosphatases (GTPases) called Ras-related 
GTPases or “Rags” (RagA/B, RagC/D; Efeyan et al., 2012). By changing their confirmation to 
an active state, the Rags, which are located at the lysosomal surface, are able to bind mTORC1 
(Sancak et al., 2008; Efeyan et al., 2012). Activation of mTORC1 may then occur by leucine 
directly binding to sestrin2 (Saxton et al., 2016), a negative regulator of mTORC1 activity 
(Wolfson et al., 2016). Subsequently, sestrin2 releases a GTPase-activating protein named GAP 
activity towards Rags 2 (GATOR2), which positively regulates mTORC1 activity 
(Chantranupong et al., 2014; Wolfson et al., 2016). Once activated, mTORC1 phosphorylates 
several downstream targets, including the eukaryotic initiation factor 4E binding protein-1 and 
the ribosomal protein S6 kinase-1 (S6K1), which themselves regulate translation and ribosomal 
biogenesis in a more direct manner (Richter and Sonenberg, 2005; Wang and Proud, 2006). 
However, during conditions of restricted energy and nutrient (AA) supply, cells may rapidly 
reduce mTORC1 signaling in order to save substrates (Dodd and Tee, 2012).  
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Figure 3. Activation of the mechanistic target of rapamycin complex 1 (mTORC1) via leucine (Leu). 
Small Ras-related GTPases (RagA/B, RagC/D) tether mTORC1 to the lysosomal membrane. By binding 
to sestrin2, Leu revokes the bond between sestrin2 and the GAP activity towards Rags 2 (GATOR2) 
protein, enabling stimulation of mTORC1 activity via GATOR2. Simplified illustration according to 
Saxton et al. (2016) and Wolfson et al. (2016). 
 
Further studies showing that BCAA might also affect the release of certain hormones, like 
insulin (Lynch et al., 2002b), leptin (Roh et al., 2003; Lynch et al., 2006) and glucagon-like 
peptide-1 (Chen and Reimer, 2009), support the idea of BCAA as nutrient signals regulating 
metabolism. Thus, BCAA have become of particular interest in the context of many metabolic 
dysfunctions such as obesity, IR and type 2 diabetes mellitus (T2DM) in humans (Lynch and 
Adams, 2014). Albeit, during such metabolic states, BCAA metabolism seems to be profoundly 
altered, likely due to a dysfunction of BCAA degrading enzymes in certain tissues (see chapter 
1.4.2).  
 
1.3.1 BCAA transporters 
Cellular protein synthesis and other metabolic processes are highly dependent on the 
continuous supply of all AA at the appropriate sites (D’Mello, 2003). As AA cannot readily 
pass lipid membranes, membrane-spanning transporter proteins are necessary to move AA in 
and out of a cell as well as between intracellular membranous compartments (Taylor, 2014). 
Intracellular AA homeostasis is thereby largely maintained through the external AA supply 
(Dodd and Tee, 2012). In most cases, AA uptake is coupled with the counter transport of certain 
ions, such as sodium, in an energy-dependent manner, making use of the electrochemical 
gradient the sodium-potassium adenosine triphosphatase (Na+/K+-ATPase) maintains across 
mTORC1
Sestrin2
Leu
GATOR2
RagA/B
RagC/D
+
-
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the plasma membrane; in other cases, one AA is transported in exchange for another (Souba 
and Pacitti, 1992). 
Depending on their substrate specificity, transport mechanism and regulatory characteristics, 
AA transporters can be classified into different “systems” (Hyde et al., 2003). In case of BCAA, 
which are considered neutral AA, the preferred system is the sodium-independent L-type 
system with the large neutral amino acid transporter small subunit 1 (LAT1; Baumrucker, 1985; 
Hyde et al., 2003; Batistel et al., 2017) as the most relevant transport protein for BCAA uptake. 
The LAT1, ubiquitously expressed (Hundal and Taylor, 2009) and encoded by the solute carrier 
family 7 member 5 (SLC7A5) gene, can directly import BCAA from extracellular space in 
exchange for glutamine. However, other neutral AA transporters may also shuttle BCAA across 
the membrane or are indirectly involved in their transport, such as the A-type sodium-dependent 
neutral amino acid transporter 2 (SNAT2, encoded by SLC38A2) and the ASC-type sodium-
coupled neutral amino acid transporter type 2 (ASCT2, encoded by SLC1A5). Both SNAT2 and 
ASCT2 are ubiquitously expressed as well (Fuchs and Bode, 2005; Hundal and Taylor, 2009), 
yet, they usually bind smaller AA like glutamine, facilitating the intracellular accumulation of 
this AA as efflux substrate to regulate LAT1-mediated BCAA transport (Kanai et al., 1998; 
Mastroberardino et al., 1998). Hence, the integration of primary active transport (export of 
sodium via the Na+/K+-ATPase) as well as secondary (sodium-dependent import of glutamine 
via SNAT2 and ASCT2) and tertiary active transport (import of BCAA in exchange for 
glutamine via LAT1) jointly modulates intracellular free AA pools (Figure 4). 
While LAT1, SNAT2 and ASCT2 are all involved in the cellular import of BCAA, it seems 
that other transporters are responsible for the BCAA efflux back into the bloodstream. Although 
this area has not been studied in detail yet, there is evidence that in humans and mice, the system 
L transporter LAT3 (SLC43A1) exports BCAA mostly via facilitated diffusion, e.g., from liver, 
skeletal muscle and pancreas (Babu et al., 2003; Fukuhara et al., 2007; Bodoy et al., 2013).  
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Figure 4. Mechanism of branched-chain amino acid (BCAA) uptake by the A-type sodium-
dependent neutral amino acid transporter 2 (SNAT2), ASC-type sodium-coupled neutral amino acid 
transporter type 2 (ASCT2) and large neutral amino acid transporter small subunit 1 (LAT1). The 
sodium-potassium adenosine triphosphatase (Na+/K+-ATPase) exports intracellular sodium (primary 
active transport; 1), which is required by the SNAT2 and ASCT2 transporters, co-transporting 
extracellular sodium and glutamine (Gln) into the intracellular space (secondary active transport; 2). Via 
LAT1, BCAA are then imported in exchange for intracellular Gln (tertiary active transport; 3). Self-
designed illustration. 
 
During the transport process, transporters generally undergo various conformational 
changes, which could be used to relay signals about nutrient abundance to the inner cell (Bröer 
and Bröer, 2017). It has therefore been proposed that some AA transporters in mammalian cells 
may regulate nutrient signaling not only indirectly through their capacity to control the free 
intracellular AA pool but also directly through their ability to sense extracellular AA 
availability upstream of intracellular signaling pathways such as mTORC1 (Hyde et al., 2007; 
Hundal and Taylor, 2009; Pinilla et al., 2011; Taylor, 2014). This dual transporter-receptor or 
“transceptor” function (Thevelein and Voordeckers, 2009) thus enables cells to respond 
adequately and instantaneously to nutrient changes, which may be caused by different 
metabolic events. Especially for SNAT2 a direct (and indirect) nutrient signaling action has 
been observed (Hyde et al., 2007), whereas ASCT2 and LAT1 are thought to serve as conduits 
activating mTORC1 indirectly through the delivery of their substrates (Nicklin et al., 2009; 
Sinclair et al., 2013). The exact mechanism of how SNAT2 is able to transmit cellular signals 
is still uncertain, yet seems to involve increased transcription (Palii et al., 2004), elevated 
protein translation (Gaccioliy et al., 2006), increased mRNA stability as well as decreased 
protein degradation (Jeon et al., 2015). 
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1.3.2 BCAA degrading enzymes 
Once an AA has entered the cell, it may either be used for protein synthesis or, if the supply 
exceeds the requirements, be rapidly catabolized. A unique feature of BCAA catabolism is its 
tissue specificity: Whereas most EAA are primarily degraded in the liver, BCAA catabolism 
involves the cooperation of several tissues, leading to substantial inter-organ shuttling of BCAA 
and their metabolites (Harper et al., 1984; Shimomura et al., 2006). Another characteristic is 
that the first two enzymes, the branched-chain aminotransferase (BCAT; EC 2.6.1.42) and the 
branched-chain α-keto acid dehydrogenase (BCKDH; EC 1.2.4.4) are common to all three 
BCAA (Figure 5).  
The two BCAT isoforms identified in mammals, a cytosolic BCAT (BCAT1; Hall et al., 
1993) and a mitochondrial BCAT (BCAT2; Hutson et al., 1992), both initiate degradation via 
reversible transfer of the α-amino group from the BCAA to α-ketoglutarate, resulting in the 
corresponding branched-chain α-keto acids (BCKA; α-ketoisocaproic acid, α-ketoisovaleric 
acid and α-ketomethylvaleric acid) as well as glutamate (Harris et al., 2005). In humans, 
expression of BCAT1 is mostly limited to the brain, whereas BCAT2 is ubiquitously expressed, 
but with diverging content and activity depending on the tissue. Accordingly, high levels are 
reported for pancreas, heart and kidney, intermediate levels for skeletal muscle, and low levels 
for liver (Suryawan et al., 1998). However, species-related differences may exist: Sheep muscle 
for instance expresses both BCAT isoforms and significant activity seems to originate from the 
cytosolic isoform (Faure et al., 2001). Following BCAA deamination, the resulting glutamate 
may act either as an amino group donor synthesizing alanine from pyruvate or as a substrate for 
ammonia detoxification to form glutamine (Holeček, 2018). As BCKA are potentially toxic 
(Harper et al., 1984; Harris et al., 2005), they may either be reaminated to BCAA (and e.g., 
used for protein synthesis) or further degraded.  
The second catabolic step, an irreversible oxidative decarboxylation of the BCKA to 
branched-chain acyl-coenzyme A (CoA) derivatives (i.e., isovaleryl-CoA, α-methylbutyryl-
CoA, and isobutyryl-CoA) by the BCKDH commits the BCAA to the degrading pathway 
(Figure 5). The BCKDH, a large multi-enzyme-complex, is located on the inner mitochondrial 
membrane (Harper et al., 1984). It has some structural and functional similarities to the pyruvate 
dehydrogenase (PDH) complex (Patel et al., 2014), an enzyme that precedes the tricarboxylic 
acid (TCA) cycle. Like PDH, BCKDH catalyzes the oxidative decarboxylation through the 
release of CO2 and by covalently adding a CoA group to the oxidized BCKA product (Johnson 
et al., 1972).  
12 Introduction 
 
 
 
Figure 5. The degradation of branched-chain amino acids (BCAA) occurs in plants, bacteria, fungi 
and animals. The first two steps, a reversible transamination via the branched-chain aminotransferase 
(BCAT) and an irreversible oxidative decarboxylation via the branched-chain α-keto acid 
dehydrogenase (BCKDH), are common to all three BCAA. The BCKDH complex is composed of the 
different subunits E1, E2 and E3. The BCKDH kinase (BCKDK) inhibits BCKDH via phosphorylation 
of E1, whereas the BCKDH phosphatase (also known as protein phosphatase 2Cm; PP2Cm) activates it 
via dephosphorylation of E1. Further abbreviations: ACAD8, acyl-CoA dehydrogenase family member 
8; ACADSB, short/branched-chain acyl-CoA dehydrogenase; ACAT1, acetyl-CoA acetyltransferase 1; 
α-KIC, α-ketoisocaproic acid; α-KIV, α-ketoisovaleric acid; α-KMV, α-ketomethylvaleric acid; 
ALDH6A1, aldehyde dehydrogenase 6 family member A1; AUH, AU RNA-binding methylglutaconyl-
CoA hydratase; BAIBA, ß-amino-isobutyric acid; BCFA, branched-chain fatty acid(s); CoA, coenzyme 
A; HADHA, hydroxyacyl-CoA dehydrogenase subunit α; HIBADH, 3-hydroxyisobutyrate 
dehydrogenase; HIBCH, 3-hydroxyisobutyryl-CoA hydrolase; HMGCL, 3-hydroxymethyl-3-
methylglutaryl-CoA lyase; HSD17B10, hydroxysteroid 17-ß dehydrogenase 10; IVD, isovaleryl-CoA 
dehydrogenase; MCCC, methylcrotonoyl-CoA carboxylase; MUT, methylmalonyl-CoA mutase; 
OCFA, odd-chain fatty acid(s); OXCT1, 3-oxoacid CoA transferase; P, phosphorylation; PCCB, 
propionyl-CoA carboxylase subunit ß; TCA, tricarboxylic acid cycle. Modified from Neinast et al. 
(2019). 
 
 
 
BCAA degradation
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Further, BCKDH also consists of multiple copies of three enzymes (Pettit et al., 1978; Paxton 
and Harris, 1982): A thiamine-dependent decarboxylase (E1) with α and ß subunits (encoded 
by the BCKDHA and BCKDHB genes, respectively) catalyzing the actual decarboxylation of 
the BCKA (Tsuruta et al., 1998); a lipoate-dependent dihydrolipoamide branched-chain 
transacylase (DBT; E2), that transfers the acyl groups from the BCKA to CoA; and a flavin 
adenine dinucleotide (FAD)-dependent dihydrolipoyl dehydrogenase (DLD; E3), that transfers 
the released electrons to the oxidized form of nicotinamide adenine dinucleotide (NAD+) 
generating energized reduced NADH. The E1 and E2 are specific to the BCKDH, whereas E3 
is also part of other α-keto acid dehydrogenases like PDH (Tsuruta et al., 1998).  
Similar to BCAT(2), BCKDH is distributed ubiquitously throughout the human body with 
high activity in kidney, brain and liver and relatively low activity in muscle and AT (Suryawan 
et al., 1998). The oxidative decarboxylation is the rate-limiting step in overall BCAA 
catabolism, therefore activity of BCKDH is tightly regulated through phosphorylation 
(inactivation) and dephosphorylation (activation) of the E1α subunit by a specific kinase 
(branched-chain α-keto acid dehydrogenase kinase; EC 2.7.11.4) and phosphatase (branched-
chain α-keto acid dehydrogenase phosphatase, also known as protein phosphatase 2Cm; EC 
3.1.3.16), respectively (Shimomura et al., 1990; Lu et al., 2009).  
After decarboxylation, the catabolic pathways for each of the BCAA diverge and resemble 
the oxidation of fatty acids, ultimately leading to ketogenic or glucogenic precursors (i.e., 
acetoacetate and acetyl-CoA for leucine, succinyl-CoA and acetyl-CoA for isoleucine, and 
succinyl-CoA for valine), some of which can enter the TCA cycle (Harper et al., 1984). Through 
these linkages in the TCA cycle BCAA catabolism and fatty acid metabolism are closely 
connected. It is assumed that e.g. in AT, where BCAA and their metabolites can also be 
catabolized (Herman et al., 2010), BCAA may have regulatory functions on glyceroneogenesis 
as well as fatty acid oxidation (Kainulainen et al., 2013). Increased BCAA degradation may 
thus replenish intermediates of other metabolic pathways (Shimomura et al., 2004; Green et al., 
2016), a process also known as anaplerosis. 
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1.4 BCAA metabolism during different physiological and pathophysiological states 
1.4.1 BCAA metabolism during lactation 
Free AA in the blood are the most essential precursors of milk proteins (Mepham, 1982). 
Different adaptive mechanisms throughout the body, e.g., a decrease in AA use by 
extramammary tissues, an enhanced blood flow to and an elevated rate of AA extraction by the 
MG, thereby increase AA availability to the MG (Tesseraud et al., 1993; Tovar et al., 2001). 
The net mammary uptake of AA typically represents output as milk protein as well as cell 
growth and catabolism (Cant et al., 2018), with milk protein yield amounting to approximately 
90% of uptake (Cant et al., 1993).  
Due to the high demand of AA for milk protein synthesis, the capacity of the MG for AA 
transport is greatly increased in lactating versus non-lactating mammals, as shown by the 
augmented expression and activity of AA transporters (Manjarin et al., 2014) and the elevated 
maximum reaction rate (Vmax) of transporters, which in turn is dependent on the number and 
activity of functional transporters on the cell membrane (Verma and Kansal, 1993). Some AA 
transport systems like system A and L also appear to be upregulated by hormones important for 
the establishment and maintenance of lactation, such as estradiol, prolactin and insulin (Sharma 
and Kansal, 1999; López et al., 2006).  
Circulating BCAA, originating from a complex mixture of degraded dietary, microbial and 
endogenous protein, represent about 30% of total AA taken up by the bovine MG (Cant et al., 
1993; Metcalf et al., 1996). Because mammary uptake of BCAA greatly exceeds their output 
in milk protein (Mepham, 1982; Bequette et al., 1996; Bequette and Douglass, 2010), any 
surplus is mostly directed towards the synthesis of NEAA (Mepham, 1982). Non-essential AA, 
like alanine and glutamine, are usually not extracted at levels required for milk protein synthesis 
(Manjarin et al., 2014), thus, BCAA serve as an essential source. Moreover, alanine and 
glutamine significantly contribute to gluconeogenesis (Holeček, 2002), one of the most 
important metabolic pathways generating energy and lactose in (lactating) ruminants (LeBlanc, 
2010; De Koster and Opsomer, 2013). Alternatively, the BCAA themselves may also be (fully) 
oxidized to provide energy or might be incorporated into lipids (Vina and Williamson, 1981), 
further ensuring preservation of milk production. 
During lactation, whole-body BCAA metabolism is increased, especially in the MG 
(Tesseraud et al., 1993; DeSantiago et al., 1998a), where BCAT activity rises by a factor of 10 
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and BCKDH is in a fully activated state (DeSantiago et al., 1998a). In rats, a strong positive 
correlation between total mammary BCAT activity and level of milk production has been 
observed (Tovar et al., 2001), indicating a possible metabolic connection, which could be 
founded by the fact that BCKA may also be readily reaminated to BCAA via BCAT and hence 
any conserved nitrogen might sustain the high rate of milk protein synthesis for lactation 
(DeSantiago et al., 2001). Due to the changes in BCAA partitioning related to lactation, the 
capacity for BCAA transamination and BCKA oxidation in the MG may be much higher than 
in other tissues, e.g., skeletal muscle and liver (DeSantiago et al., 1998b; Bequette et al., 2002), 
likely favoring BCAA metabolism by the MG. According to Lei et al. (2013), it may be 
assumed that an increased activity of BCAA catabolic enzymes in bovine mammary epithelial 
cells could in part be caused by lactation-related decreases in insulin and growth hormone 
and/or elevated cortisol and glucagon levels. 
Different studies in mice, pigs and cows have shown that milk protein synthesis can be 
regulated by BCAA to some extent (Richert et al., 1997; Moshel et al., 2006; Rulquin and 
Pisulewski, 2006; Appuhamy et al., 2012; Doelman et al., 2015). By acting both as building 
blocks and as anabolic factors via mTORC1, BCAA, and particularly leucine, may increase 
protein translation (see chapter 1.3). However, despite growing evidence in this context, 
literature is still inconsistent and further studies are therefore warranted. 
During late pregnancy and early lactation, bovine AT exhibits a distinct metabolic activity 
(McNamara, 1991). Besides providing lipids for energy and milk fat synthesis, AT is known to 
be an endocrine gland regulating, for example, glucose and lipid homeostasis through adipokine 
secretion. Yet, its role in BCAA metabolism is largely unknown in dairy cows. 
 
1.4.2 BCAA metabolism during metabolic disorders 
Excess lipids have long been considered as one of the main causes for IR (Morino et al., 
2006; Muoio and Newgard, 2008). Recently however, numerous reports in monogastrics have 
found a strong connection between BCAA and metabolic disorders: Plasma concentrations of 
BCAA (and their metabolites) are consistently elevated in different models of obesity, IR, fatty 
liver and T2DM when compared to healthy subjects (She et al., 2007; Newgard et al., 2009; 
Nakamura et al., 2014; Lake et al., 2015; Polakof et al., 2018; David et al., 2019). As they seem 
to manifest already before disease onset, increased BCAA levels, at least in humans, are also 
considered as independent predictors of future IR (or T2DM) development (Wang et al., 2011; 
16 Introduction 
 
McCormack et al., 2013). Albeit, the exact role of increased BCAA, meaning whether they are 
a causative or a resulting factor of such metabolic dysfunctions, as well as the underlying 
mechanisms are still under debate.  
Generally, plasma BCAA levels arise from the difference between their rates of appearance 
and disappearance in the circulation, which in turn are affected by dietary intake and tissue 
proteolysis and by BCAA degradation and protein synthesis, respectively (She et al., 2013). It 
is suggested that alterations in BCAA tissue metabolism (i.e., reduced cellular utilization and/or 
incomplete degradation), especially in the AT, may not only promote elevated circulating 
BCAA levels (Herman et al., 2010) but may also contribute to the above mentioned 
dysfunctions (She et al., 2007; Polakof et al., 2018). In this context, different studies in humans, 
pigs and rodents have demonstrated a reduced abundance and activity of the BCAA catabolic 
enzymes in AT under obese and diabetic conditions (She et al., 2007; Pietiläinen et al., 2008; 
Lackey et al., 2013; Polakof et al., 2018); in some cases this was also associated with an 
upregulation of AT genes involved in inflammation (Klimcáková et al., 2011; Serralde-Zúniga 
et al., 2014). Consequently, the accumulation of BCAA and, more importantly, potentially toxic 
intermediates, such as BCKA, in blood and tissues (She et al., 2013) could trigger oxidative 
stress and mitochondrial dysfunction in pancreatic ß cells or elsewhere (Barschak et al., 2006; 
Lynch and Adams, 2014; Olson et al., 2014; Giesbertz and Daniel, 2016), thus leading to 
compromised cellular functions and ultimately, cell death. All of these processes, interfering 
with insulin signaling, are usually also involved during the manifestation of IR (Lynch and 
Adams, 2014). It should be noted however, that IR itself, once it is established, might also 
further increase BCAA levels, building some form of feed-forward loop (Mahendran et al., 
2017; Wang et al., 2017). 
Despite the possible role of AT in impaired BCAA catabolism, considering that systemic 
BCAA metabolism is substantially interorgan-dependent (Harper et al., 1984), other tissues 
might contribute to these perturbations as well. Accordingly, depending on the origin and 
severity of the metabolic disorder, alterations in BCAA metabolism in skeletal muscle (Lerin 
et al., 2016; David et al., 2019) and/or liver (Shin et al., 2014) might also be likely. Especially 
in the case of fatty liver diseases, an accumulation of BCAA, or rather their keto acids, may 
lead to mitochondrial overload and disruption of the BCAA degrading pathway in the liver, 
comprising further metabolic processes (Lake et al., 2015). 
Apart from BCAA dysmetabolism, the involvement of nutrient signaling in IR has emerged 
as another possibility of how elevated BCAA levels are linked to impaired insulin action. 
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According to this theory, excessive nutrient intake associated with obesity also results in 
increased levels of insulin and BCAA, or more specifically leucine, which would both activate 
mTORC1 and downstream factors, such as S6K1 (Um et al., 2004; 2006; Tremblay et al., 2007). 
Chronic mTORC1/S6K1 activation may lead to an uncoupling of the insulin receptor from 
insulin receptor substrate-1, an important mediator of insulin signaling (Newgard et al., 2009; 
Lynch and Adams, 2014). Impaired insulin action would however drastically raise the demand 
for insulin. In relation to this, BCAA (particularly leucine) have also been reported to have a 
stimulatory effect on insulin secretion, e.g., in humans and rats (Lynch et al., 2002b; Newgard 
et al., 2009; Newsholme et al., 2014). A constant secretory pressure on the ß cells through an 
increased insulin demand potentiated by elevated BCAA levels may eventually lead to ß cell 
dysfunction and give rise to IR and other metabolic disorders (Newgard, 2012; Lynch and 
Adams, 2014). However, for cows this might not be the case, as a (single-dose) duodenal 
infusion of leucine did not induce an apparent insulin response (Sadri et al., 2017).  
Even though the aforementioned studies in humans, pigs and rodents point out several 
possibilities of how BCAA may be connected to metabolic dysfunctions, as of yet there are no 
such data available in dairy cattle. And despite the fact that transition cows are often challenged 
with metabolic disorders showing a similar symptomology to IR or T2DM, due to the onset of 
lactation and all metabolic changes associated therewith, the situation might be partially 
different for them as compared to above mentioned species. 
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2 Objectives 
The BCAA fulfill numerous metabolic functions throughout the body. Both their cellular 
transport and catabolism are tightly regulated and involve the complex interaction of several 
metabolic tissues. However, studies on the relevant BCAA transporters or the degrading key 
enzymes in different metabolic tissues of (lactating) ruminants are sparse. In high-yielding dairy 
cows, various tissue-specific metabolic processes, e.g., in AT, support the metabolic adaptation 
to the high demands for energy and nutrients in lactation. Yet, the contribution of AT to 
systemic protein and AA metabolism, especially during different physiological and 
pathophysiological states, has hardly been addressed in dairy cows so far.  
With regards to these factors, the objectives of this thesis were: 
 
(1) To characterize the potential enzymatic capacity of AT, alongside liver, muscle and 
MG, in BCAA metabolism in dairy cows during (late gestation and) early lactation,  
 
(2) To analyze the concentrations of BCAA in the circulation as well as the abundance (and 
activity) of the BCAA transporters and catabolic enzymes in major metabolic tissues of 
dairy cows during late gestation and early lactation, 
 
(3) To investigate the effect of over-conditioning at calving on the aforementioned variables 
of systemic and tissue BCAA metabolism in dairy cows during late gestation and early 
lactation. 
 
It was hypothesized that early lactation is associated with tissue-specific changes in the 
BCAA transporters and catabolic key enzymes due to particular metabolic adaptations and that 
BCAA metabolism in AT contributes significantly to the degrading pathway. It was further 
assumed that over-conditioned cows, having a higher tissue mobilization than cows with normal 
body condition, would exhibit particular alterations in their systemic and tissue-specific BCAA 
metabolism. 
 
Manuscript I 19 
 
3 Manuscript I (published in Journal of Dairy Science) 
J. Dairy Sci. 102: 3556-3568 
https://doi.org/10.3168/jds.2018-14463 
© American Dairy Science Association®, 2019. 
 
Changes in tissue abundance and activity of enzymes related to branched-chain 
amino acid catabolism in dairy cows during early lactation 
 
L. A. Webb,1 H. Sadri,2*† D. von Soosten,3 S. Dänicke,3 S. Egert,4 P. Stehle,4 and H. Sauerwein1 
 
1Institute of Animal Science, Physiology and Hygiene Unit, University of Bonn, 53115 Bonn, Germany 
2Department of Clinical Science, Faculty of Veterinary Medicine, University of Tabriz, 516616471 
Tabriz, Iran 
3Institute of Animal Nutrition, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, 
38116 Brunswick, Germany 
4Department of Nutrition and Food Sciences, Nutritional Physiology, University of Bonn, 53115 Bonn, 
Germany 
 
ABSTRACT 
Branched-chain α-keto acid 
dehydrogenase (BCKDH) complex 
catalyzes the irreversible oxidative 
decarboxylation of branched-chain α-keto 
acids. This reaction is considered as the 
rate-limiting step in the overall branched-
chain amino acid (BCAA) catabolic 
pathway in mammals. For characterizing 
the potential enzymatic involvement of 
liver, skeletal muscle, adipose tissue (AT), 
and mammary gland (MG) in BCAA 
metabolism during early lactation, tissue 
and blood samples were examined on d 1, 
42, and 105 after parturition from 25 
primiparous Holstein cows. Serum BCAA 
profiles were analyzed and the mRNA and 
protein abundance as well as the activity in 
the different tissues were assessed for the 
BCAA catabolic enzymes, partly for the 
branched-chain aminotransferase and 
completely for BCKDH. Total BCAA 
concentration in serum was lowest on d 1 
after parturition and increased thereafter to 
a steady level for the duration of the 
experiment. Pronounced differences 
between the tissues were observed at all 
molecular levels. The mRNA abundance of 
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the mitochondrial isoform of branched-
chain aminotransferase (BCATm) was 
greatest in AT as compared with the other 
tissues studied, indicating that AT might be 
an important contributor in the initiation of 
BCAA catabolism in dairy cows. From the 
different subunits of the BCKDH E1 
component, only the mRNA for the β 
polypeptide (BCKDHB), not for the α 
polypeptide (BCKDHA), was elevated in 
liver. The BCKDHA mRNA abundance was 
similar across all tissues except muscle, 
which tended to lower values. Highest 
BCKDHA protein abundance was observed 
in both liver and MG, whereas BCKDHB 
protein was detectable in these tissues but 
could not be quantified. Adipose tissue and 
muscle only displayed abundance of the α 
subunit, with muscle having the lowest 
BCKDHA protein of all tissues. We found 
similarities in protein abundance for both 
BCKDH E1 subunits in liver and MG; 
however, the corresponding overall 
BCKDH enzyme activity was 7-fold greater 
in liver compared with MG, allowing for 
hepatic oxidation of BCAA transamination 
products. Reduced BCKDH activity in MG 
associated with no measurable activity in 
AT and muscle may favor sparing of BCAA 
for the synthesis of the different milk 
components, including nonessential AA. 
Deviating from previously published data 
on BCAA net fluxes and isotopic tracer 
studies in ruminants, our observed results 
might in part be due to complex counter-
regulatory mechanisms during early 
lactation. 
Key words: branched-chain amino acid 
metabolism, branched-chain amino-
transferase, branched-chain α-keto acid 
dehydrogenase, tissue abundance/activity 
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INTRODUCTION 
The 3 branched-chain AA (BCAA), Ile, 
Leu, and Val, represent about 30% of total 
AA taken up by the bovine mammary gland 
(MG; Cant et al., 1993; Metcalf et al., 
1996). The BCAA fulfill numerous 
metabolic functions; that is, as precursors 
for NEAA, as substrates for (milk) protein, 
as energy substrates, and as anabolic 
nutritional signals, regulating protein 
synthesis via insulin-dependent and -
independent mechanisms (e.g., in muscle 
and mammary tissue; Bequette et al., 2002; 
Appuhamy et al., 2012). Homeostasis of 
BCAA is almost exclusively maintained at 
their catabolic steps.  
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A unique feature of BCAA catabolism in 
mammals is its tissue specificity; most EAA 
are degraded in the liver, whereas for 
BCAA the first catabolic step mainly occurs 
extrahepatically (Suryawan et al., 1998). 
However, subsequent catabolic steps seem 
to take place in liver again (Ananieva et al., 
2017), necessitating substantial shuttling of 
BCAA and their intermediates between the 
periphery and liver. In this regard, 
degradation of BCAA (transamination or 
oxidative decarboxylation of the 
transamination products) has been studied 
in different tissues of ruminants, including 
the digestive tract (Pell et al., 1986; MacRae 
et al., 1997), liver (Lapierre et al., 2002), 
muscle (Pell et al., 1986; Bequette et al., 
2002), and MG (Bequette et al., 1996a,b; 
Thivierge et al., 2002). However, 
previously published data on BCAA net 
fluxes and isotopic tracer studies in dairy 
cows have shown that, quantitatively, 
hepatic removal of BCAA (and their 
metabolites) is limited, as is their oxidation 
(Lapierre et al., 2002; Raggio et al., 2004; 
Larsen et al., 2015).  
Another specific feature of BCAA 
catabolism is that the first 2 enzymes, the 
branched-chain aminotransferase (BCAT; 
EC 2.6.1.42) and the branched-chain α-keto 
acid dehydrogenase (BCKDH; EC 1.2.4.4), 
are common to all 3 BCAA. Two isoforms 
of BCAT are identified in mammals, with 
the mitochondrial BCAT (BCATm) being 
more abundant than the cytosolic BCAT 
(BCATc; Sweatt et al., 2004). Degradation 
begins with deamination of BCAA, 
catalyzed by both BCAT isoforms, 
resulting in the respective branched-chain 
α-keto acids (BCKA; keto-isoleucine, keto-
leucine, keto-valine) and glutamate. The 
ensuing oxidative decarboxylation of the 
BCKA to branched-chain acyl-CoA 
derivatives occurs via the E1 component of 
the mitochondrial BCKDH complex. 
Unlike BCAT, BCKDH works irreversibly 
and is considered rate-limiting (Harper et 
al., 1984). After decarboxylation, the 
catabolic pathways for each of the BCAA 
diverge, ultimately leading to glucogenic or 
ketogenic precursors. 
During lactation, whole-body BCAA 
catabolism is enhanced and BCAA are used 
to partially cover the increased energetic 
and nutritional needs of the tissues, 
especially the MG (Li et al., 2009). Studies 
on the actual BCAA catabolism enzymes in 
ruminants are sparse. However, flux studies 
in ruminants have shown that the lactating 
MG itself catabolizes significant amounts 
of BCAA (Wohlt et al., 1977; Bequette et 
al., 1996a). Based on BW, the relative rates 
of BCAA deamination and BCKA 
oxidation by the MG are much higher than 
those of the hind leg muscle (Bequette et al., 
2002), likely favoring BCAA metabolism 
by the MG. 
22  Manuscript I 
 
Besides storing lipids, adipose tissue 
(AT) is known to be an endocrine gland 
regulating; for example, glucose and lipid 
homeostasis through adipokine secretion. 
Nevertheless, its role in systemic protein 
and AA metabolism has not been widely 
studied, particularly in ruminants. Herman 
et al. (2010) reported the potential capacity 
for AT to regulate circulating BCAA levels 
in vivo. Those authors demonstrated that 
transplantation of wild-type AT into mice 
globally defective in peripheral BCAA 
metabolism reduced their circulating 
BCAA levels by 30 and 50% in the fasted 
and fed states, respectively. Assessing 
BCAA metabolism in AT via flux studies, 
as done for MG, liver, and muscle, is hardly 
possible due to the multiple locations of AT 
and the heterogeneity of function in 
different depots. Hence, in the current 
study, we aimed to test the potential 
enzymatic capacity of AT (alongside liver, 
muscle, and MG) in BCAA metabolism in 
dairy cows during early lactation. We 
hypothesized that (1) early lactation is 
associated with tissue-specific changes in 
the key enzymes of BCAA metabolism due 
to particular metabolic adaptations and that 
(2) BCAA enzymes in AT contribute 
significantly to the degrading pathway. 
Studying the changes in abundance and 
activity of BCAA catabolic enzymes in 
different tissues of dairy cows during early 
lactation in more detail would allow for 
estimating their importance in the adaptive 
processes. 
 
MATERIALS AND METHODS 
Animals and Sample Collection 
Different tissues [i.e., liver, skeletal 
muscle, MG, subcutaneous (scAT) and 
visceral adipose tissue (vAT)] as well as 
blood samples were obtained from 25 
primiparous German Holstein cows (mean 
± SD age at first calving = 23 ± 0.2 mo) at 
3 different slaughter time points: d 1, 42, 
and 105 after parturition. The animals were 
part of a comprehensive study conducted at 
the Friedrich-Loeffler-Institut, Federal 
Research Institute for Animal Health 
(Brunswick, Germany), on the effect of 
dietary CLA on performance and changes 
in body composition, including body fat and 
protein, and on energy utilization during 
early lactation (von Soosten et al., 2011, 
2012). On the day after parturition, 5 
animals were euthanized, whereas the 
remaining 20 cows were assigned to either 
a control (100 g/d of stearic acid; Silafat, 
BASF SE, Ludwigshafen, Germany; n = 
10) or CLA-supplemented diet (100 g/d; 
1.7% trans-10,cis-12, 1.6% cis-9,trans-11 
CLA isomers; Lutrell Pure, BASF SE; n = 
10). Five cows per group were then 
slaughtered at d 42 and 105. The CLA 
supplementation did not significantly affect 
any of the herein examined variables; thus, 
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and to increase the statistical power, 
treatment groups at the respective slaughter 
time points were pooled as d 1 (n = 5), 42 
(n = 10), and 105 (n = 10).  
All protocols of the study were designed 
and performed in strict accordance with the 
European Union guidelines, established by 
the European Community Council 
Directives 86/609/EEC (European Council, 
1986), concerning the protection of 
experimental animals, with approval by the 
Lower Saxony State Office for Consumer 
Protection and Food Safety (LAVES), 
Oldenburg, Germany (File Number 
33.11.42502–04–071/07). Animals were 
kept in group pens in a freestall barn with 
free access to water. The partial mixed 
ration fed prepartum consisted of 60% corn 
silage and 40% grass silage (6.7 MJ of 
NEL/kg of DM) on a DM basis for ad 
libitum consumption and 2 kg of 
concentrate (6.7 MJ of NEL/kg of DM). 
Postpartum, cows received a partial mixed 
ration of 25% corn silage and 38% grass 
silage (7.5 MJ of NEL/kg of DM) and 37% 
concentrate (8.7 MJ of NEL/kg of DM) on 
a DM basis for ad libitum intake as well as 
an additional 3.5 kg of concentrate 
containing the respective rumen-protected 
CLA or control fat supplements. The 
additional 2 and 3.5 kg of concentrate were 
fed via a computerized concentrate feeding 
station (RIC; Insentec B.V., Marknesse, the 
Netherlands). All diets were formulated 
according to the recommendations of the 
German Society of Nutrition Physiology 
(GfE, 2001). A detailed description of the 
ingredients as well as the composition of the 
diets can be found in von Soosten et al. 
(2011). Postcalving, daily individual feed 
intake was recorded automatically (RIC; 
Insentec B.V) from wk 2 to 15 after the start 
of lactation. Cows were milked twice daily 
(Lemmer-Fullwood, Lohmar, Germany) 
with automatic recordings of milk yield. 
Milk samples were taken twice per week 
and stored at 4°C until analysis. 
Right before slaughter, blood samples 
were taken via jugular venipuncture. Serum 
was obtained after clotting and 
centrifugation (3,000 × g, 10 min, 4°C) and 
stored at −80°C until analysis. Samples of 
liver, skeletal muscle (semitendinosus 
muscle), MG (udder parenchyma), scAT 
(tail head), and vAT (omental fat) were 
collected after slaughter, rinsed with 0.9% 
NaCl, and immediately snap-frozen in 
liquid nitrogen and stored at −80°C for the 
respective extractions and analyses. 
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Milk and Blood Analyses 
Milk composition was assessed using an 
infrared milk analyzer (Milkoscan FT 6000 
combined with a Fossomatic 5000, Foss 
Electric, Hillerød, Denmark). Serum BCAA 
concentrations were measured via HPLC in 
an RF-10A XL fluorescence detector 
(Shimadzu, Kyoto, Japan) based on o-
phtaldialdehyde/3-mercaptopropionic acid 
derivatization as previously described 
(Fürst et al., 1990). Inter- and intra-assay 
variances were <5%. 
 
RNA Extraction and Quantitative Real-
Time Reverse Transcription-PCR 
Total RNA extraction and cDNA 
synthesis were conducted as described by 
Saremi et al. (2012a). Analysis by 
quantitative real-time reverse transcription 
PCR (qPCR) was carried out in accordance 
with the Minimum Information for 
Publication of Quantitative Real-Time PCR 
Experiments (MIQE) guidelines (Bustin et 
al., 2009) using the sample maximization 
method. Triplicates were run in a total 
volume of 10 μL, with 2 μL of cDNA 
(diluted 1:4) as template, 1 μL of assay-
specific primer mix, 2 μL of water, 5 μL of 
DyNAmo ColorFlash SYBR Green qPCR 
Kit (Thermo Fisher Scientific, Dreireich, 
Germany) for the target genes branched-
chain aminotransferase, mitochondrial 
(BCATm), branched-chain α-keto acid 
dehydrogenase E1, α polypeptide 
(BCKDHA), and branched-chain α-keto 
acid dehydrogenase E1, β polypeptide 
(BCKDHB), or 5 μL of SYBR Green 
JumpStart Taq Readymix (Sigma-Aldrich, 
Steinheim, Germany) for the reference 
genes; analysis was carried out in Mx3000P 
cycler systems (1 from Stratagene, 
Amsterdam, the Netherlands, and 1 from 
Agilent, Santa Clara, CA). Each run 
included a negative template control, a no-
reverse transcriptase control as well as 2 
inter-run calibrators prepared from plate-
specific pool samples. Quantification of the 
samples was performed against a cDNA 
standard curve with serial dilutions for the 
target genes and against a PCR product 
standard curve with serial dilutions for the 
reference genes. Target genes were 
normalized with the most stable reference 
genes, namely emerin (EMD), hippocalcin-
like 1 (HPCAL1), eukaryotic translation 
initiation factor 3 (EIF3K), RNA 
polymerase II (POLR2A), and lipoprotein 
receptor-related protein 10 (LRP10), which 
were previously selected from a set of 9 
genes according to Saremi et al. (2012b). 
Reference genes were evaluated based on 
their average expression stability (M) and 
pairwise variation (V) values (accepted M 
<1.5 and V <0.15) using the geNormPLUS 
algorithms of qBasePLUS 2.1 software 
(Biogazelle, Ghent, Belgium). Primer 
sequences as well as qPCR conditions were 
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the same for a given gene in all tissues and 
are provided in Table 1. 
 
Quantification of Target Proteins 
Tissue samples were homogenized in 
ice-cold Tris/HCl lysis buffer (pH 7.4) 
containing protease inhibitors [cOmplete, 
Mini Protease Inhibitor Cocktail, 1 tablet 
per 10 mL; Roche Diagnostics, Mannheim, 
Germany; Pefabloc SC, also known as 4-(2-
aminoethyl)benzenesulfonyl fluoride 
hydrochloride, 1 mM, Sigma Aldrich, St. 
Louis, MO] for inhibiting serine, cysteine, 
and metalloproteases in a tissue-to-buffer 
ratio of 1:8 (liver), 1:4 (muscle and MG), or 
1:2 (AT) using the Precellys 24 system 
(VWR/Peqlab Biotechnologie, Erlangen, 
Germany). Total protein concentration was 
measured via Bradford assay (Roti 
Nanoquant K880, Carl Roth, Karlsruhe, 
Germany). 
Protein quantification was performed by 
Simple Western size-based protein assay 
(WES, Protein Simple, San Jose, CA), an 
automated capillary-based electrophoretic 
immunoassay, as per the manufacturer’s 
instructions (https://www.proteinsimple. 
com/technical_library.html). In brief, 
samples were first diluted with 0.1× sample 
buffer to adjust the protein concentration to 
a dilution within the linear range (between 
0.3125 and 0.9375 μg/μL depending on 
tissue type) and then diluted 4:1 by adding 
2.5 μ L of the 5× master mix. The final 
samples were heated for 5 min at 95°C, 
placed on ice for 5 min, briefly centrifuged 
twice (2,500 × g, 5 s, 20°C) with short 
vortex spins in between, and applied to the 
wells in duplicates. A control sample 
(bovine liver) was also loaded on every 
plate to correct for inter-run variations 
(accepted inter-assay CV <10%, intra-assay 
CV <8%). Primary antibodies against total 
BCKDHA (#ab138460; Abcam, 
Cambridge, UK) and total BCKDHB 
(#ab182255; Abcam) were diluted 1:50 and 
1:25, respectively. All other reagents 
(antibody diluent, secondary antibodies, 
streptavidin-HRP, luminol-S, hydrogen 
peroxide) loaded on the plate were obtained 
from ProteinSimple and used according to 
the recommendations. Simple Western 
analysis was performed with multi-image 
exposures and otherwise instrument default 
settings at room temperature (RT). 
Using Compass Software 
(ProteinSimple), the area under the curve, 
which represents the signal intensity of the 
chemiluminescent immunoreaction, and 
which directly correlates with the 
abundance of the target protein, was 
assessed for each sample and normalized to 
the control.  
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Table 1. Characteristics of primers and real-time polymerase chain reaction conditions 
Gene1 Sequences (5'-3') 
NCBI accession 
no. 
bp 
Concentration 
(nM) 
Mean 
Cq2 
Annealing3 
(s/°C) 
BCATm       
  Forward CATTTCCACATTCCCACCAT 
NM_001013593.2 130 400 30.86 30/61 
  Reverse AGCGTAGCCCAGAGCATTAC 
BCKDHA       
  Forward AGAACCAGCCCTTCCTCATT 
NM_174506.1 108 200 26.61 30/61 
  Reverse TGTCCCAGTAGTTGACCTCGT 
BCKDHB       
  Forward GGCCAAAGATCCTACGGCAGTAAT 
NM_174507.2 129 400 27.09 30/61 
  Reverse CCTTGTTCACACAGTGGGGT 
EMD       
  Forward GCCCTCAGCTTCACTCTCAGA 
NM_203361 100 400 25.99 45/59 
  Reverse GAGGCGTTCCCGATCCTT 
HPCAL1       
  Forward CCATCGACTTCAGGGAGTTC 
NM_001098964 99 400 28.57 30/60 
  Reverse CGTCGAGGTCATACATGCTG 
EIF3K       
  Forward CCAGGCCCACCAAGAAGAA 
NM_001034489 125 400 26.68 45/59 
  Reverse TTATACCTTCCAGGAGGTCCATGT 
POLR2A       
  Forward GAAGGGGGAGAGACAAACTG 
X63564 86 800 24.32 60/60 
  Reverse GGGAGGAAGAAGAAAAAGGG 
LRP10       
  Forward CCAGAGGATGAGGACGATGT 
BC149232 139 400 25.32 30/61 
  Reverse ATAGGGTTGCTGTCCCTGTG 
1BCATm = branched-chain aminotransferase, mitochondrial; BCKDHA = branched-chain α-keto acid 
dehydrogenase E1, α polypeptide; BCKDHB = branched-chain α-keto acid dehydrogenase E1, ß polypeptide; EMD 
= emerin; HPCAL1 = hippocalcin like 1; EIF3K = eukaryotic translation initiation factor 3 subunit K; POLR2A = 
RNA polymerase II; LRP10 = lipoprotein receptor-related protein 10. 
2Mean quantification cycle for all tissues combined. 
3Initial denaturation for 10 min at 95 °C; denaturation for 30 s at 95 °C; extension for 30 s at 72 °C, except for 
POLR2A (60 s at 72 °C). 
 
 
Enzyme Activity 
Enzyme activity of the BCKDH complex 
was determined spectrophotometrically in a 
Synergy H1 microplate reader (BioTek, 
Winooski, VT) according to Nakai et al. 
(2000). Approximately 100 mg of frozen 
tissue were homogenized (Precellys 24) in 
1,200 μL of ice-cold extraction buffer. After 
removing insoluble material by 
centrifugation (20,000 × g, 5 min, 4°C), the 
supernatant was incubated with 27% 
(wt/vol) polyethylene glycol for 20 min on 
ice. Following a second centrifugation step 
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(12,000 × g, 10 min, 4°C), the pellet was 
dissolved in a suspension buffer by 
pipetting up and down while keeping the 
sample on ice. Protein concentrations of the 
prepared homogenates were assessed with 
Bradford assay (Roti Nanoquant K880, Carl 
Roth) and the activity assay was performed 
directly afterward. For this, samples were 
diluted 1:10 with 2× assay buffer and sterile 
water to a volume of 1 mL. Before adding 
the homogenate, the buffer-water mixture 
was preheated to 30°C and 200 μL of the 
final assay-mixture was then loaded onto 
96-well polystyrene microplates. The 
absorbance at 340 nm and 30°C was 
recorded for 5 min to establish a baseline 
and the reaction was initiated with 20 μL of 
10 mM α-ketoisovalerate (final 
concentration 1 mM) as substrate 
prewarmed to 30°C. In contrast to Nakai et 
al. (2000), the assay buffer was prepared 
without exogenous dihydrolipoamide 
dehydrogenase, as validated by Wessels et 
al. (2016). A control sample (bovine liver) 
with comparable BCKDH activity was 
included on each plate for inter-run 
calibration (accepted inter-assay CV <15%, 
intra-assay CV <5%) and sample data were 
normalized to the control. 
 
 
 
 
Statistical Analyses 
In case of the mRNA data, final results 
were calculated by qBasePLUS (i.e., the 
calibrated normalized relative quantities 
values were used for statistical analysis of 
the data). Statistical analysis was carried out 
with SPSS 24 (IBM, Armonk, NY). Before 
analysis, data were tested for normal 
distribution and, when necessary (in case of 
mRNA data), log10 transformed. All 
analyses were conducted with the different 
dietary treatments in the respective model at 
first. Due to non-significance and an 
increase in statistical power, groups were 
combined in the final models given below. 
Data for performance and serum BCAA 
were analyzed as repeated measures using a 
linear mixed model and Bonferroni post-
hoc tests for correcting multiple 
comparisons: 
Yij = μ + cowi + timej + eij, 
 
where Yij = response variable, μ = overall 
mean, cowi = random effect of cow (i = 1 to 
25), timej = fixed effect of sampling time (j 
= wk 2 to 15 of lactation and d 1, 42, or 105 
after parturition, respectively), and eij = 
residual error. 
Data concerning mRNA and protein 
abundance as well as enzyme activity were 
evaluated using a linear mixed model and 
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Bonferroni correction according to the 
following equation: 
Yijk = μ + cowi + tissuej + timek + tissuej 
× timek + eijk, 
 
where Yijk = response variable, μ = overall 
mean, cowi = random effect of cow (i = 1 to 
25), tissuej = fixed effect of tissue type (j = 
liver, muscle, MG, scAT, vAT), timek = 
fixed effect of sampling time (k = d 1, 42, 
or 105 after parturition), tissuej × timek = 
fixed tissue × time interaction, and eijk = 
residual error. 
Data are expressed as means ± standard 
error of the means. Level of significance 
was set at P < 0.05. Trends were declared at 
0.05 < P ≤ 0.10. 
 
RESULTS 
Animal Performance 
A detailed description of animal 
performance was reported by von Soosten 
et al. (2011). No significant differences 
between the treatment groups were 
observed in the performance parameters 
described in the current study; thus, data 
were merged for analysis of time effects 
(Figure 1). In brief, as expected, DMI 
changed over time (P < 0.001) and 
increased with week in milk (wk 2 versus 
all subsequent time points; P < 0.05). Milk 
yield reached a plateau around wk 4 after 
parturition. During peak lactation, cows 
yielded, on average, 27.5 ± 1.0 kg of milk 
and 0.86 ± 0.02 kg of milk protein. 
 
Serum BCAA Concentrations 
The CLA supplementation did not affect 
BCAA concentrations in serum. 
Concentrations of Leu were not affected by 
time (P = 0.18; Figure 2a), whereas 
concentrations of Ile and Val showed 
significant differences between the 3 time 
points (P < 0.001 and P = 0.001; Figure 2b 
and 2c, respectively). For Ile and Val, 
concentrations increased from d 1 (68 ± 14 
and 138 ± 48 μM) to 42 (180 ± 17 and 337 
± 21 μM; both P = 0.001).  
Serum concentrations of total BCAA 
(calculated as the sum of Leu, Ile, and Val) 
changed over time (P = 0.002; Figure 2d). 
The lowest concentrations, 298 ± 92 μM, 
were observed on d 1 after parturition, 
which then increased to 652 ± 47 μM on d 
42 (P = 0.002). From d 42 to 105 after 
parturition, all BCAA concentrations 
remained unaltered. 
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Figure 1. Weekly DMI, milk yield, and milk protein yield of cows during the experimental period. 
Data are given as means ± SEM. Dashed lines indicate slaughtering time points (d 1, 42, and 105 after 
parturition).  
 
mRNA Abundance of BCAA Key Enzymes 
The mRNA abundance of the enzymes 
related to BCAA catabolism did not differ 
between the 2 treatment groups. The 
BCATm mRNA abundance varied with 
tissue type and sampling time (P < 0.001 
and P = 0.01, respectively; Figure 3), 
whereby interactions between these factors 
were observed (P = 0.01). Within tissues, 
we also noted time effects; that is, for scAT 
and vAT, BCATm mRNA abundance was 
lowest on d 1 and increased more than 3 
fold until d 105 after parturition (both P = 
0.02). For direct tissue comparisons, data 
from the different time points were merged, 
and BCATm mRNA was around 4-times 
greater in both fat depots compared with 
corresponding abundances in liver, muscle, 
and MG (P < 0.001). The mRNA 
abundance of BCKDHA was overall 
significantly influenced by tissue (P < 
0.001) and time (P = 0.001), but we found 
no interaction of tissue × time (P = 0.63; 
Figure 4). 
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Figure 2. Serum concentrations of leucine (a), isoleucine (b), valine (c), and total branched-chain 
amino acids (BCAA; d) in dairy cows on d 1 (n = 5), 42 (n = 10), and 105 (n = 10) after parturition. 
Data are given as means ± SEM. Different letters (A,B) indicate differences (P < 0.05) between the 3 
time points. Total BCAA are calculated as the sum of leucine, isoleucine, and valine. 
Muscle tissue had the lowest BCKDHA 
mRNA, whereas liver, MG, and scAT 
possessed higher (all P < 0.05) yet similar 
abundance among each other. We observed 
an increase of BCKDHA mRNA over time 
in MG and in vAT, with the lowest values 
on d 1 followed by a continuous increase 
until d 105 (P = 0.01 and P = 0.03, 
respectively Tissue type and time both 
affected BCKDHB mRNA abundance (P < 
0.001, P = 0.01, respectively; Figure 5), but 
we observed no interaction of tissue × time 
(P = 0.78). The BCKDHB mRNA 
abundance was around 5 times greater in 
liver than in any of the other tissues tested 
(each P < 0.001). Within MG, BCKDHB 
mRNA abundance increased steadily from 
d 1 to 105 (P = 0.02). For vAT, we noted a 
trend for an increase from d 1 to 105 (P = 
0.06).
a) b)
c) d)
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Figure 3. The mRNA abundance (arbitrary units; AU) of the mitochondrial branched-chain 
aminotransferase (BCATm) in liver, skeletal muscle, mammary gland (MG), and subcutaneous (scAT) 
and visceral adipose tissue (vAT) of dairy cows on d 1 (n = 5), 42 (n = 10), and 105 (n = 10) after 
parturition. Data are given as means ± SEM. Different lowercase letters (a–c) indicate differences (P < 
0.05) between tissues; different uppercase letters (A,B) indicate differences (P < 0.05) between time 
points within one tissue. 
 
 
 
Figure 4. The mRNA abundance (arbitrary units; AU) of the branched-chain α-keto acid 
dehydrogenase E1, α polypeptide (BCKDHA) in liver, skeletal muscle, mammary gland (MG), and 
subcutaneous (scAT) and visceral adipose tissue (vAT) of dairy cows on d 1 (n = 5), 42 (n = 10), and 
105 (n = 10) after parturition. Data are given as means ± SEM. Different lowercase letters (a–c) indicate 
differences (P < 0.05) between tissues; different uppercase letters (A,B) indicate differences (P < 0.05) 
between time points within one tissue. 
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Figure 5. The mRNA abundance (arbitrary units; AU) of the branched-chain α-keto acid 
dehydrogenase E1, β polypeptide (BCKDHB) in liver, skeletal muscle, mammary gland (MG), and 
subcutaneous (scAT) and visceral adipose tissue (vAT) of dairy cows on d 1 (n = 5), 42 (n = 10), and 
105 (n = 10) after parturition. Data are given as means ± SEM. Different lowercase letters (a–c) indicate 
differences (P < 0.05) between tissues; different uppercase letters (A,B) indicate differences (P < 0.05) 
between time points within one tissue, whereas italic letters indicate trends (0.05 < P < 0.1). 
Protein Abundance of the BCKDH E1 
Subunits 
No differences related to the CLA 
supplementation were observed for the 
protein abundance of the BCKDH E1 
subunits. Total BCKDHA protein 
abundance was affected by tissue type (P < 
0.001), but not by time (P = 0.07); however, 
the interaction of tissue × time was 
significant (P = 0.01; Figure 6). Liver and 
MG expressed BCKDHA the most, 
followed by the 2 AT and then muscle. For 
MG and both AT separately, partially 
significant but irregular changes in 
BCKDHA protein over time could be 
detected.  
Total BCKDHB protein was 
qualitatively detected in liver and MG, but 
not in muscle or AT (data not shown). 
However, quantification of BCKDHB 
protein in liver and MG was not possible 
due to lack of antibody saturation. 
  
Activity of the BCKDH Complex  
The activity of the whole BCKDH 
complex was not influenced by the CLA 
treatment. Even so, enzyme values for 
muscle and both AT were below the limit of 
detection. 
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B
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Figure 6. Protein abundance [arbitrary units (AU)/μg of protein] of the branched-chain α-keto acid 
dehydrogenase E1, α polypeptide (BCKDHA) in liver, skeletal muscle, mammary gland (MG), and 
subcutaneous (scAT) and visceral adipose tissue (vAT) of dairy cows on d 1 (n = 5), 42 (n = 10), and 
105 (n = 10) after parturition. Data are given as means ± SEM. Different lowercase letters (a–c) indicate 
differences (P < 0.05) between tissues; different uppercase letters (A,B) indicate differences (P < 0.05) 
between time points within one tissue. 
 
Activity of BCKDH was affected by 
tissue type (P < 0.001) and sampling time 
(P = 0.01), but we found no tissue × time 
interaction (P = 0.12; Figure 7). At all 3 
time points, BCKDH activity was, on 
average, 7-fold greater in liver as compared 
with MG. Further, a slight increase of 
BCKDH activity in liver from d 1 to 42 after 
parturition was observed (P = 0.02). In 
contrast, we detected no significant time-
dependent changes for MG. 
  
 
 
DISCUSSION 
In this study, we aimed to investigate the 
potential enzymatic capacity of different 
tissues in BCAA metabolism in dairy cows 
during early lactation by analyzing the 
concentrations of BCAA in the circulation 
as well as the mRNA and protein abundance 
and activity of the catabolic enzymes in 
liver, muscle, AT, and MG, mainly 
regarding the rate-limiting key enzyme 
BCKDH. The CLA treatment did not affect 
any of those variables, probably due to the 
timing of the supplementation, which only 
started on the day after parturition. 
MG
Days after parturition
a ab c c
A
B
AB
AB
A
B
A
AB
B
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Figure 7. Enzyme activity of the branched-chain α-keto acid dehydrogenase (BCKDH) complex in 
liver and mammary gland (MG) of dairy cows on d 1 (n = 5), 42 (n = 10), and 105 (n = 10) after 
parturition. Data are given as means ± SEM. Different lowercase letters (a,b) indicate differences (P < 
0.05) between tissues; different uppercase letters (A,B) indicate differences (P < 0.05) between time 
points within one tissue.  
  
Further, the applied CLA dosage, 
although in the common range for the 
primarily targeted effect in dairy cows (i.e., 
milk fat reduction), might not have been 
sufficient for the supplements to 
accumulate in the body. Using the same 
study population, von Soosten et al. (2013) 
reported only marginal CLA concentrations 
in the tissues [e.g., 0.01% trans-10,cis-12 
CLA in scAT, vAT, MG, and offal 
(containing liver) of CLA-supplemented 
cows versus no detectable CLA in the 
control group; contents in muscle were 
below the limit of detection for both groups] 
and, in case of the cis-9,trans-11 CLA 
isomer, no change in the amount of CLA 
because of supplementation. In summary, it 
can be assumed that because of the overall 
low transfer of the supplemented isomers 
into the body, the CLA treatment was not 
effective enough to elicit a response at 
tissue level and, thus, affect BCAA 
metabolism. 
Concerning the tissue distribution of 
BCAA catabolic enzymes, the current 
literature is quite ambiguous and is mainly 
based on studies in nonruminants. To our 
knowledge, this is the first report on tissue-
specific differences in abundance as well as 
activity of BCAA key enzymes in dairy 
cows, allowing for estimating the 
importance of different tissues in the 
adaptive processes occurring during early 
lactation. 
MG
a b
A
B
AB
Days after parturition
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It is likely that the observed lower 
BCAA concentrations on d 1 after 
parturition were due to reduced feed intake 
before calving, which is described in 
several publications (e.g., Grummer, 1995). 
In our study, DMI could only be recorded 
from the second week of lactation onwards; 
nevertheless, DMI was still lower at wk 2 
compared with all subsequent time points. 
Moreover, metabolic stress, related to the 
negative energy balance during the 
transition from late pregnancy to lactation, 
is associated with an increase in positive 
acute phase proteins such as serum amyloid 
A (Meglia et al., 2005) and haptoglobin 
(Saremi et al., 2012a). Both proteins, 
containing BCAA and in the milligrams per 
milliliter range close to parturition, require 
substantial AA supply. In addition, it is 
known that human immune cells oxidize 
BCAA in vitro to release energy and to use 
them for the synthesis of new cells or 
effector molecules (Calder, 2006). 
After absorption, most EAA are 
degraded by the liver, whereas catabolism 
of BCAA seems to be under the joint 
control of several metabolically active 
tissues (Goodwin et al., 1987; Suryawan et 
al., 1998). Based on data from AA net 
fluxes and isotopic tracer studies in dairy 
cows, hepatic removal of BCAA (and their 
metabolites) has been described as greatly 
reduced even at high AA supply (Wray-
Cahen et al., 1997; Lapierre et al., 2002; 
Raggio et al., 2004) both in dry and 
lactating animals. However, some 
variations in the extent of hepatic removal 
relative to portal absorption have been 
reported (Raggio et al., 2004), with 
variation likely due to differences in the 
metabolic need of AA in various 
physiological stages. Pell et al. (1986), 
using both radiolabeled Leu and keto-
leucine, the deamination product of Leu, 
showed that around 75% of the keto-leucine 
released from the hindquarter, portal 
drained viscera, and remaining tissues of 
infused sheep is oxidized in the liver, 
compared with only 17% in the hindquarter 
of fed sheep. Goodwin et al. (1987) and 
Papet et al. (1988) observed highest 
BCKDH activity in ovine liver (and kidney) 
compared with muscle, AT, and jejunum, 
demonstrating hepatic involvement in 
BCAA metabolism to some extent. Even if 
full hepatic BCKA oxidation may be 
relatively low, high BCKDH activity would 
ensure the removal of excess BCKA, which 
are toxic at high blood concentrations.  
In general, it has been acknowledged that 
the initial step in BCAA catabolism, the 
reversible deamination via BCAT, may 
occur extrahepatically [e.g., in muscle 
(Bequette et al., 2002), AT (Bergen et al., 
1988), or MG (Bequette et al., 1996a)]. 
Depending on the tissue, this is followed by 
either the export of the resulting BCKA into 
the blood stream or direct oxidative 
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decarboxylation of BCKA to acyl-CoA 
derivatives via BCKDH and, hence, not 
adding to the plasma flux (Lapierre et al., 
2002). 
In the current study, BCATm mRNA in 
liver was marginal, which may point to low 
BCAA transamination in this tissue and, 
consequently, a greater availability of 
absorbed BCAA to peripheral tissues. 
However, measuring mRNA cannot be used 
as surrogate for the corresponding protein; 
thus, further studies including protein 
abundance and activity of BCAT(m) are 
warranted to support our assumption. 
Surprisingly, low BCATm mRNA 
abundance was also detected in MG and 
skeletal muscle. According to Mepham 
(1982), and confirmed in other bovine 
studies (e.g., Raggio et al., 2006; Larsen et 
al., 2014), BCAA (and Lys), arising 
primarily from muscle mobilization, are 
usually taken up in excess to their output as 
milk protein, even during early lactation, 
supporting the synthesis of NEAA as 
mammary uptake of NEAA is generally 
insufficient for milk protein synthesis. For 
this, at least some transamination is 
necessary; however, it may be possible that 
the decreased BCATm abundance in MG in 
our study was a result of a counter-effective 
downregulation to avoid further promotion 
of postpartum AA deficiencies. 
Moreover, it has been reported that sheep 
muscle (M. longissimus dorsi) expresses 
both BCAT isoforms, BCATm and BCATc, 
and that significant activity may be 
attributed to the cytosolic isoform (Faure et 
al., 2001). It remains to be clarified whether 
BCAA transamination in muscle and MG of 
dairy cows may also in part or even largely 
be mediated by BCATc. 
The mRNA abundance of BCATm was 
greatest in both scAT and vAT compared 
with all other tissues, which indicates that, 
on a transcriptional level, AT might be an 
important contributor in the initiation of 
BCAA catabolism in dairy cattle. This 
notion is in line with a study by Bergen et 
al. (1988), who showed that Leu 
deamination activity as well as the 
predicted deamination capacity based on 
body and tissue weights was highest in 
scAT compared with muscle, liver, and 
kidney of mature sheep. More recently, 
Green et al. (2016) demonstrated the 
importance of BCKA oxidation in 
adipogenic differentiation and that 
inhibition of BCAA catabolism 
compromised adipogenesis. Moreover, it 
was assumed that, through linkages in the 
citric acid cycle, BCAA catabolism might 
regulate glyceroneogenesis as well as fatty 
acid oxidation in AT for the maintenance of 
lipid homeostasis (Kainulainen et al., 
2013). The extent of a possible contribution 
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of BCAA catabolism to milk fat synthesis is 
yet unclear. 
During early lactation, bovine AT 
exhibits a pronounced metabolic activity 
(McNamara, 1991). Glutamate, resulting 
from BCAA deamination in AT, may be 
used for the synthesis of NEAA, such as Ala 
and Gln (Tischler and Goldberg, 1980), 
providing important “N shuttles” between 
different tissues and therefore supporting 
lactogenic processes in the MG. 
Initially avoiding hepatic degradation, 
BCAA or their metabolites may still be 
catabolized in the liver to some degree, 
most likely to maintain BCAA/BCKA 
homeostasis (Ananieva et al., 2017). 
Therefore, it could be assumed that liver 
tissue generally has a high BCKDH mRNA 
expression. This expectation was only met 
by the findings for the β subunit, but not for 
the α subunit of the BCKDH E1 component. 
Although BCKDHA mRNA in liver was 
equally low in MG and AT, BCKDHB 
mRNA abundance was more than 5-fold 
greater in liver compared with all other 
tissues. Most studies in mammals focused 
on assessing the α subunit of the BCKDH 
E1 component (Harris et al., 1997; Herman 
et al., 2010; Nichols et al., 2016), assuming 
it to be one of the main subunits responsive 
to nutritional and hormonal influences and 
therefore regulating enzymatic activity. 
Until now, it has not been clear whether this 
also applies for the ruminant organism. The 
sole upregulation of BCKDHB mRNA 
could imply that the β subunit might also 
partake in the hepatic disposal of BCAA (or 
more specifically, BCKA) in dairy cows. 
Yet, in the current study, this could not be 
fully supported at the level of protein, as 
only a qualitative detection of BCKDHB 
protein was possible. Both BCKDHA as 
well as BCKDHB mRNA increased in MG 
and vAT during the course of the 
experiment, indicating a possible 
enhancement of BCKA oxidation in these 
tissues to meet the rising energetic and 
nutritional demands with progressing 
lactation. In partial support of this, 
DeSantiago et al. (1998) described a 10-fold 
increase of Leu oxidation in MG of rats in 
peak lactation in comparison to 
nonlactating rats. No data have been 
published yet regarding BCAA metabolism 
in AT of lactating individuals. 
Highest BCKDHA protein abundance 
was observed in liver and MG, followed by 
AT, and lowest in muscle, suggesting a 
relatively low oxidative capacity of the 
latter tissue in dairy cows during early 
lactation. The actual changes of BCKDHA 
protein abundance with time in MG and AT 
were rather negligible and did not follow 
any regular patterns; therefore, 
interpretation is not reasonable. Based on 
calculations of isotopic transfers in Lapierre 
et al. (2002), liver contributes only 3 to 19% 
to whole-body Leu oxidation compared 
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with 31 to 37% for the portal drained 
viscera in lactating dairy cows. However, 
the high capacity for hepatic oxidation of 
BCKA enabled through increased BCKDH 
abundance (and activity), as shown in our 
study, could be a counter-regulatory 
response to the quantitatively low liver net 
flux of BCAA and their metabolites, 
ensuring all possible substrates or energy 
sources be used for milk production. 
Moreover, the possibility of hepatic BCKA 
degradation could be seen as a form of 
preventive measure, only truly affecting 
hepatic fluxes in case of perilously high 
BCKA concentrations in the circulation, 
which under regular feeding regimens 
would naturally be avoided. 
Likewise, the observed elevated 
BCKDH protein abundance in MG may 
facilitate irreversible degradation of BCAA 
deamination products and, therefore, 
provide additional energy for lactation; 
however, oxidation might vary with AA 
supply (Bequette et al., 1996a). In a 
different study, Bequette et al. (2002) 
described a higher oxidation rate of 4-
methyl 2-oxopentanoate (MOP; keto-
leucine) in the hind leg compared with MG 
of lactating goats. For the hind leg, 
however, the uptake of MOP was negative 
throughout the whole experiment, 
indicating endogenous MOP production for 
which those authors did not correct. 
Further, it has already been hypothesized 
that, during early lactation, ovine skeletal 
muscle is less responsive to both AA 
supplies (Tauveron et al., 1994) and insulin 
(Debras et al., 1989) compared with mid 
lactation, ensuring optimal availability of 
nutrients for lactation. A downregulation of 
BCAA degrading enzymes in muscle may 
therefore support the flux of BCAA (and 
their intermediates) toward the MG. 
Activity of the BCKDH complex is 
regulated through phosphorylation 
(inactivation) and dephosphorylation 
(activation) of the E1α subunit of the 
enzyme complex by a specific kinase 
(branched-chain α-keto acid dehydrogenase 
kinase; EC 2.7.11.4) and phosphatase 
(branched-chain α-keto acid dehydrogenase 
phosphatase; EC 3.1.3.16), respectively 
(Shimomura et al., 1990; Lu et al., 2009). In 
mature sheep, BCKDH is almost fully 
activated in the liver (Goodwin et al., 1987); 
hence, the ability of liver to respond acutely 
to metabolic events is limited and probably 
requires the synthesis of additional enzyme 
protein (Lapierre et al., 2002). On the 
contrary, in tissues such as skeletal muscle 
or AT, most of the BCKDH enzyme is 
inactive (Goodwin et al., 1987; Papet et al., 
1988) and thus acutely sensitive to 
metabolic regulators such as insulin, energy 
status, and BCAA supply (Aftring et al., 
1986; Hutson, 1986). The presence of 
BCKDH in its inactive form might 
therefore explain the unquantifiable 
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activities of the enzyme in muscle and AT 
in the present study. Moreover, a high ratio 
of BCAT to BCKDH activity in muscle, 
favoring the release of BCKA into the 
circulation instead of their oxidation, as 
well as a high BCKDH-to-BCAT activity 
ratio in liver, allowing for BCKA oxidation 
(Hutson et al., 2005), would both support a 
continuous exchange of metabolites 
between these tissues. 
During lactation, the MG is prioritized in 
nutrient use over other peripheral tissues 
(Bauman and Currie, 1980), and BCAA 
uptake by the MG was shown to be 
enhanced in lactating ruminants (Davis et 
al., 1978; Guinard and Rulquin, 1994). 
Consequently, protein synthesis in other 
tissues, such as muscle, declines (Baracos et 
al., 1991), resulting in increased relative 
contributions from the splanchnic tissues 
and MG to whole-body protein metabolism 
(Lapierre et al., 2002). Our results have 
shown that, despite the similarities in 
protein abundance in liver and MG, the 
corresponding BCKDH enzyme activity 
was only increased in liver, probably due to 
physiological stimuli regulating BCAA 
homeostasis or distinct tissue-specific 
responses to insulin. This form of 
decoupling might lead to a greater amount 
of interorgan shuttling of BCAA and their 
metabolites, which could allow for a more 
differential regulation and support BCAA 
conservation. Accordingly, the lower 
enzyme activity observed in the MG 
possibly directs the flux of BCAA (or rather 
their keto acids) to de novo protein 
synthesis as EAA and NEAA. 
However, having measured specific 
enzyme activity (i.e., enzyme activity 
related to protein mass) under saturated 
substrate conditions ex vivo may not 
necessarily reflect the real activity within 
the cell. Therefore, the applicability of 
results obtained to in vivo systems might 
have some limitations, particularly because 
data on BCAA/BCKA tissue transfers are 
missing in our study. However, for the 
investigated tissues, BCKDH activity was 
measured under the same conditions; thus, 
a tissue-wise comparison of the enzymatic 
capacity for BCKA oxidation is still 
possible. 
Nevertheless, given that BCKDH 
catalyzes the rate-limiting step in the 
BCAA catabolic pathway, alterations in 
enzyme activity may play an important role 
in determining the metabolic fate of BCAA; 
that is, whether these AA should be used as 
energy sources or, eventually, for the 
synthesis of (milk) protein during lactation.
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CONCLUSIONS 
The presented data reveal that the key 
enzymes of BCAA catabolism vary in their 
contribution to BCAA degradation in major 
metabolic tissues of dairy cows. The 
greatest abundance of BCATm mRNA in 
both scAT and vAT as compared with other 
tissues may indicate that AT is an important 
contributor in the reversible degradation of 
BCAA to BCKA during early lactation. 
Reduced BCKDH enzyme activity in MG 
along with no measurable activity in AT 
and muscle may favor sparing of BCAA for 
the synthesis of the different milk 
components, including NEAA. Among the 
tissues studied, liver had high BCKDH 
abundance and the greatest enzyme activity. 
Based on previous flux studies in ruminants 
and our observations, these data might 
suggest a counter-regulatory mechanism 
employed by liver during early lactation. It 
is also likely that BCKDH is fully activated 
in the liver and, hence, the ability of liver to 
respond acutely to metabolic events might 
be limited. Given that protein abundance 
may not proportionally correspond to 
mRNA, future research that includes 
protein abundance and activity of 
BCAT(m) may provide additional clues to 
the involvement of the studied tissues in 
BCAA metabolism in dairy cows. 
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ABSTRACT 
Branched-chain amino acids (BCAA) 
are major components of milk protein and 
important precursors for non-essential AA. 
Thus, the BCAA transport and break-down 
play a key role in the metabolic adaptation 
to the high nutrient demands in lactation. 
However, in monogastrics, increased 
BCAA levels have been linked with obesity 
and certain metabolic disorders such as 
impaired insulin sensitivity. Our objective 
was to study the effect of over-conditioning 
at calving on plasma BCAA levels as well 
as the tissue abundance of the most relevant 
BCAA transporters and degrading enzymes 
in dairy cows during late pregnancy and 
early lactation. Thirty-eight Holstein cows 
were allocated 15 wk antepartum to either a 
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normal- (NBCS) or over-conditioned 
(HBCS) group, receiving 6.8 or 7.2 MJ of 
NEL/kg of DM, respectively, during late 
lactation to reach the targeted differences in 
body condition score (BCS) and back fat 
thickness (BFT; NBCS: BCS < 3.5, BFT < 
1.2 cm; HBCS: BCS > 3.75, BFT > 1.4 cm) 
until dry-off. During the dry period and next 
lactation, cows were fed the same diets, 
whereby differences in BCS and BFT were 
maintained: prepartum means were 3.16 ± 
0.06 and 1.03 ± 0.07 cm (NBCS) vs. 3.77 ± 
0.08 and 1.89 ± 0.11 cm (HBCS), 
postpartum means were 2.89 ± 0.06 and 
0.81 ± 0.05 cm (NBCS) vs. 3.30 ± 0.06 and 
1.38 ± 0.08 cm (HBCS). Blood and biopsies 
from liver, M. semitendinosus, and 
subcutaneous adipose tissue (scAT) were 
sampled at d 49 antepartum, 3, 21 and 84 
postpartum. Free BCAA were analyzed and 
the mRNA abundance of solute carrier 
family 1 member 5 (SLC1A5), SLC7A5, and 
SLC38A2 as well as branched-chain 
aminotransferase 2 (BCAT2), branched-
chain α-keto acid dehydrogenase E1α 
(BCKDHA), and branched-chain α-keto 
acid dehydrogenase E1ß (BCKDHB) as 
well as the protein abundance of BCKDHA 
were assessed. Concentrations of all BCAA 
changed with time, most markedly in HBCS 
cows, with a nadir around calving. Apart 
from Ile, neither individual nor total BCAA 
differed between groups. The HBCS group 
had greater BCKDHA mRNA as well as 
higher prepartum BCKDHA protein 
abundance in scAT than NBCS cows 
pointing to a greater oxidative capacity for 
the irreversible degradation of BCAA 
transamination products in scAT of over-
conditioned cows. Prepartum hepatic 
BCKDHA protein abundance was lower in 
HBCS than in NBCS cows. In both groups, 
SLC1A5, SLC7A5 and BCAT2 mRNA were 
most abundant in scAT, whereas SLC38A2 
was higher in scAT and muscle compared 
with liver, and BCKDHA and BCKDHB 
mRNA were greatest in liver and muscle, 
respectively. Our results indicate that scAT 
may be a major site of BCAA uptake and 
initial catabolism, with the former, 
however, being independent of BCS and 
time relative to calving in dairy cows. 
Keywords: Branched-chain amino acid 
transporter, branched-chain amino acid 
enzyme, body condition 
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INTRODUCTION 
During the transition from late 
pregnancy to lactation, dairy cows have to 
mobilize body reserves from adipose tissue 
(AT) and skeletal muscle to cover the 
increasing nutrient demands imposed by the 
onset of milk production (Plaizier et al., 
2000; Kuhla et al., 2011). The extent of 
peripartal tissue mobilization is thereby 
largely influenced by body condition. After 
calving, over-conditioned cows (BCS ≥ 
3.75; 5-point scale) mobilize relatively 
more body reserves than cows in moderate 
(2.75 ≤ BCS ≤ 3.5) or lean condition (BCS 
≤ 2.5; Reid et al., 1986; Drackley et al., 
2005; Pires et al., 2013). A greater reduction 
before parturition as well as a slower 
increase of feed intake after parturition are 
often observed in cows with high BCS 
(Garnsworthy and Topps, 1982; Hayirli et 
al., 2002; Roche et al., 2009) and are 
considered as the main reasons for such 
increased tissue mobilization (Roche et al., 
2009). Consequently, over-conditioned 
cows undergo a more pronounced and 
prolonged negative energy and protein 
balance and bear a greater risk for 
developing metabolic disorders such as 
ketosis, mastitis or milk fever (Holtenius et 
al., 2003; Roche et al., 2009). Enhanced 
peripheral insulin resistance (IR), a 
frequent issue in modern high-yielding 
dairy cows during early lactation (Chagas et 
al., 2009), is often associated with the 
development of these dysfunctions. Further, 
in obese humans, rodents and pigs, elevated 
levels of branched-chain amino acids 
(BCAA) have been linked with IR 
(Newgard et al., 2009; Polakof et al., 2018). 
Circulating BCAA, generally originated 
from a complex mixture of degraded 
dietary, microbial and endogenous protein, 
may be used by tissues as precursors for 
NEAA and as substrates for milk protein 
synthesis as well as for generating energy 
(DeSantiago et al., 1998; Thivierge et al., 
2002). Additionally, BCAA, in particular 
Leu, have emerged as signaling molecules, 
directly activating the mechanistic target of 
rapamycin complex 1 (mTORC1) pathway 
and thus regulating tissue protein synthesis 
in both ruminants (Toerien et al., 2010; 
Appuhamy et al., 2012) and nonruminants 
(Lynch et al., 2002; Suryawan et al., 2012). 
For the cellular uptake of AA, specific 
transporters are required. In case of BCAA, 
the preferred transporter is the sodium-
independent L-type large neutral amino 
acid transporter small subunit 1 (LAT1; 
Baumrucker, 1985; Hyde et al., 2003; 
Batistel et al., 2017), which is encoded by 
the solute carrier family 7 member 5 
(SLC7A5) gene and can directly import 
BCAA from extracellular space in 
exchange for Gln. Nonetheless, other 
neutral transporters, likewise ubiquitously 
expressed (Fuchs and Bode, 2005; Hundal 
and Taylor, 2009), may also directly 
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transport BCAA or are indirectly involved 
in their transport, such as the A-type 
sodium-coupled neutral amino acid 
transporter 2 (SNAT2, encoded by 
SLC38A2) and the ASC-type sodium-
dependent neutral amino acid transporter 
type 2 (ASCT2, encoded by SLC1A5). Both 
SNAT2 and ASCT2 prefer the cellular 
import of smaller AA such as Gln, enabling 
the cytoplasmic accumulation of this AA as 
“exchange currency” for the BCAA 
transport via LAT1 (Kanai et al., 1998; 
Mastroberardino et al., 1998). 
In contrast to most other EAA, only a 
small proportion of absorbed BCAA is 
directly removed by the ruminant liver 
(Lapierre et al., 2002; Raggio et al., 2004) 
and at least the initial catabolic step, the 
reversible deamination via the branched-
chain aminotransferase (BCAT; EC 
2.6.1.42), yielding the respective branched-
chain α-keto acids (BCKA; ketoisoleucine, 
ketoleucine, ketovaline) and glutamate, 
may occur extrahepatically [e.g., in muscle 
(Bequette et al., 2002) and AT (Bergen et 
al., 1988)]. However, the subsequent 
oxidative decarboxylation of the BCKA to 
branched-chain acyl CoA derivatives, 
catalyzed by the rate-limiting branched-
chain α-keto acid dehydrogenase 
(BCKDH; EC 1.2.4.4) complex, may take 
place in liver again in order to maintain 
physiological BCAA/BCKA levels 
(Ananieva et al., 2017; Webb et al., 2019). 
Whole-body BCAA homeostasis is 
therefore highly dependent on the cross-talk 
between various tissues. 
So far, the tissue abundance of BCAA 
transporters (BCAAT) has been assessed in 
bovine mammary gland (Bionaz and Loor, 
2011), placenta (Batistel et al., 2017) and 
AT (Liang et al., 2019). However, no 
comparative study has been conducted yet 
comparing different tissues of transition 
dairy cows.  
Different studies have shown that AT 
may be an important site for BCAA 
metabolism (Bergen et al., 1988; Herman et 
al., 2010; Liang et al., 2019; Webb et al., 
2019), in some cases even during periods of 
negative energy balance. Regardless of this 
however, a possible link between BCAA 
degradation and fatty acid metabolism, in 
particular glyceroneogenesis and fatty acid 
oxidation might exist via the tricarboxylic 
acid (TCA) cycle (Kainulainen et al., 
2013). As body condition may influence 
both lipid as well as protein mobilization in 
transition dairy cows (Kokkonen et al., 
2005), we hypothesized that over-
conditioned cows, having a more intense 
mobilization of body reserves than normal-
conditioned cows due to the greater 
metabolic challenge during early lactation, 
would also show particular alterations 
within their systemic and tissue-specific 
BCAA metabolism. 
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Thus, we aimed (1) to investigate the 
changes in plasma BCAA concentrations in 
cows that were over- or normal-conditioned 
at calving and (2) to identify the differences 
in the mRNA abundance of the most 
relevant BCAAT as well as the mRNA and 
protein abundance of the BCAA 
catabolizing enzymes in subcutaneous AT 
(scAT), muscle and liver of these animals 
during the transition from late pregnancy to 
early lactation. 
 
MATERIALS AND METHODS 
Animals and sample collection 
The trial was conducted at the 
experimental station of the Educational and 
Research Center for Animal Husbandry, 
Hofgut Neumühle, Münchweiler a.d. 
Alsenz, Germany. All protocols of the study 
were designed and performed in strict 
accordance with the European Union 
Guidelines concerning the protection of 
experimental animals, with approval by the 
local authority for animal welfare affairs 
(Landesuntersuchungsamt Rheinland-
Pfalz, Koblenz, Germany [G 14-20-071]). 
The animals were part of a trial aiming to 
establish an experimental model of high 
versus normal body tissue mobilization 
during the transition from pregnancy to 
lactation. A detailed description of the 
experimental design together with 
performance data has already been reported 
(Schuh et al., 2019). Briefly, 15 wk before 
calving, 38 multiparous German Holstein 
cows (average parity 2.9 ± 0.3) were 
allocated to either a normal-conditioned 
(NBCS; n = 19) or high-conditioned group 
(HBCS; n = 19). To reach the targeted 
differences in body condition score (BCS) 
and back fat thickness (BFT) in the 
experimental groups (NBCS: BCS < 3.5 
and BFT < 1.2 cm; HBCS: BCS > 3.75 and 
BFT > 1.4 cm) until dry-off (wk 7 
antepartum, a.p.), NBCS cows received a 
low-energy ration (6.8 MJ of NEL/kg of 
DM) and HBCS cows were fed a ration with 
greater energy density (7.2 MJ of NEL/kg of 
DM) during late lactation. During the dry-
period and subsequent lactation both groups 
received the same diets. The animals 
obtained all diets for ad libitum intake as 
total mixed rations consisting of 74% 
roughage and 26% concentrate in the low-
energy ration and 63% roughage and 37% 
concentrate in the high-energy ration. All 
diets were formulated according to the 
recommendations of the German Society of 
Nutrition Physiology (GfE, 2001). A 
detailed description of the ingredients as 
well as the composition of the diets is given 
in Supplemental Table S1 
(https://doi.org/10.3168/jds.2019-17147). 
During the whole trial (15 wk a.p. until 
15 wk postpartum, p.p.), BCS and BFT 
were assessed every 2 wk by the same 
person. Animals were kept in a freestall 
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barn with free access to water and feed. 
Daily individual feed intake was recorded 
automatically (RIC; Insentec, B.V; 
Marknesse, The Netherlands) from wk 3 
a.p. until wk 14 p.p. Cows were milked 
twice daily (GEA Farm Technologies 
GmbH, Boenen, Germany) with automatic 
recordings of milk yield. Milk samples were 
taken weekly and stored at 4°C until 
analysis. In addition, blood from the V. 
caudalis mediana was collected weekly, 
and samples from d 49 a.p. and 3, 21 and 84 
p.p. were used herein. Plasma was obtained 
after centrifugation (10 min at 2000 × g, 
4°C) and stored at -20°C until analysis. 
Further, tissue biopsies from liver, 
skeletal muscle and scAT were collected at 
d 49 (±5) a.p. and 3 (±2), 21 (±2) and 84 
(±2) p.p. under local anesthesia (procaine 
hydrochloride, 20 mg/mL, 8 mL per biopsy 
in case of liver and muscle, 9 mL per biopsy 
for scAT; Richter Pharma AG, Wels, 
Austria) and while the animals were sedated 
(xylazine i.v., 20 mg/mL, 0.1 mL/100 kg 
BW; CP-Pharma Handels GmbH, 
Burgdorf, Germany) and fixed in a 
headlock. In total, 28, 31 and 24 animals 
had the full sets of liver, muscle and scAT 
biopsies, respectively. Liver tissue was 
obtained by performing a small incision 
through the skin at the 11th and 12th 
intercostal space on a line between the 
olecranon and the tuber coxae with a 14G 
biopsy needle (Dispomed Witt oHG, 
Gelnhausen, Germany). Samples of muscle 
(M. semitendinosus) were collected through 
a 1-cm incision with a Bard Magnum 
biopsy instrument and Bard Magnum core 
tissue biopsy needles (12 gauge × 20 cm, 
C.R. Bard Inc., Tempe, AZ). Adipose tissue 
was excised from the tail head region with 
a scalpel through an incision of 1 cm width. 
Immediately after sampling, incisions were 
closed with a sterile needle and sterile 
absorbable suture (Spool suture PGA, USP 
1, EP 4, LOT 15B27, Henry Schein U.K. 
Holdings Ltd, Gillingham, U.K.). To 
prevent infection and for analgesia, 
respectively, oxytetracycline hydrochloride 
was applied to the skin (25 mg/mL, 
EngemycinTM, MSD Animal Health 
Innovation GmbH, Schwabenheim an der 
Selz, Germany) and a ketoprofen injection 
(100 mg/mL, 3 mL/100 kg BW; Streuli 
Pharma AG, Uznach, Switzerland) was 
given. All tissue samples were rinsed with 
0.9% NaCl to remove any blood 
contamination, immediately snap-frozen in 
liquid nitrogen and stored at -80°C for the 
respective extractions and analyses. 
 
Milk and Blood Analyses 
Milk composition was assessed using an 
infrared milk analyzer (Bentley FTS, 
Bentley Instruments, Inc., Chaska, MN, 
USA). Plasma BCAA concentrations were 
measured via high performance liquid 
Manuscript II  51 
 
chromatography (HPLC) in a RF-10A XL 
fluorescence detector (Shimadzu, Kyoto, 
Japan) based on o-phtaldialdehyde/3-
mercaptopropionic acid derivatization as 
previously described (Fürst et al., 1990). 
Inter- and intra-assay variances were <5%.  
 
RNA Extraction and Quantitative Real-
Time Reverse Transcription-PCR 
Tissues (20, 100, 200 mg of liver, muscle 
and scAT, respectively) were homogenized 
in 1 mL of QIAzol (Qiagen N.V., Hilden, 
Germany) using the Precellys 24 system 
(VWR/Peqlab Biotechnologie, Erlangen, 
Germany). The extracted total RNA was 
purified with spin columns according to the 
Qiagen mini kit protocol (RNeasy Mini Kit, 
Qiagen). The concentration and the purity 
of the RNA obtained were assessed with the 
Nanodrop 1000 (VWR/Peqlab 
Biotechnologie) by measuring the 
absorbance at 260 and 280 nm. Using 
ethidium bromide denaturing RNA gel 
electrophoresis, the integrity of the RNA 
was checked. For cDNA synthesis, 250 ng 
total RNA per 20 μL reaction were reverse 
transcribed in duplicate for each sample 
with RevertAid reverse transcriptase 
(Thermo Fisher Scientific, Dreieich, 
Germany) in a thermocycler Alpha-SC 
(Analytik Jena, Jena, Germany). 
Analysis by quantitative real-time 
reverse transcription PCR (qPCR) was 
carried out in Mx3000P qPCR systems 
(Stratagene, Amsterdam, The Netherlands, 
and Agilent, Santa Clara, CA) in 
accordance with the Minimum Information 
for Publication of Quantitative Real-Time 
PCR Experiments (MIQE) guidelines 
(Bustin et al., 2009). Samples were run as 
triplicates in a total volume of 10 μL, with 
2 μL cDNA (diluted 1:4) as template, 1 μL 
assay-specific primer mix, 2 μL water, and 
5 μL DyNAmo ColorFlash SYBR Green 
qPCR Kit (Thermo Fisher Scientific). 
Relative quantification of the target genes, 
i.e., solute carrier family 1, member 5 
(SLC1A5), solute carrier family 38, member 
2 (SLC38A2), solute carrier family 7, 
member 5 (SLC7A5), branched-chain 
aminotransferase 2 (BCAT2), branched-
chain α-keto acid dehydrogenase E1α 
(BCKDHA), and branched-chain α-keto 
acid dehydrogenase E1ß (BCKDHB), was 
performed with standard curves using 
cDNA serial dilutions to calculate the 
abundance based on run-specific PCR 
efficiency. Each run included a no-template 
control and a no-reverse-transcriptase 
control. 
To remove any systematic bias caused 
by random and technical variations between 
the plates, a factor correction, taking into 
account all overlapping technical and 
biological replicates, was conducted using 
Factor-qPCR software (Ruijter et al., 2015). 
Target genes were normalized with the 4 
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most stable reference genes, namely 
hippocalcin-like 1 (HPCAL1), emerin 
(EMD), RNA polymerase II (POLR2A), and 
eucariotic translation initiation factor 3 
(EIF3K), which were evaluated based on 
their average expression stability (M) and 
pairwise variation (V) values (M < 1.0 and 
V = 0.18) using the geNormPLUS algorithms 
of qBasePLUS 3.2 software (Biogazelle, 
Ghent, Belgium). Primer sequences as well 
as qPCR conditions were the same for a 
given gene in all tissues and are provided in 
Table 1.  
 
Protein quantification 
Protein extraction and quantification via 
Simple Western size-based protein assay 
(WES, ProteinSimple, San Jose, CA) were 
described earlier (Webb et al., 2019). In 
brief, after tissue homogenization, samples 
were diluted with 0.1 × sample buffer to a 
protein concentration of 0.325 mg/mL for 
liver and 0.5 mg/mL for muscle and scAT, 
respectively and then mixed with 5 × master 
mix containing 40 mM dithiothreitol. 
Following denaturation (5 min, 95°C), 
samples were pipetted in duplicate onto the 
plate. A control sample (bovine liver) was 
also loaded on every plate to correct for 
inter-run variations. The primary antibody 
against total BCKDHA (#ab138460; 
Abcam, Cambridge, UK) was diluted 1:50. 
All other reagents (antibody diluent, 
secondary antibody, streptavidin-HRP, 
luminol-S, and hydrogen peroxide) were 
obtained from ProteinSimple and used 
according to the recommendations. Simple 
Western analysis was performed with 
instrument default settings at room 
temperature. Using Compass Software 
(ProteinSimple), the area under the curve 
was assessed for each sample and 
normalized to the control of the applicable 
plate of the sample and over all plates, 
respectively. 
 
Statistical Analyses 
In case of the mRNA data, final results 
(i.e., calibrated normalized relative 
quantities) were calculated by qBasePLUS. 
Statistical analysis for all data was carried 
out with SPSS 25 (IBM, Armonk, NY). 
Before analysis, data were tested for normal 
distribution and when necessary (in case of 
mRNA data) were log10 transformed. Using 
a Linear Mixed Model and Bonferroni 
correction for multiple comparisons, data 
were analyzed as repeated measures with 
“group” (treatment), “time” (week or day 
relative to calving), “tissue type” (in case of 
mRNA and protein data) and the interaction 
thereof as fixed effects, and “cow” as a 
random factor. For all graphs, 
nontransformed data (means ± SEM) were 
used. The level of significance was set at P 
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< 0.05. Trends were declared at 0.05 < P ≤ 
0.10. 
 
Table 1. Characteristics of primers and real-time polymerase chain reaction conditions 
Gene1 Sequences (5'-3') 
NCBI2 accession 
no. 
bp 
Concentration 
(nM) 
Mean 
Cq3 
Annealing4 
(s/°C) 
BCAT2       
  Forward CATTTCCACATTCCCACCAT 
NM_001013593.2 130 400 28.69 30/61 
  Reverse AGCGTAGCCCAGAGCATTAC 
BCKDHA       
  Forward AGAACCAGCCCTTCCTCATT 
NM_174506.1 108 200 25.99 30/61 
  Reverse TGTCCCAGTAGTTGACCTCGT 
BCKDHB       
  Forward GGCCAAAGATCCTACGGCAGTAAT 
NM_174507.2 129 400 25.42 30/61 
  Reverse CCTTGTTCACACAGTGGGGT 
EIF3K       
  Forward CCAGGCCCACCAAGAAGAA 
NM_001034489 125 400 26.35 45/59 
  Reverse TTATACCTTCCAGGAGGTCCATGT 
EMD       
  Forward GCCCTCAGCTTCACTCTCAGA 
NM_203361 100 400 25.59 45/59 
  Reverse GAGGCGTTCCCGATCCTT 
HPCAL1       
  Forward CCATCGACTTCAGGGAGTTC 
NM_001098964 99 400 27.05 30/60 
  Reverse CGTCGAGGTCATACATGCTG 
POLR2A       
  Forward GAAGGGGGAGAGACAAACTG 
X63564 86 800 24.97 60/60 
  Reverse GGGAGGAAGAAGAAAAAGGG 
SLC1A5       
  Forward GGCTAGCAGCTGTTTACTCCT 
NM_174601.2 129 200/400 27.31 30/60 
  Reverse AGTCTGGGGGCTAGAAGACG 
SLC38A2       
  Forward TGAAAAGCCATTATGCCGATGT 
NM_001082424.1 148 400 24.06 30/60 
  Reverse CCCACAATCGCATTGCTCAG 
SLC7A5       
  Forward GGGTGACGTAGCCAATCTGG 
NM_174613.2 107 200 29.59 30/60 
  Reverse ATCCCCCATAGGCAAAGAGG 
 
1BCAT2 = branched-chain aminotransferase 2; BCKDHA = branched chain α-keto acid dehydrogenase E1α; BCKDHB = 
branched chain α-keto acid dehydrogenase E1ß; EMD = emerin; HPCAL1 = hippocalcin like 1; EIF3K = eukaryotic translation 
initiation factor 3 subunit K; POLR2A = RNA polymerase II; SLC1A5 = solute carrier family 1, member 5; SLC38A2 = solute 
carrier family 38, member 2; SLC7A5 = solute carrier family 7, member 5. 
2NCBI = National Center for Biotechnology Information. 
3Mean quantification cycle for all tissues combined.  
4Initial denaturation for 10 min at 95°C; denaturation for 30 s at 95°C; extension for 30 s at 72°C, except for POLR2A and 
SLC1A5 (60 s at 72°C). 
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RESULTS 
Body condition and animal performance 
A summary of disease incidence in the 
cows studied herein is provided in 
Supplemental Table S2 (https://doi.org/10 
.3168/jds.2019-17147). In the present 
study, the number of animals was too small 
to allow for valid comparisons of disease 
incidence. All cows enrolled in the study (n 
= 40) were free of disease, including 
mastitis. Results from 2 cows (one cow 
from each group), that failed to complete 
the sampling schedule, were excluded, thus 
data of 38 cows were used. No clinical 
health events occurred before calving. 
Mastitis was the most common clinical 
ailment postpartum. Numerical differences 
existed between HBCS and NBCS cows in 
the number of cows affected by clinical 
events (i.e., total clinical events were 
observed for 27 HBCS vs. 15 NBCS cows, 
including 4 HBCS vs. 2 NBCS cows with 
ketosis and 4 HBCS vs. 2 NBCS cows with 
milk fever). 
A more detailed description of variables 
characterizing body condition as well as 
animal performance is given in Schuh et al. 
(2019). In brief, both BCS and BFT differed 
between the two treatment groups during 
the whole study, with HBCS cows having 
greater values than NBCS cows (both P < 
0.001; Figure 1). Prepartum BCS and BFT 
values (as means ± SEM) were 3.77 ± 0.08 
and 1.89 ± 0.11 cm for HBCS vs. 3.16 ± 
0.06 and 1.03 ± 0.07 cm for NBCS, whereas 
postpartum values were 3.30 ± 0.06 and 
1.38 ± 0.08 cm for HBCS vs. 2.89 ± 0.06 
and 0.81 ± 0.05 cm for NBCS. During the 
dry period, when both groups received the 
same diet, body condition increased 
independent of treatment. Previously 
established differences between NBCS and 
HBCS cows remained until wk 1 a.p. (Δ = 
0.7 BCS points, 1.1 cm BFT). Average 
calving BCS and BFT were 4.04 ± 0.07 and 
2.24 ± 0.09 cm for the HBCS group and 
3.38 ± 0.09 and 1.28 ± 0.08 cm for the 
NBCS group, respectively. With the onset 
of lactation, body condition decreased in 
both groups, whereby the decline until wk 
15 p.p. was greater for HBCS (Δ = 0.9 BCS 
points, 1.2 cm BFT) compared to NBCS 
cows (Δ = 0.6 BCS points, 0.7 cm BFT). 
Due to technical conditions, daily 
individual feed intake a.p. could only be 
recorded from wk 3 a.p. onwards (Figure 
2A). Group (P = 0.04), time (P < 0.001) and 
the interaction of both (P = 0.001) all 
influenced DMI: Before calving, NBCS 
cows had a higher DMI than HBCS cows. 
At wk 1 p.p. both groups reached the same 
nadir. Thereafter DMI increased faster for 
NBCS compared to HBCS until levels 
became equal again at wk 11 p.p. When 
DMI was adjusted for BW, the pattern was 
similar, except that the differences between 
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the two groups became clearer (P = 0.001; 
Figure 2B) and included more time points.
.
Figure 1. Changes in BCS and back fat thickness (BFT) from wk 15 antepartum to wk 15 
postpartum of high BCS (HBCS; n = 19) and normal BCS (NBCS; n = 19) cows [modified from Schuh 
et al. (2019)]. Data are given as means ± SEM. Asterisks (***) indicate differences (P < 0.001) between 
HBCS and NBCS within one time point. The vertical dotted lines indicate calving.
.
 
No group difference was observed for 
overall milk yield (Figure 2C). However, 
the interaction of group × time was 
significant (P < 0.001). During the first 4 
wk of lactation, cows in the NBCS group 
yielded on average 2.3 kg milk more than 
cows in the HBCS group. Milk protein yield 
did not differ between the two treatment 
groups (Figure 2D).  
 
Plasma BCAA concentrations 
Plasma concentrations of Leu, Ile and 
Val as well as total BCAA, calculated as the 
sum of the three, were not different between 
the two groups (Figure 3). Albeit for Ile, a 
significant group × time interaction was 
observed (P = 0.03): At d 3 p.p. HBCS cows 
tended to have lower Ile concentrations than 
NBCS cows (P = 0.08) and vice versa at d 
21 (P = 0.02). Concentrations of all BCAA 
changed with time (P ≤ 0.01). However, this 
mainly applied to the HBCS group: From 
pre-calving to calving, their concentrations 
mostly decreased and increased again 
thereafter to initial values. Changes in total 
AA concentration were also more 
prominent for HBCS cows, with highest 
values observed on d 21 p.p. (Supplemental 
Table S3; https://doi.org/10.3168/jds.2019-
17147).
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Figure 2. Changes in DMI (A) and DMI as % of BW (B) from wk 3 antepartum to wk 14 postpartum 
(p.p.), milk yield (C) and milk protein yield (D) from wk 1 to wk 14 p.p. of high BCS (HBCS; n = 19) 
and normal BCS (NBCS; n = 19) cows [in part modified from Schuh et al. (2019)]. Data are given as 
means ± SEM. Asterisks (*, **, ***) indicate differences (0.01 < P < 0.05, 0.001 < P < 0.01 and P < 
0.001, respectively) between HBCS and NBCS within one time point. Trends (0.05 < P ≤ 0.1) are 
marked with daggers (†). The vertical dotted lines indicate calving. 
mRNA abundance of the BCAA 
transporters and enzymes  
The mRNA abundance of the three 
BCAA transporters assessed in this study 
was not affected by over-conditioning at 
calving (Table 2). For SLC1A5, the 
abundance varied with tissue type and time 
(both P < 0.001), whereby interactions 
between these factors were observed (P 
<0.001; Figure 4A). Over all time points 
and for both groups, SLC1A5 mRNA in 
scAT was on average 30-fold higher than in 
liver and 9-fold higher compared to muscle 
(both P < 0.001). Time effects were most 
prominent for muscle in which the 
abundance increased continuously from d 
49 a.p. to d 21 p.p. and decreased again at 
the last sampling time point, both for the 
HBCS and NBCS groups. 
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Figure 3. Plasma concentrations of free leucine, isoleucine, valine, and total branched-chain 
amino acids (BCAA) of high BCS (HBCS; n = 19) and normal BCS (NBCS; n = 19) cows on d -49, 3, 
21 and 84 relative to parturition. Data are given as means ± SEM. Different letters (A,B) indicate 
differences (P < 0.05) between time points within the HBCS group. Asterisks (*) indicate differences 
(P < 0.05) between HBCS and NBCS within one time point. Trends (0.05 < P ≤ 0.1) are marked with 
daggers (†). Total BCAA were calculated as the sum of leucine, isoleucine and valine. 
 
Table 2. Level of significance (P-values) for the effects of body condition (group), type of tissue, time 
relative to calving, as well as the respective interactions on the abundance of transporters and enzymes 
related to branched-chain AA metabolism in dairy cows during late pregnancy and early lactation 
Variable1 Group Tissue Time 
Group × 
Tissue 
Group × 
Time 
Tissue × 
Time 
Group × Tissue × 
Time 
SLC1A5 0.149 <0.001 <0.001 0.668 0.845 <0.001 0.399 
SLC7A5 0.618 <0.001 <0.001 0.97 0.919 <0.001 0.521 
SLC38A2 0.107 <0.001 0.002 0.856 0.273 <0.001 0.823 
BCAT2 0.345 <0.001 <0.001 0.522 0.011 <0.001 0.519 
BCKDHA 0.002 <0.001 0.028 0.002 0.067 <0.001 0.033 
BCKDHB 0.902 <0.001 0.037 0.93 0.153 <0.001 0.772 
BCKDHA2 0.119 <0.001 0.062 0.008 0.795 <0.001 0.03 
1SLC1A5 = solute carrier family 1 member 5; SLC7A5 = solute carrier family 7 member 5; SLC38A2 = solute 
carrier family 38 member 2; BCAT2 = branched-chain aminotransferase 2; BCKDHA = branched-chain α-keto 
acid dehydrogenase E1α; BCKDHB = branched-chain α-keto acid dehydrogenase E1ß. 
2Protein abundance.
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A
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The mRNA abundance of SLC7A5 was 
altogether influenced by tissue and time as 
well as tissue × time (all P < 0.001; Figure 
4B). Again, over all time points and 
independent of group, highest abundance 
was detected in scAT compared with the 
other two tissues. However, changes with 
time were only observed for liver and 
muscle. Hepatic SLC7A5 mRNA was 
expressed at fairly constant levels until d 84 
p.p. when values decreased by factor 2 
compared to the previous time points p.p. in 
the HBCS group.  For NBCS cows, hepatic 
SLC7A5 mRNA abundance was lower at d 
84 p.p. than at d 49 a.p. and 3 p.p. In muscle, 
SLC7A5 mRNA abundance increased from 
d 49 a.p. to d 21 p.p. and, in case of NBCS 
cows, levels decreased again thereafter. 
Abundance of SLC38A2 changed with 
tissue, time and the interaction thereof (all 
P < 0.01; Figure 4C). On average, levels in 
both scAT and muscle were about 4-times 
higher than in liver. Time dependent 
changes were only detected for the latter 
tissue and were more notable in the NBCS 
group, where SLC38A2 mRNA decreased at 
d 84 p.p. compared with previous time 
points (bar d 49 a.p.).
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Figure 4. mRNA abundance of the main branched-chain AA transporters, solute carrier family 1 
member 5 (SLC1A5, A), SLC7A5 (B), and SLC38A2 (C), in liver, skeletal muscle, and subcutaneous 
adipose tissue (scAT) of high BCS (HBCS; n = 19) and normal BCS (NBCS; n = 19) cows on d -49, 3, 
21 and 84 relative to parturition. Data are given as means ± SEM. Differences between tissues are 
marked with && (0.001 < P < 0.01) or &&& (P < 0.001). Different uppercase letters (A-C) indicate 
differences (P < 0.05) between time points within HBCS. Different lowercase letters (a-c) designate 
differences (P < 0.05) between time points within NBCS. AU = arbitrary units. 
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The mRNA abundance of the enzymes 
related to BCAA catabolism was primarily 
influenced by type of tissue and time of 
sampling (Table 2).  
For BCAT2, no difference between the 
two groups was observed (Figure 5A). 
Abundance only changed with tissue and 
time (both P < 0.001). Interactions of group 
× time as well as tissue × time were 
significant (both P ≤ 0.01). Regardless of 
time points and for both groups, BCAT2 
abundance was on average 5.5- and 7-times 
greater in scAT compared to muscle and 
liver (all P < 0.001), respectively. In case of 
muscle, BCAT2 mRNA abundance in the 
NBCS group increased from d 49 a.p. to all 
subsequent time points (all P < 0.05, except 
for d 49 a.p. vs. 21 p.p.; P = 0.07). For 
scAT, BCAT2 abundance in both groups 
was highest at d 49 a.p. compared to all 
other time points (all P < 0.001) and 
decreased until d 21 p.p. At d 84 p.p., levels 
seemed to slightly increase again, albeit for 
HBCS cows, initial values were not reached 
again. 
The mRNA abundance of BCKDHA was 
overall influenced by group, tissue and time 
(all P < 0.05) with significant interactions 
of group × tissue (P = 0.002), tissue × time 
(P < 0.001) and group × tissue × time (P = 
0.03; Figure 5B). Considering the 3 tissues 
in this study, scAT showed the strongest 
group effect: At all time points except for d 
84 p.p., BCKDHA mRNA in scAT was 
between 1.4- to 1.9-times higher in HBCS 
than in NBCS cows (all P < 0.05). 
Abundance in muscle and liver did not 
differ between the two groups. Independent 
of group, the mRNA abundance of 
BCKDHA was mostly greatest in liver 
compared to the other tissues (P < 0.001, 
bar d 3 p.p. in muscle). Changes with time 
were observed for all tissues but liver. In 
muscle, BCKDHA abundance in the HBCS 
group increased more than 3-fold from d 49 
a.p. to d 3 p.p. and declined to previous 
levels thereafter. In scAT of HBCS cows, 
BCKDHA mRNA was higher at d 49 a.p. 
compared to subsequent time points (except 
d 3 p.p.). For NBCS cows, BCKDHA 
mRNA in muscle and scAT only changed 
numerically.  
Tissue type and time (both P < 0.05) but 
not group affected BCKDHB mRNA 
abundance (Figure 5C). In addition, a 
significant tissue × time interaction was 
observed (P < 0.001). Overall, the 
BCKDHB abundance was higher in muscle, 
and partly liver, compared to scAT (muscle 
vs. scAT: P < 0.001, except for d 49 a.p.; 
liver vs. scAT: P < 0.001, except for d 49 
a.p.). Time dependent changes were only 
detected for scAT, where for both groups, 
BCKDHB mRNA decreased by a factor of 
2 from d 49 a.p. to subsequent time points.
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Figure 5.  mRNA abundance of the branched-chain AA enzymes, branched-chain aminotransferase 
2 (BCAT2, A), branched-chain α-keto acid dehydrogenase E1α (BCKDHA, B) and branched-chain α-keto 
acid dehydrogenase E1ß (BCKDHB, C), in liver, skeletal muscle, and subcutaneous adipose tissue (scAT) 
of high BCS (HBCS; n = 19) and normal BCS (NBCS; n = 19) cows on d -49, 3, 21 and 84 relative to 
parturition. Data are given as means ± SEM. Differences between tissues are marked with && (0.001 < 
P < 0.01) or &&& (P < 0.001). Asterisks (*) indicate differences (P < 0.05) between HBCS and NBCS 
within one time point. Different uppercase letters (A-C) indicate differences (P < 0.05) between time 
points within HBCS. Different lowercase letters (a-c) designate differences (P < 0.05) between time points 
within NBCS. AU = arbitrary units. 
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Protein abundance of the BCKDHA 
Due to limitations in the amount of tissue 
available, 10 animals per group with the 
most complete sets of biopsies were 
selected for the measurement of BCKDHA 
protein abundance (Figure 6). Overall, cows 
with high or normal body condition at 
calving were not different in their 
BCKDHA protein. However, significant 
group × tissue (P = 0.008) and group × 
tissue × time interactions (P = 0.03) were 
observed. At d 49 a.p., BCKDHA protein 
abundance in liver of HBCS cows was 
lower compared with NBCS cows (P < 
0.001), and vice versa in scAT (P = 0.04). 
In general, liver had approximately 13-
times greater BCKDHA abundance than 
muscle and 9-times higher values than 
scAT. Because of significant interactions of 
tissue and time (P < 0.001) and, as 
mentioned above, group, tissue and time, 
time effects were different within tissues 
and treatment groups: For liver, BCKDHA 
abundance of both groups increased from d 
49 a.p. to d 3 p.p. and decreased again 
subsequently (P < 0.001). But, unlike the 
NBCS group, BCKDHA protein in liver of 
HBCS cows did not reach initial values 
again. In scAT of HBCS cows, highest 
abundance was observed at d 49 a.p. which 
then decreased around the factor of 4.6 at 
the following time points (P < 0.001). No 
time effects were detected for scAT in the 
NBCS group or for muscle in either group.
Figure 6.  Protein abundance of the branched-chain α-keto acid dehydrogenase E1α (BCKDHA) in liver, 
skeletal muscle, and subcutaneous adipose tissue (scAT) of high BCS (HBCS; n = 19) and normal BCS 
(NBCS; n = 19) cows on d -49, 3, 21 and 84 relative to parturition. Data are given as means ± SEM. 
Differences (P < 0.001) between tissues are marked with &&&. Asterisks (*) indicate differences (P < 
0.05) between HBCS and NBCS within one time point. Different uppercase letters (A-C) illustrate 
differences (P < 0.05) between time points within HBCS. Different lowercase letters (a-b) designate 
differences (P < 0.05) between time points within NBCS. AU = arbitrary units. 
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DISCUSSION 
An experimental model characterizing 
dairy cows with normal versus high tissue 
mobilization was successfully established 
(Schuh et al., 2019). The over-conditioned 
cows in our trial were more metabolically 
challenged during early lactation than the 
cows with normal body condition due to a 
more severe and persistent negative energy 
balance, a higher lipomobilization, and 
probably a lower insulin sensitivity (IS; 
Holtenius et al., 2003; Roche et al., 2009; 
Pires et al., 2013; Schuh et al., 2019). Most 
likely, these differences were related to the 
slower postpartal increase of feed intake 
and the lower feed intake in general that was 
observed in HBCS cows, both of which 
were especially obvious, when DMI was 
expressed as a percentage of BW. 
The BCAA are particularly responsive to 
insulin, and during metabolic states with 
reduced IS, such as obesity, their 
metabolism seems to be profoundly altered 
in monogastrics (She et al., 2007; Newgard 
et al., 2009; Polakof et al., 2018). Even 
though the underlying mechanisms in this 
relationship are not fully understood yet, 
(i.e., the cause and effect of such metabolic 
dysfunctions), it is assumed that a reduced 
BCAA oxidative capacity in scAT may be a 
contributing factor (Polakof et al., 2018). 
Nevertheless, studies in humans have 
shown that, depending on the degrees of 
obesity and decreased IS, an impaired 
BCAA catabolism in other tissues, such as 
skeletal muscle (Lerin et al., 2016) and liver 
(Lee et al., 2018), may also affect or be 
caused by alterations in IS. 
In this study we wanted to explore 
whether the plasma concentrations of 
BCAA as well as the abundance of BCAA 
transporters and enzymes in liver, skeletal 
muscle and scAT differed between normal- 
and over-conditioned dairy cows during late 
pregnancy and early lactation. Apart from 
the increased nutrient and energy demands 
of the mammary gland for lactogenesis, 
systemic AA concentrations around calving 
are greatly affected by DMI (Meijer et al., 
1995; Doepel et al., 2002; Zhou et al., 
2016). The herein observed lower feed 
intake of HBCS cows therefore most 
probably also accounted for the more 
pronounced drop of plasma BCAA 
concentrations in this group around the time 
of parturition. Even though total AA did not 
decrease around calving for HBCS cows, 
animals in this group overall had greater 
reductions in circulating AA from 
prepartum to postpartum as compared to 
NBCS cows. Yet, as over-conditioned cows 
are metabolically more challenged and 
likely closer to a pro-inflammatory status 
than animals in normal body condition 
(Akbar et al., 2015; Roche et al., 2015; 
Vailati-Riboni et al., 2016), HBCS cows 
might have had to generate more immune 
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cells and positive acute phase proteins, such 
as haptoglobin (Hp), all of which containing 
substantial portions of BCAA (Morimatsu 
et al., 1991; Calder, 2006). However, in our 
study, for the assessed serum Hp 
concentrations, differences between the two 
groups were not detectable, likely due to the 
high interindividual variation (Schuh et al., 
2019). To fully understand the relationship 
between circulating BCAA and 
inflammatory processes in cows differing in 
body condition, further indicators of 
immune responses should therefore be 
taken into account. 
In ruminants and nonruminants, whole-
body BCAA metabolism is increased 
during lactation (Tesseraud et al., 1993; 
DeSantiago et al., 1998; Li et al., 2009) and 
BCAA as well as their catabolized products 
(succinyl-CoA, acetyl-CoA, acetoacetate), 
some of which may eventually enter the 
TCA cycle, are used to partially cover the 
elevated energy and nutrient demands for 
milk production (Li et al., 2009). Further, 
BCAA can also fulfill different tissue-
specific regulatory functions: the regulation 
of glyceroneogenesis and fatty acid 
oxidation in AT through linkages in the 
TCA cycle (Kainulainen et al., 2013), the 
regulation of protein synthesis in muscle via 
activation of the mTORC1 pathway (Dodd 
and Tee, 2012), and the modulation of cell 
growth and proliferation in liver also via 
mTORC1 signaling (Kimura and Ogihara, 
2005). Clearly, in order to exert these 
effects, transporters are needed to bring 
BCAA into the cell.  
As insulin also partly mediates cellular 
AA uptake and increases mRNA encoding 
AA transporters, such as SLC7A5 in 
mammalian cells (Malmberg and Adams, 
2008), we hypothesized that cows differing 
in body condition and likely expressing 
different degrees of IS (Holtenius et al., 
2003; Dann et al., 2006; Jaakson et al., 
2018; Schuh et al., 2019), would also show 
variations in their BCAAT mRNA 
abundance. However, within the present 
study model this was not the case. During 
early lactation, nutrient availability is, 
regardless of body condition, thought to be 
physiologically limited for all tissues except 
the mammary gland (Bauman and Currie, 
1980). Yet, the consistently high abundance 
of SLC1A5, SLC7A5 and SLC38A2 mRNA 
in scAT of both normal- and over-
conditioned cows indicates that AT, or 
rather scAT, may still be a major site of 
BCAA metabolism, or more specifically 
BCAA uptake, that seems however 
independent of BCS and time relative to 
calving at transcription level in dairy cows. 
As adipose metabolism is crucial for 
contributing to the efficiency of milk 
production during the transition period 
(Khan et al., 2013), an upregulation of 
BCAA uptake would clearly increase the 
intracellular availability of BCAA. Partially 
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supporting this is data by Liang et al. 
(2019), showing that transporters for 
BCAA, i.e., SLC7A5, SLC1A5 and SLC3A2, 
were constantly expressed at mRNA level 
from d -10 to 30 relative to parturition in 
bovine scAT. In addition, the protein 
abundance of SLC1A5 and 
SLC1A3/SLC3A1 was gradually increasing 
from late pregnancy to early lactation 
pointing to an actually growing capability 
of AT for BCAA uptake even during 
periods of negative energy balance. 
However, it should be noted that the 
SLC1A3/SLC3A1 and SLC3A2 
transporters are not clearly specified in the 
aforementioned paper. 
The changes over time detected for 
muscle SLC1A5 and SLC7A5 mRNA of 
both HBCS and NBCS cows, with peaks at 
d 21 p.p., could however imply a more acute 
form of adaptive response in this tissue, 
likely to the slowly increasing DMI. 
Consistent with this notion, EAA ingestion 
led to an upregulation of mRNA and protein 
abundance of AA transporters in human 
muscle within 3 h post meal (Drummond et 
al., 2010). For liver, time effects herein 
were only limited to a downregulation 
toward the latest sampling time point, 
probably mirroring the attenuated 
metabolic pressure on the tissue caused by 
the slowly instating decrease in milk 
production at that stage. 
According to our results, the transport of 
BCAA into liver and partly muscle appears 
to be lower than into scAT, assuming not a 
primary demand of BCAA in these tissues 
during late pregnancy and early lactation. 
Nonetheless, as mRNA measurements are 
not fully representative of the actual 
protein, future studies comparing different 
metabolic tissues for their ability to use AA, 
should include the assessment of protein 
abundance and transporter activity in order 
to support this idea. Yet, based on the 
possibility that, at translation level, AA may 
be readily taken up by scAT especially 
toward the end of the transition period 
(Liang et al., 2019), it is certainly 
conceivable that BCAA (and other AA) are 
utilized within cellular adipose metabolism, 
i.e., to sustain metabolic turnover. 
Following cellular uptake, BCAA may 
be used either for anabolic processes or, if 
the supply exceeds the requirement, be 
rapidly catabolized in the different tissues 
(Blouin et al., 2002). Generally, the liver is 
considered as the major organ of AA 
disposal; however, its capacity for direct 
BCAA degradation is limited in ruminants 
(Lapierre et al., 2002; Raggio et al., 2004). 
It has been acknowledged though, that the 
initial step in BCAA catabolism, the 
reversible deamination via BCAT mostly 
occurs in extrahepatic tissues, such as 
muscle and AT (Bergen et al., 1988; 
Lapierre et al., 2002; Zhang et al., 2017). 
66  Manuscript II 
 
Consequently, and in support of previously 
published data (Suryawan et al., 1998; 
Webb et al., 2019), we detected lowest 
BCAT2 mRNA abundance in liver. This 
may be indicative of a reduced hepatic 
BCAA transamination capacity, allowing 
for a greater availability of BCAA to 
peripheral tissues regardless of differences 
in DMI. In fact, greatest BCAT2 abundance 
was observed in scAT: Together with the 
observed elevated abundance of BCAAT in 
scAT, it seems that scAT not only may be 
important for BCAA uptake but also for 
their initial degradation. 
Human studies have shown that 
prolonged periods of negative energy 
balance may lead to decreases in body mass 
due to losses of both body fat and skeletal 
muscle, with a ratio of approximately 75% 
AT and 25% fat-free mass (Carbone et al., 
2012). And because body condition might 
affect lipid as well as protein mobilization 
in transition dairy cows (Kokkonen et al., 
2005), we presumed that the over-
conditioned cows in our study, being 
metabolically more challenged because of a 
more severe negative energy balance 
associated with a more reduced early 
lactation DMI (Schuh et al., 2019), could 
have had a higher tissue mobilization in 
general. The observed differences in pre- 
and postpartum BCS and BW between the 
two groups (HBCS: prepartum 3.77 ± 0.08 
and 810 ± 28 kg, postpartum 3.30 ± 0.06 
and 674 ± 11 kg; NBCS: prepartum 3.16 ± 
0.06 and 715 ± 25 kg, postpartum 2.89 ± 
0.06 and 631 ± 12 kg) would clearly be in 
favor of this. Further data collected from the 
same study population as used herewith, 
indicate that high BCS and BFT were 
associated with a greater mRNA abundance 
of the two muscle-specific ligases muscle 
RING finger protein-1 (MuRF-1) and 
atrogin-1 (Ghaffari et al., 2019), and 
consequently, a more stimulated proteolysis 
in these cows seems likely. Over-
conditioned cows might then also have a 
greater reservoir of BCAA and 
counteractively a higher tissue abundance 
of BCAA degrading enzymes. However, 
only the latter could be confirmed in parts. 
The decreased feed and thus protein intake 
of HBCS cows, leading to at least greater 
reductions in plasma BCAA around the 
time of parturition, might have masked any 
such effects concerning circulating BCAA. 
As the rate-limiting enzyme of BCAA 
catabolism and due to the tight regulation of 
its activity (Harris et al., 1994), the BCKDH 
complex is considered probably the most 
important key enzyme in overall BCAA 
metabolism. For the mRNA abundance of 
BCKDHA, the E1α subunit of BCKDH, we 
were able to observe group differences in 
scAT, with HBCS cows having almost 
continuously higher BCKDHA mRNA 
abundances than NBCS cows. Thus, despite 
the lesser feed intake and probably because 
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of the higher BW, HBCS cows could have 
had a greater capacity for the irreversible 
degradation of BCAA, or rather their keto 
acids, in scAT than NBCS animals. This 
would be in contrast to most studies in 
nonruminants, where a greater body 
condition (i.e., obesity) has often been 
associated with a downregulation of 
adipose BCAA catabolism (She et al., 2007; 
Pietiläinen et al., 2008; Connor et al., 2010; 
Polakof et al., 2018). However, there is also 
some evidence of increased BCAA 
oxidation in obese subjects likely due to 
increased protein turnover (Welle et al., 
1992; She et al., 2013). Nonetheless, the 
differences in BCKDHA mRNA between 
HBCS and NBCS slightly decreased over 
time possibly reflecting the greater 
metabolic change of HBCS cows starting 
off in a more anabolic situation prepartum 
and then, in consequence of the possibly 
greater tissue mobilization, approaching a 
more catabolic situation during early 
lactation as compared to NBCS cows. 
We did not see any group differences 
concerning the mRNA abundance of the 
E1ß subunit of BCKDH (BCKDHB). Based 
on studies in nonruminants by Shimomura 
et al. (1990) and Lu et al. (2009), it has been 
concluded that the E1α subunit is the 
enzyme complex’s main site of 
phosphorylation (deactivation) and 
dephosphorylation (activation) by a specific 
kinase and phosphatase, respectively. 
Further, the E1α subunit seems more 
responsive to nutritional and hormonal 
influences than other subunits (Harris et al., 
1997; Shimomura et al., 2001; Kadota et al., 
2013). Any metabolic differences caused by 
variations in body condition of the cows 
may therefore rather be expected for 
BCKDHA than BCKDHB. However, 
previously published results by our group 
showing greater BCKDHB mRNA 
abundance in liver as compared to muscle 
and scAT in early-lactating dairy cows 
(Webb et al., 2019) could not be confirmed. 
Herein we observed highest BCKDHB 
mRNA in muscle, followed by liver and 
then scAT. In contrast to the present study, 
the animals used in the prior trial were all 
primiparous cows, not yet fully mature. The 
existence of age-dependent changes in 
BCAA catabolism has been well 
documented for different tissues in sheep: 
Both BCAT and BCKDH activities seem to 
be affected by the ever-changing nutrient 
demand and cellular composition of tissues 
such as liver, muscle and AT during various 
developmental stages (Goodwin et al., 
1987; Bergen et al., 1988; Faure et al., 
2001). It is possible that this is also valid for 
dairy cows of different ages. 
At all time points and for both groups, 
greatest BCKDHA protein abundance was 
observed in liver, followed by scAT and 
muscle, which had almost similar values. 
Even though flux studies have shown that 
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hepatic degradation of BCAA/BCKA is 
limited in lactating dairy cows (Lapierre et 
al., 2002; Raggio et al., 2004), upregulation 
of the main enzyme responsible for 
irreversible liver BCKA oxidation could be 
seen as a negative feedback mechanism 
compensating for the possibly low hepatic 
BCAA flux and thus, ensuring overall 
BCAA/BCKA homeostasis. Different 
human studies have shown that in the 
context of metabolic disorders such as IR 
and non-alcoholic fatty liver, 
concentrations of BCAA and their 
downstream catabolites, like short-chain 
acylcarnitines, can be elevated in plasma 
(Newgard et al., 2009) and liver (Lake et al., 
2015), respectively, due to a dysregulation 
of BCAA degrading enzymes. In transition 
dairy cows, propionyl-carnitine (i.a. a by-
product of Ile and Val catabolism) has been 
reported to be increased in plasma during 
various disease states (i.e., mastitis, 
metritis, laminitis, and retained placenta; 
Hailemariam et al., 2014). Yet, to our 
knowledge, BCAA metabolism in relation 
to the acylcarnitine status of metabolically 
challenged cows has not been described yet. 
At d 49 a.p. the protein abundance of 
BCKDHA was lower in liver and higher in 
scAT of HBCS compared to NBCS cows. 
At this time cows were dried off and 
previous differential feeding (starting 15 wk 
a.p.) was ceased. An energetic surplus 
appears likely and could explain the more 
reduced need of HBCS cows to oxidize 
BCAA transamination products. Due to 
over-conditioning and despite lower DMI, 
animals in the HBCS group had greater fat 
reserves and probably an increased 
metabolic turnover in AT allowing for more 
BCKA to be degraded in this tissue as well 
as for the respective end products to be used 
for anabolic processes like 
glyceroneogenesis. By testing different 
tracer substrates for their contribution to 
TCA metabolism as well as adipocyte 
differentiation, Green et al. (2016) found 
that catabolism of BCAA accounts for one-
third of lipogenic acetyl-CoA generation 
and that functional knockdown of BCAA 
degradation may impair lipid accumulation 
and adipocyte differentiation. Through 
increased BCKA oxidation and the 
donation of additional carbon sources, 
BCAA catabolism thus fuels anaplerosis as 
well as de novo lipogenesis. It is therefore 
possible that, before parturition, HBCS 
cows also used BCAA, or rather their 
metabolites, to build up more body fat. 
Normal-conditioned cows, being in a less 
anabolic state, were on the other hand 
probably sufficiently supplied by glycolytic 
processes generating acetyl-CoA and 
further fatty acids and glycerol for 
prepartum lipogenesis. The metabolic shift 
to lactation, however, seemed to level off 
previously established differences in 
BCKDHA protein abundance between the 
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two groups, leading to decreased postpartal 
values in scAT of both HBCS and NBCS 
cows. Contrary to previously described 
results in obese rats, humans and pigs (She 
et al., 2007; Newgard et al., 2009; Polakof 
et al., 2018), we did not detect any general 
downregulation of BCAA catabolic 
enzymes in the AT of HBCS cows 
compared to NBCS cows. However, the 
event of lactation is a very specific situation 
and may lead to changes of many regulatory 
processes as well as shifts in metabolic 
priorities of nutrients. It might also be that 
in our case over-conditioning was not 
severe enough to elicit such a strong tissue 
response as observed in the aforementioned 
studies. 
Regardless of body condition, hepatic 
BCKDHA abundance peaked at d 3 p.p., 
which could be related to the fact that 
during the first weeks after parturition 
energy balance is usually the most negative 
in dairy cows (e.g., Tienken et al., 2015). 
Herein, despite differences in DMI, energy 
balance of both groups reached the same 
nadir in the first week after calving. To 
antagonize this energy deficit, protein 
abundance of BCKDHA may be increased 
around calving to enable the generation of 
additional energy via irreversible oxidation 
of BCKA. As the energy balance slowly 
increases again during lactation, the need 
for additional energy diminishes and 
BCKDHA protein may decrease again.  
 
CONCLUSIONS 
In this study, cows calving with high 
BCS were likely oversupplied with 
nutrients during late pregnancy and were 
therefore in a more anabolic situation than 
the normal-conditioned animals. 
Consequently, as indicated by the lower 
hepatic BCKDHA protein abundance 
prepartum, the over-conditioned cows may 
have relied less on the oxidation of BCAA 
transamination products for the generation 
of energy. However, given the greater 
prepartal BCKDHA protein abundance in 
scAT, high BCS cows may have instead 
catabolized BCKA in AT supporting 
metabolic turnover therein. Steadily 
increased mRNA abundance of the most 
relevant BCAAT as well as BCAT2 in 
scAT during late pregnancy and early 
lactation indicates that AT, or more 
precisely scAT, may be an important site of 
BCAA uptake and initial degradation in 
dairy cows that is by contrast not influenced 
by body condition.
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Supplemental Table S1. Ingredients and chemical composition of the diets [from Schuh et al (2019)] 
Item 
Late lactation  Dry period  Early lactation 
Wk 15 to 7 a.p. 
 
 
Wk 7 a.p. to 
parturition  
Wk 1 to 14 p.p. 
HBCS NBCS  HBCS / NBCS  HBCS / NBCS 
Ingredient       
Grass silage 22.4 32.0  32.0  22.4 
Corn silage 20.7 32.0  32.0  20.7 
Pressed beet pulp silage 12.5 -  -  12.5 
Hay 5.5 5.4  5.4  5.5 
Straw 2.3 4.1  4.1  2.3 
Vitamin and mineral mix1 0.4 0.7  0.7  0.4 
Concentrate2 36.2 25.8  25.8  36.2 
Chemical composition       
ME (MJ/kg DM) 10.8 10.6  10.6  10.8 
NEL (MJ/kg DM) 7.2 6.8  6.8  7.2 
Crude protein (g/kg DM) 170 157  157  170 
Utilizable crude protein 
(g/kg DM) 
156 149  
149 
 156 
aNDFOM † (g/kg DM) 359 382  382  359 
ADFOM ‡ (g/kg DM) 204 223  223  204 
Ruminal N balance (g/d) 3.4 2.3  2.3  3.4 
1Provided per kg total mixed ration (on DM basis): Ca, 0.36 g; P, 0.36 g; sodium, 0.36 g; Mg, 0.40 g; Zn, 28 mg; 
Mn, 17 mg; Cu, 6.0 mg; Co, 0.24 mg; I, 0.80 mg; Se, 0.21 mg; vitamin A, 4.000 IU, vitamin D, 600 IU, vitamin 
E, 20 mg (RINDAMIN K11 ATG, Schaumann, Pinneberg, Germany). 
2Concentrate portion consisting of barley (6.5% of DM), corn grain (8.8% of DM), soybean meal (5.9% of DM), 
and canola meal (6.5% of DM). 
† aNDFOM, ash free Neutral Detergent Fiber of organic matter. 
‡ ADFOM, Acid Detergent Fiber of organic matter. 
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Supplemental Table S2. Number of cows affected by clinical conditions occurring from calving to the 
first 6 weeks after calving in HBCS and NBCS cows 
1 dystocia, inflammation of the conjunctiva of the eye  
Clinical condition HBCS (n = 19) NBCS (n = 19) 
 No. cows No. cases No. cows No. cases 
   Mastitis 8 16 6 11 
   Ketosis 4 5 2 2 
   Milk fever 4 5 2 4 
Locomotion 7 8 3 4 
   Retained fetal membranes/endometritis 1 1 2 2 
   Other conditions1 3 4 3 3 
   Total clinical conditions 27 39 15 26 
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Supplemental Table S3. Plasma amino acid (AA) concentrations (µmol/L) of high (HBCS) and normal 
body condition score cows (NBCS) on d -49, 3, 21 and 84 relative to parturition 
  Time P-value1 
 Group -49 3 21 84 G T G × T 
Ala 
HBCS 283.2 ± 26.6ab 209 ± 16.4c 241.8 ± 25.6bc 329.5 ± 25.8a 
0.214 <0.001 0.729 
NBCS 294.6 ± 22.5ab 257.7 ± 19.9b 253.6 ± 17.4b 329.4 ± 37.4a 
         
Arg 
HBCS 78.4 ± 5.5a 
3 
21 
84 
48.7 ± 3.2b 66.8 ± 6.9a 84.1 ± 7.2a 
0.471 <0.001 0.238 
NBCS 75.7 ± 4.7ab 59.3 ± 4.8b 60.6 ± 4.4b 96.1 ± 8.3a 
         
Asn 
HBCS 37.4 ± 2.7b 35 ± 3b 49.1 ± 4.1a 56.7 ± 5.2a 
0.421 <0.001 0.309 
NBCS 42.2 ± 3.5b 39.9 ± 3.5b 43.8 ± 2.9b 62.6 ± 6.3a 
         
Glu 
HBCS 78.5 ± 6.2a,* 52.0 ± 3.9b,* 62.7 ± 5.4ab 65.7 ± 4.6ab 
0.240 <0.001 0.020 
NBCS 89.3 ± 7.0a 66.3 ± 5.3b 58.7 ± 3.2b 58.8 ± 2.6b 
         
Gln 
HBCS 352.8 ± 28.8 320.1 ± 28.3 326.8 ± 36.8 294.7 ± 23 
0.911 0.017 0.414 
NBCS 347.6 ± 24.8 338.7 ± 24.2 279.4 ± 22.3 288.3 ± 19.0 
         
Gly 
HBCS 244.1 ± 30.3c 554.8 ± 46.1b 854.6 ± 57.9a,* 433.1 ± 42.2b 
0.019 <0.001 <0.001 
NBCS 304.5 ± 35.7c 552.1 ± 52.2ab 576.4 ± 48.8a 416.1 ± 51.4bc 
         
His 
HBCS 39.6 ± 3.9 30.3 ± 1.9 32.5 ± 3.7 35.8 ± 3.9 
0.485 0.093 0.483 
NBCS 33.6 ± 3.5 33.1 ± 3.9 26.7 ± 2.3 34.3 ± 3.5 
         
Ile 
HBCS 139.4 ± 10.1b 115.7 ± 9.9b 179.1 ± 13.2a,* 140.8 ± 12.6b 
0.930 0.010 0.027 
NBCS 142.2 ± 8.6 142.2 ± 12.3 158.9 ± 26.3 150.9 ± 9.7 
         
Leu 
HBCS 160.2 ± 11.5a 108.7 ± 8.0b 145.6 ± 11.3a 149.0 ± 14.8a 
0.792 0.003 0.181 
NBCS 141.4 ± 10.9 128.3 ± 11.1 136.2 ± 18.0 162.7 ± 12.2 
         
Lys 
HBCS 110.0 ± 9.7a 63.5 ± 4.9c 81.8 ± 6.2bc 94.5 ± 8.9ab 
0.168 <0.001 0.065 
NBCS 81.2 ± 7.1ab 66.2 ± 5.6b 64.4 ± 4.4b 95.6 ± 10.7a 
         
Met 
HBCS 28.9 ± 2.4a 22.3 ± 2.1b 20.3 ± 2.2b 23.7 ± 2.7ab 
0.851 0.001 0.237 
NBCS 25.6 ± 2.1 25.9 ± 2.3 18.0 ± 1.7 22.1 ± 1.9 
         
Phe 
HBCS 50.0 ± 3.3 45.3 ± 3.1 43.3 ± 3.2 47.5 ± 3.7 
0.366 0.164 0.384 
NBCS 51.3 ± 3.1 53.5 ± 4.8 42.2 ± 2.9 48.9 ± 2.8 
         
Ser 
HBCS 84.8 ± 5.4b 102.6 ± 8.6ab 114.5 ± 9.0a 111.0 ± 9.6ab 
0.405 <0.001 0.259 
NBCS 86.3 ± 6.8b 125.5 ± 10.9a 112.1 ± 7.5a 110.0 ± 11.9ab 
         
Thr 
HBCS 104.3 ± 8.3ab 78.9 ± 8.3c 92.4 ± 10.8bc 136.1 ± 14.8a 
0.806 <0.001 0.847 
NBCS 107.2 ± 9.2ab 87.2 ± 8.1b 88.8 ± 7.7b 152.1 ± 15.9a 
         
Trp 
HBCS 32.0 ± 2.5a 23.2 ± 2.1b 29.3 ± 2.2ab 37.9 ± 3.6a 
0.307 <0.001 0.536 
NBCS 35.0 ± 4.5ab 28.6 ± 2.6b 27.7 ± 2.2b 39.2 ± 3.2a 
         
Tyr 
HBCS 59 ± 5a 32.2 ± 3.0c 42.8 ± 3.6bc 56.3 ± 6.8ab 
0.685 <0.001 0.424 
NBCS 55.7 ± 3.9a 40.4 ± 4.1b 39.3 ± 2.4b 57.4 ± 5.2a 
         
Val 
HBCS 298.8 ± 22.9a 228.0 ± 18.6b 306.2 ± 25.6a 307.5 ± 25.6a 
0.324 0.002 0.167 
NBCS 254.4 ± 16.7 247.7 ± 18.4 275.7 ± 30.3 318.3 ± 20.7 
         
80  Manuscript II 
 
 
Total 
AA 
HBCS 2181.6 ± 151.1b 2070.3 ± 130.2b 2689.6 ± 184.1a 2404.1 ± 178.3ab 
0.615 0.028 0.052 
NBCS 2167.7 ± 139.8 2292.5 ± 152.4 2262.6 ± 135.8 2442.7 ± 186.5 
         Total 
BCAA 
HBCS 600.7 ± 39.1a 451.8 ± 36.0b 655.8 ± 47.6a 593.2 ± 47.4a 
0.568 0.008 0.117 
NBCS 538.0 ± 35.4 518.2 ± 40.8 570.9 ± 73.9 631.9 ± 41.3 
         
3-MH2 
HBCS 4.3 ± 1.4b 16.0 ± 2.9a 7.3 ± 2.2b 3.0 ± 1.3b 
0.587 <0.001 0.233 
NBCS 7.4 ± 2.8b 12.1 ± 2.2a 4.1 ± 0.9b 3.3 ± 0.5b 
         1 Statistical comparisons: G = group effect; T = time effect; G × T = group by time interaction.  
Means in a row with superscripts without a common letter differ (P < 0.05).  
* Different from NBCS (P < 0.05) within the same time point.  
2 3-methylhistidine.
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5 General discussion and conclusions 
The overall aim of the present thesis was to investigate the regulation of BCAA metabolism 
in major metabolic tissues of dairy cows during late pregnancy and early lactation. For this, two 
studies were carried out (manuscript I and II). The first one (manuscript I) was conducted to 
characterize the potential enzymatic capacity of AT, alongside liver, muscle and MG, in BCAA 
metabolism in dairy cows during early lactation by assessing the serum BCAA profile, the 
tissue abundance as well as the activity of the main BCAA catabolic enzymes (in part for BCAT 
and completely for BCKDH). The second study (manuscript II) aimed at examining the changes 
in BCAA metabolism, i.e., the plasma BCAA concentrations and the abundance of the BCAA 
transporters and degrading enzymes in AT, muscle and liver of transition cows that were either 
normal- or over-conditioned at calving. It was hypothesized that early lactation is associated 
with tissue-specific changes in the BCAA transporters and catabolic enzymes and that BCAA 
metabolism in AT contributes significantly to the degrading pathway. Moreover, it was 
assumed that over-conditioned cows, having a higher tissue mobilization than cows with normal 
body condition, would exhibit specific alterations in their systemic and tissue-specific BCAA 
metabolism. 
 
Potential capacity of different bovine tissues for BCAA metabolism 
After absorption, most EAA are degraded in the liver, whereas catabolism of BCAA may 
occur in a wide range of metabolic tissues, e.g., liver, AT, muscle and kidney, both in ruminants 
and nonruminants (Goodwin et al., 1987; Suryawan et al., 1998), requiring significant 
interorgan transport of BCAA and their metabolites. Generally, the uptake and output of AA 
across an organ may provide an indication of the tissue’s metabolic capacity to degrade or use 
them for protein synthesis. This can be assessed indirectly by measuring the arteriovenous (A-
V) difference via indwelling catheters, i.e., the AA concentration in the artery leading into the 
organ (afferent vessel) and in the vein leading out of the organ (efferent vessel), respectively 
(Baumrucker, 1985). The A-V difference may then be multiplied by the rate of blood (or 
plasma) flow across the respective organ to obtain a more quantitative entity: the organ-specific 
AA net flux (Brosnan, 2003). A negative flux thereby indicates substrate uptake (or removal) 
and a positive flux substrate release. It should be noted though, that measuring nutrient fluxes 
may also have its boundaries, e.g., underestimation of actual transport rates as cellular transport 
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can occur bidirectionally (Baumrucker, 1985) or inaccurate assumption of constant intracellular 
substrate pools (Nielsen, 2003). Assessing the tissue abundance and activity of specific AA 
transporters and enzymes may however be an alternative estimate of AA flux and might give 
additional information about possible contributions of and regulatory targets within 
metabolically important tissues.  
For decades it has been known that AT is an important storage of lipids as well as an 
endocrine gland regulating lipid and glucose metabolism. Albeit, its role in systemic AA and 
protein metabolism has been less appreciated, especially in ruminants. It has already been 
described that, in vivo, human AT can take up significant amounts of glutamate and may in turn 
release glutamine and alanine (Frayn et al., 1991), all of which are important by-products of 
BCAA metabolism. In a later study, Herman et al. (2010) demonstrated the possible capacity 
of murine AT to catabolize circulating BCAA and that BCAA degrading enzymes in AT may 
contribute to the coordinated regulation to modulate circulating BCAA levels. Very recently, it 
was also shown for dairy cows that through upregulation (mRNA and protein) of different 
transporters (e.g., SLC1A5, SLC1A3 and SLC38A1), bovine AT may take up significant 
amounts of AA from plasma depending on nutrient availability (Liang et al., 2019). According 
to the results of the present studies, where up to 5 different tissues (liver, skeletal muscle, MG, 
one or two types of AT) were compared for their potential capacity to metabolize BCAA, AT 
consistently had the greatest mRNA abundance of the BCAA transporters, i.e., SLC1A5, 
SLC7A5 and SLC38A2, and the BCAA transaminating enzyme BCAT2, underscoring that AT 
may be an important site of BCAA uptake and initial degradation in dairy cows. In support of 
this, earlier studies by Bergen et al. (1988) and Papet et al. (1988) have revealed that, in vitro, 
ovine AT may exhibit highest leucine deamination and intermediate (keto-)leucine 
decarboxylation activity when compared to other tissues like muscle, liver and kidney. 
As some end products of BCAA catabolism (e.g., succinyl-CoA and acetyl-CoA) may enter 
the TCA cycle, there is a close connection between BCAA and fatty acid metabolism 
(Kainulainen et al., 2013). But also, at virtually every other step of BCAA catabolism, the 
resulting metabolites may be diverted for fatty acid metabolism or other anaplerotic pathways 
(see Figure 5; chapter 1.3.2). Correspondingly, it has been reported that AT readily converts 
BCAA carbon skeletons into de novo fatty acids and that insulin may increase the conversion 
rate of leucine to lipids in murine AT but not in liver or muscle (Rosenthal et al., 1974). 
Furthermore, Green et al. (2016) observed that inhibition of BCAA catabolism (via knockdown 
of Bckdha in 3T3-L1 cells) can compromise adipocyte differentiation, demonstrating the 
importance of BCKA oxidation in adipogenesis. It should be noted however that with the onset 
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of lactation, dairy cows are usually already in a catabolic situation (with low circulating insulin 
levels and decreased peripheral insulin sensitivity), thus, any excess BCAA not directed 
towards the MG likely contribute more towards the generation of local cellular energy via the 
TCA cycle rather than towards anabolic processes such as lipogenesis or adipogenesis. In fact, 
unpublished data from one of our trials showed that close to parturition, as the cows enter a 
NNB, mRNA abundance of the key enzyme for fatty acid synthesis (fatty acid synthase) in 
scAT is down-regulated as compared to later time points. In contrast, around mid-lactation, 
when the cows achieve a state of positive energy balance again and mobilization of lipid 
storages subsides (Schuh et al., 2019), and peripheral IS is likely improved again, BCAA, or 
rather their metabolites, might be used for the restoration of previously lost body reserves. This 
is in agreement with our observation that in some cases BCKDHA mRNA and protein 
abundance in scAT may decrease over time during early lactation, illustrating some form of 
adjustability of AT for irreversible BCAA degradation depending on the metabolic status of the 
animal. However, according to Goodwin et al. (1987) and also based on our own findings for 
BCKDH, it is apparent that, despite high mRNA and protein abundances, the actual enzyme 
itself is acutely sensitive to metabolic regulators such as insulin, energy status and BCAA 
supply (Aftring et al., 1986; Hutson, 1986), and thus, under particular metabolic circumstances, 
might not be fully active in certain tissues (e.g., AT or muscle).  
Concerning the potential capacity of other tissues for BCAA metabolism, studies have 
shown that, due to a considerably high expression and activity of BCAA enzymes (based on 
tissue weight) and the elevated respective net fluxes, skeletal muscle may also metabolize 
significant amounts of BCAA (Wijayasinghe et al., 1983; Pell et al., 1986; Suryawan et al., 
1998; Faure et al., 2001). Yet, our results could not quite confirm this: Except for SLC38A2, 
which is only indirectly involved in BCAA transport, and BCKDHB, mRNA of BCAA 
transporters and degrading enzymes was less abundant in skeletal muscle than in AT or most 
other tissues by comparison. Further, muscle displayed the lowest BCKDHA protein abundance 
and, as for AT, the activity of the whole BCKDH complex was below the limit of detection. 
Thus, the overall capacity of semitendinosus muscle for BCAA metabolism seems to be 
restricted to BCAA supply through muscle mobilization, but otherwise appears to be relatively 
minor in dairy cows during the herein studied periods. As stated above, with the onset of 
lactation, anabolic processes, i.e., protein synthesis in this case, requiring BCAA, have a 
subordinate role in peripheral tissues. However, a generally low abundance of muscle BCAA 
metabolism related parameters was already observable before parturition [day (d) 49 
prepartum]. In cattle, the last trimester of gestation is marked by intense fetal growth (Ferrell 
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et al., 1976), and self-evidently, there is a great demand for AA. Due to the high uteroplacental 
uptake and catabolism of BCAA (Lemons and Schreiner, 1984; Goodwin et al., 1987), it is 
suggested that BCAA are particularly important for fetal metabolism. In sheep, during late 
pregnancy, maternal tissues (particularly muscle) exhibit low BCAT activity, while fetal muscle 
and placenta both display high corresponding activities (Goodwin et al., 1987). This adaptation, 
also conceivable for dairy cows, may limit maternal BCAA (or rather BCKA) oxidation while 
BCAA utilization for protein synthesis in the growing fetus and placenta is likely promoted via 
increased reamination (Goodwin et al., 1987).  
Surprisingly, our results also revealed comparably low BCAT2, BCKDHA and BCKDHB 
mRNA abundance in MG. Even though the present work is lacking protein data for BCAT2, 
this observation is in contrast to previous studies, where, during lactation, MG displays greatly 
elevated abundance and activity of both BCAA catabolic key enzymes as well as increased 
respective fluxes in relation to other metabolic tissues (DeSantiago et al., 1998a; Bequette et 
al., 2002; Li et al., 2009). Usually, BCAA are taken up by the MG in excess to their output as 
milk protein, supporting the synthesis of NEAA (Mepham, 1982). For this, at least some 
transamination would be necessary; however, in our study, counter-regulatory mechanisms 
might have caused a downregulation of BCAA enzyme mRNA to avoid a further promotion of 
AA deficiency during early lactation. Albeit, the low BCKDH enzyme activity we observed in 
MG (despite a high corresponding protein abundance), was associated with BCAA being spared 
from oxidation and possibly directed to de novo protein synthesis. This would be in support of 
the idea that via mTORC1 activation BCAA, particularly leucine, may stimulate milk protein 
synthesis under certain conditions (Moshel et al., 2006; Appuhamy et al., 2012; Doelman et al., 
2015). If less (keto-) leucine is irreversibly oxidized, more protein could theoretically be 
synthesized, thus ensuring milk production. 
Previously published data on BCAA net fluxes and isotopic tracer studies in dairy cows have 
illustrated that hepatic degradation of BCAA (and their keto acids) may be greatly reduced as 
compared to other splanchnic tissues or whole body degradation (Lapierre et al., 2002; Raggio 
et al., 2004; Larsen et al., 2015). Our results confirm that possibly due to the marginal hepatic 
abundance of BCAA transporters and BCAT2, BCAA cannot be directly degraded in the liver, 
but are first available to peripheral tissues, most likely AT. The elevated hepatic mRNA and 
protein abundance as well as the activity of BCKDH detected herein suggest that bovine liver 
could still be a significant site of BCAA metabolism and that only after BCAA are converted 
to their respective keto acids, the liver may oxidize them (Harper et al., 1984; Pell et al., 1986; 
Zhang et al., 2017). Even if full hepatic BCAA/BCKA oxidation may be comparably low in 
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dairy cows, high BCKDH abundance and activity, and thus, high oxidative capacity in the liver, 
would ensure clearance of toxic BCAA metabolites from portal blood and avoid plasma 
hyperaminoacidemia. As AA cannot be stored in tissues (unlike lipids and carbohydrates), 
regulation of circulating AA via catabolic enzymes plays an important role. However, 
depending on the physiological situation of the animal, the metabolic capacity of tissues for 
degradation may change. 
 
BCAA metabolism during late gestation and early lactation in dairy cows  
In both studies, a decrease of individual and total serum/plasma BCAA concentrations was 
observed around parturition. Generally, this can be associated with the lower feed intake the 
animals expressed during that time (Von Soosten et al., 2011; Schuh et al., 2019), as apart from 
microbial and endogenous protein degradation, circulating AA are largely affected by dietary 
intake. During late pregnancy, close to parturition, feed intake in dairy cows is physiologically 
reduced (Grummer, 1995; Allen et al., 2005), most likely due to endocrine changes, the 
initiation of lipomobilization and hence, the increase in anorexiant metabolites, as well as the 
limited rumen capacity because of the growing fetus (Ingvartsen, 2006). However, metabolic 
stress, related to the NNB during the transition period, is linked to an enhanced immune 
response, e.g., an increase in immune cells and positive acute phase proteins (Esposito et al., 
2014), some of which containing substantial amounts of BCAA (Morimatsu et al., 1991; Calder, 
2006), and, thus, may further reduce their availability in the circulation. This is particularly 
applicable for our second trial, where cows, continuously differing in body condition, expressed 
differences in their tissue mobilization (Schuh et al., 2019) and therefore might have had 
dissimilar manifestations of metabolic stress. In fact, it was shown that, compared with the 
normal-conditioned cows [NBCS; BCS < 3.5; back fat thickness (BFT) < 1.2 cm], the cows 
calving with high body condition (HBCS; BCS > 3.75; BFT > 1.4 cm) were metabolically more 
challenged because of a more severe and persistent NNB, a higher lipomobilization and 
possibly a lower IS (Holtenius et al., 2003; Roche et al., 2009; Pires et al., 2013; Schuh et al., 
2019). Further, over-conditioned cows displayed a lower feed intake than NBCS cows 
throughout the study period (Schuh et al., 2019) and could have been closer to a pro-
inflammatory status (Akbar et al., 2015; Roche et al., 2015; Vailati-Riboni et al., 2016) as the 
nadir of their plasma BCAA concentrations around calving was more pronounced.  
Prolonged periods of NNB may lead to losses of both body fat and skeletal muscle, with a 
ratio of approximately 75% AT and 25% lean mass (Carbone et al., 2012). And because body 
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condition might affect lipid as well as protein mobilization in transition dairy cows (Kokkonen 
et al., 2005), it was assumed that HBCS cows, could have had a higher tissue mobilization in 
general. In support of this, different data from our trial indicate that high BCS and BFT were 
associated with a greater mRNA abundance of the two muscle-specific ligases muscle RING 
finger protein-1 (MuRF-1) and atrogin-1 (Ghaffari et al., 2019), thus, an increased proteolysis 
in these cows seems likely. Consequently, the HBCS cows would then also have had a greater 
pool of BCAA and, counteractively, an increased tissue abundance of BCAA transporters and 
catabolic enzymes. However, this could only be confirmed in parts. The complex metabolic 
changes and adaptations occurring in the bovine organism during the shift from pregnancy to 
lactation might in some cases have had a greater effect on BCAA metabolism than the 
differences in body condition of the animals.  
During lactation, when energy and nutrient demands rise substantially, whole-body BCAA 
transport and degradation mostly appear elevated as compared to non-lactating states 
(Tesseraud et al., 1993; DeSantiago et al., 1998a). Accordingly, except for scAT, where we 
observed constant expression levels of the BCAA transporters, we mainly detected increases in 
tissue transporter mRNA from prepartum (d 49 prepartum) to postpartum for both groups, with 
respective peaks at d 21 after calving (despite overall low abundance in muscle and liver). The 
downregulation at the last sampling time point (d 84 after parturition) thereby likely reflected 
the attenuated metabolic pressure on the tissues and the reduced demand for BCAA as milk 
production slowly started to decrease at that time. In partial support of this, data by Liang et al. 
(2019) revealed that transporters for BCAA, i.e., SLC7A5, SLC1A5 and SLC3A2, were steadily 
expressed at mRNA level from d 10 prepartum to 30 postpartum in bovine scAT. Additionally, 
the protein abundance of SLC1A5 and SLC1A3 was gradually increasing during this time 
period pointing to an actually growing capability of AT for BCAA uptake even during periods 
of NNB.  
Concerning the BCAA enzymes, the changes over time were less consistent in tissues other 
than AT. It seemed that overall, especially for HBCS cows, mRNA levels of BCAA degrading 
enzymes in scAT were constantly higher before than after parturition, suggesting an elevated 
capacity for adipose BCAA catabolism in these cows before the onset of lactation. Even though 
a greater prepartum BCAA catabolism is in contrast to what is reported in the literature until 
now (Tesseraud et al., 1993; DeSantiago et al., 1998a), one possible explanation could be that 
over-conditioned animals having a greater fat mass, or more specifically a larger size and 
number of adipocytes (Jo et al., 2009), generally possess a higher abundance of mitochondrial 
BCAA enzymes in this tissue, but that during early lactation, when tissue mobilization reaches 
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its maximum, the greater lipolysis in HBCS cows might diminish these circumstances. In 
addition, over-conditioned cows are more likely to experience a nutrient oversupply during late 
pregnancy (Ingvartsen, 2006); an upregulation of catabolizing enzymes in peripheral tissues 
would therefore be an efficient countermeasure to regulate elevated nutrient levels. 
As the rate-limiting enzyme in BCAA catabolism and due to the sensitive regulation of its 
activity (Harris et al., 1994), the mitochondrial BCKDH complex is considered probably the 
most important key enzyme in overall BCAA metabolism. The E1α subunit (BCKDHA) is 
thereby especially responsive to nutritional and hormonal influences (Harris et al., 1997; 
Shimomura et al., 2001; Kadota et al., 2013) and is most likely the enzyme’s main site of 
regulation (Shimomura et al., 1990; Lu et al., 2009). For both the mRNA and protein abundance 
of BCKDHA, we observed group differences in scAT, with HBCS cows having higher 
expression values than NBCS cows. Therefore, despite the lesser feed intake, HBCS cows could 
have had a greater ability to irreversibly catabolize BCAA, or rather their keto acids, in scAT 
compared to NBCS animals. Moreover, the differences in scAT BCKDHA mRNA between the 
two groups, which were almost permanently observed, slightly decreased over time possibly 
reflecting the bigger metabolic change of HBCS cows: The HBCS cows, having greater tissue 
reserves, started off in a more anabolic situation but due to the higher mobilization rate, reached 
a more catabolic condition during early lactation, thus, leveling up to the NBCS group. Further, 
it is likely that due to the nutrient surplus, animals in the HBCS group had an increased 
metabolic turnover in AT during late pregnancy allowing for more BCAA metabolites to also 
be used for synthesizing even more body fat. Normal-conditioned cows, being in a less anabolic 
state prepartum could have been sufficiently supplied by glycolytic processes providing acetyl-
CoA and fatty acids and might have been less in need of BCAA to additionally support 
lipogenesis. This possible anaplerotic link between BCAA catabolism and lipid metabolism in 
HBCS cows is further substantiated by a study of Schäff et al. (2012), where a more intensive 
mobilization of body fat after calving was associated with a lower feed intake and increased 
anaplerosis, TCA cycling and mitochondrial oxidation in dairy cows. 
Interestingly, in liver we observed a different picture: Prepartum, HBCS cows had a lower 
hepatic BCKDHA protein abundance than NBCS cows. Yet, for both groups abundance peaked 
around parturition and particularly for the HBCS group values were lower before than after 
calving. It appears as if prepartum over-conditioned cows were less in need of hepatic BCKA 
oxidation than normal-conditioned cows. However, at calving, when energy balance is usually 
the most negative (Tienken et al., 2015), protein abundance of BCKDHA in the liver could be 
upregulated for the generation of additional energy via irreversible BCKA oxidation. As the 
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energy balance slowly increases again during early lactation, the need for additional energy 
may decrease. The subsequent decline of BCKDHA protein could thus reflect the lower 
metabolic pressure on the liver. 
Within our first trial only the time from d 1 to 105 after parturition was covered. Both the 
mRNA as well as the protein abundance of the assessed BCAA enzymes mostly increased 
during the course of the experiment, especially in AT and MG, allowing in this case for 
enhanced BCAA degradation in these tissues with progressing lactation. However, as for the 
assessed BCKDH activity, only liver showed time dependent changes which could point to 
more metabolic flexibility in this tissue. 
 
Conclusions 
The herein presented studies show that the metabolism of BCAA is a tightly regulated 
system, which involves the complex interactions of several metabolic tissues to fulfill the ever-
changing nutrient demands of high-yielding dairy cows in different physiological and 
pathophysiological conditions. Studying the changes of BCAA transporters and catabolic 
enzymes in different tissues of dairy cows during the transition from late gestation to early 
lactation has revealed that AT may be an important site of BCAA uptake and (initial) 
degradation at that time, thus, confirming our hypothesis. Enhanced capacity for BCAA 
catabolism in AT, particularly observed for the cows with high body condition, might be linked 
with lipid metabolism through increased anaplerosis, especially during late gestation, when 
animals are in a more anabolic situation and may use additional substrates such as BCAA 
metabolites to build up body fat. However, further research involving e.g., radio-labelled 
isotopes should address more quantitatively the exact contributions of BCAA catabolism to 
lipogenic and adipogenic processes in dairy cows.  
According to the mostly low abundance (and activity) of BCAA transporters and enzymes, 
semitendinosus muscle appears to play a subsidiary role in BCAA metabolism of transition 
dairy cows, that is except for the supply of BCAA through muscle mobilization. Whether other 
types of muscle could have a greater capacity for BCAA transport and degradation is not clear 
yet and should be investigated in the future. Intriguingly, we also observed mainly low 
abundance and activity of BCAA enzymes in MG. In contrast to studies in other mammalian 
species, where the NNB might not be as deep and persistent, actual BCAA/BCKA degradation 
in the MG could be downregulated in high-yielding dairy cows to avoid further deficiencies 
and spare BCAA for milk protein synthesis. 
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Despite probably reduced hepatic BCAA/BCKA fluxes, a counter-regulatory mechanism 
seems to allow for activation of the BCKA oxidative pathway in bovine liver, ensuring the 
degradation of possibly toxic BCAA metabolites. And depending on the manifestation of the 
energy deficit dairy cows experience during the transition period, hepatic BCKA oxidation may 
contribute more or less to the generation of energy in support of lactation. Here it seems that 
prepartum, especially cows with high body condition and likely oversupplied with nutrients 
during late gestation, might rely less on additional energy stemming from hepatic BCKA 
oxidation and instead may have catabolized BCAA transamination products in AT supporting 
the metabolic turnover therein. 
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6 Summary 
The transition from late pregnancy to early lactation is one of the most crucial times in a 
dairy cow’s life. It is characterized by drastic changes in nutrient balance as well as metabolic 
and endocrine shifts throughout the whole body. To cover the increased nutrient demands of 
lactation, dairy cows have to mobilize body reserves from adipose tissue (AT) and skeletal 
muscle. The extent of tissue mobilization is thereby more pronounced in cows that are over-
conditioned at calving. Consequently, those animals are more susceptible to develop metabolic 
disorders and a more enhanced peripheral insulin resistance (IR) than cows in normal body 
condition. While body fat is generally repartitioned to provide fatty acids for the synthesis of 
energy and milk fat, body protein is mobilized to release amino acids (AA) for protein synthesis, 
direct oxidation and hepatic gluconeogenesis. However, specific regulatory processes within 
the tissues are also involved and may be linked with each other. Although it is well established 
that AT can regulate glucose and lipid metabolism through adipokine secretion, its role in 
systemic protein and AA metabolism is less well-appreciated, especially in ruminants. The 
three branched-chain amino acids (BCAA), leucine, isoleucine and valine, are taken up by the 
bovine mammary gland (MG) in excess as they are major components of milk protein and 
important precursors for the synthesis of non-essential AA, energy and other metabolic 
intermediates. Further, high BCAA levels have been associated with obesity and certain 
metabolic dysfunctions, such as increased IR in mammals. Both the cellular transport and 
break-down of BCAA are tightly regulated processes, requiring the cooperation of different 
organs, one of them possibly AT. In terms of the many tissue-specific changes occurring during 
the periparturient period, assessing the actual BCAA transporters and degrading enzymes in 
major metabolic tissues may provide useful information about possibly regulated targets within 
BCAA metabolism and elucidate the general contributions of these tissues to BCAA 
metabolism in transition dairy cows.  
Thus, the aims of the present thesis were (1) to evaluate the potential enzymatic capacity of 
AT as well as liver, skeletal muscle and MG in BCAA metabolism in dairy cows during (late 
gestation and) early lactation, (2) to analyze the concentrations of circulating BCAA as well as 
the tissue abundance (and activity) of the most important BCAA transporters and enzymes in 
major metabolic tissues of dairy cows during late gestation and early lactation and (3) to 
investigate the effect of over-conditioning at calving on the aforementioned parameters of 
systemic and tissue BCAA metabolism in dairy cows during late gestation and early lactation. 
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In the first study (manuscript I), we aimed to test the potential enzymatic capacity of AT 
(alongside liver, muscle and MG) in BCAA metabolism in dairy cows during early lactation. 
We hypothesized that early lactation is associated with tissue-specific changes in the key 
enzymes of BCAA metabolism due to particular metabolic adaptations and that BCAA 
enzymes in AT contribute significantly to the degrading pathway. For this, tissue samples (i.e., 
subcutaneous and visceral AT, liver, M. semitendinosus and udder parenchyma) and blood were 
collected on days (d) 1, 42 and 105 postpartum (p.p.) from 25 primiparous Holstein cows during 
slaughter. Serum BCAA profiles were analyzed and the mRNA and protein abundance as well 
as the activity in the different tissues were assessed for the BCAA catabolic enzymes, partly for 
the branched-chain aminotransferase (BCAT) and completely for the branched-chain α-keto 
acid dehydrogenase (BCKDH). Total BCAA as well as individual isoleucine and valine 
concentrations in serum were lowest on d 1 p.p. and increased thereafter to a steady level for 
the duration of the experiment. This was associated with the physiologically reduced feed and 
thus protein intake around calving as well as a possible increase in immune parameters (often 
observed in cows shortly after parturition), the latter containing and using significant amounts 
of BCAA. Pronounced differences between the tissues were detected at all molecular levels. 
The mRNA abundance of the mitochondrial isoform of BCAT (BCAT2) was greater in both 
types of AT than in the other tissues studied, indicating that AT could be an important site for 
initial BCAA degradation during early lactation in dairy cows. Surprisingly, muscle mostly 
tended to overall low mRNA, protein and activity levels of BCAA enzymes which in this case 
could imply a rather subsidiary involvement in BCAA catabolism. High BCKDH abundance 
and activity in liver, possibly a countermeasure towards the therein usually reduced BCAA flux 
in cows, was linked to a greater hepatic oxidative capacity for BCAA or rather their keto acids, 
supposably to prevent hyperaminoacidemia and remove toxic BCAA intermediates. Despite 
elevated protein abundance, the corresponding BCKDH activity was reduced in MG. Therefore, 
it was assumed that, during early lactation, BCAA and their metabolites might be spared from 
mammary oxidation and instead conserved for milk protein synthesis.  
Within the second study (manuscript II) the objectives were to determine the changes in 
circulating BCAA levels in cows that were either over- or normal-conditioned at calving and 
to identify the differences in the mRNA abundance of the most relevant BCAA transporters as 
well as the mRNA and protein abundance of the BCAA key enzymes in AT, muscle and liver 
of these animals during the transition from late pregnancy to early lactation. It was hypothesized 
that over-conditioned cows, having a higher tissue mobilization and likely showing a more 
decreased insulin sensitivity than cows with normal body condition, would exhibit specific 
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alterations in BCAA metabolism. The experimental set-up included 38 multiparous Holstein 
cows that were allocated 15 weeks antepartum (a.p.) to a normal-conditioned (NBCS; n = 19) 
or high-conditioned group (HBCS; n = 19), receiving differential feeding during late lactation 
to reach the targeted differences in body condition score (BCS) and back fat thickness (BFT) 
(NBCS: BCS < 3.5 and BFT < 1.2 cm; HBCS: BCS > 3.75 and BFT > 1.4 cm) until dry-off. 
During the dry period and the next lactation, cows were fed the same diets, whereby differences 
in BCS and BFT were retained. Blood and biopsies from subcutaneous AT (scAT), M. 
semitendinosus and liver were sampled at days 49 a.p., 3, 21 and 84 p.p. Overall, HBCS cows 
were more metabolically challenged during early lactation than NBCS cows due to a more 
severe and persistent negative energy balance, a greater lipolysis and probably a lower insulin 
sensitivity after calving. For HBCS cows, we detected a nadir of total BCAA (and individual 
leucine and valine) plasma concentrations around parturition, which could be explained by the 
generally more decreased feed intake of this group. But it is also possible that because of the 
greater metabolic stress, HBCS cows were closer to a pro-inflammatory status around calving 
and thus had to use more AA for the generation of immune parameters further reducing BCAA 
levels. The greatest differences in BCAA transporter abundance were related to the type of 
tissue: Compared to the other tissues, we found steadily increased mRNA abundance of the 
BCAA transporters in scAT without any changes due to the body condition of the animals or 
the time relative to calving. As for the first study, we also detected highest BCAT2 mRNA in 
(sc)AT in study II (with no effects of BCS and BFT). Taken together, it therefore seems that, 
independent of body condition, (sc)AT could be important for both BCAA uptake and initial 
degradation in dairy cows. In contrast, liver (and partly muscle) expressed only low mRNA 
levels of the BCAA transporters and BCAT2 pointing to a decreased BCAA uptake and 
deamination capacity therein. We further observed that, in comparison to the NBCS group, the 
HBCS cows had higher BCKDH E1α (BCKDHA) mRNA and, prepartum, also higher 
BCKDHA protein levels in scAT suggesting a greater ability to irreversibly catabolize BCAA 
in AT, especially before calving. However, it was assumed that over-conditioned animals, 
having larger tissue reserves, were likely oversupplied with nutrients during late pregnancy and 
thus in a more anabolic situation as compared to normal-conditioned cows. As the lower hepatic 
BCKDHA protein abundance of HBCS cows before calving implies, over-conditioned animals 
may have relied less on the oxidation of BCAA transamination products for energy generation, 
but instead, through linkages in fatty acid and adipose BCAA metabolism, could have also used 
BCAA metabolites for synthesizing even more body fat before parturition. 
Summary 93 
 
In summary, the present thesis shows that the metabolism of BCAA in dairy cows is a 
complex and highly regulated system. Studying the tissue-specific changes of BCAA 
transporters and enzymes during the transition from late pregnancy to early lactation has 
demonstrated amongst others that AT may be a significant site of BCAA uptake and (initial) 
degradation in dairy cows at that time. For over-conditioned cows, increased BCAA catabolism 
in AT might be connected with lipid metabolism, especially during late gestation, when animals 
are still building up tissue reserves to support the impending lactation. However, further studies 
are needed to assess more quantitatively the exact contributions of BCAA metabolism to 
lipogenic and adipogenic processes in dairy cows. 
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7 Zusammenfassung 
Der Übergang von der späten Trächtigkeit zur frühen Laktation ist eine der kritischsten 
Phasen im Leben einer Milchkuh, welche sich vor allem durch systemische Veränderungen der 
Nährstoffbilanz, des Stoffwechsels und des Hormonhaushalts auszeichnet. Um den erhöhten 
Nährstoffbedarf der Laktation zu decken, müssen Kühe Körperreserven in Form von 
Fettgewebe (AT) und Skelettmuskulatur mobilisieren. Dabei ist das Ausmaß dieser 
Gewebemobilisierung um einiges ausgeprägter bei Tieren, welche zum Zeitpunkt der Kalbung 
überkonditioniert sind. Infolgedessen unterliegen diese Kühe einem höheren Risiko für die 
Entwicklung metabolischer Erkrankungen und einer erhöhten Insulinresistenz (IR) als 
normalkonditionierte Tiere. Während die Umverteilung des Körperfettes generell der 
Bereitstellung von Fettsäuren zur Synthese von Energie und Milchfett dient, werden die aus 
dem Körperprotein mobilisierten Aminosäuren vor allem für die Proteinsynthese, die direkte 
Oxidation und die hepatische Glukoneogenese genutzt. Es existieren jedoch auch spezifische 
regulatorische Prozesse innerhalb der Gewebe, die sich zudem gegenseitig beeinflussen 
können. Obwohl allgemein bekannt ist, dass AT sowohl den Glukose- als auch den 
Lipidstoffwechsel durch die Sekretion von Adipokinen regulieren kann, ist dessen Funktion im 
systemischen Protein- und Aminosäurestoffwechsel weniger geläufig, insbesondere bei 
Wiederkäuern. Die drei verzweigtkettigen Aminosäuren (branched-chain amino acids; 
BCAA), Leucin, Isoleucin und Valin, werden im Übermaß von der bovinen Milchdrüse 
aufgenommen, da sie Hauptbestandteile des Milchproteins und wichtige Vorläufer für die 
Synthese von nicht-essentiellen Aminosäuren, Energie und anderen metabolischen 
Intermediaten sind. Des Weiteren werden erhöhte BCAA-Konzentrationen mit Übergewicht 
und gewissen metabolischen Erkrankungen, wie z.B. einer erhöhten IR bei Säugetieren, 
assoziiert. Sowohl der zelluläre Transport als auch der Abbau der BCAA sind hochregulierte 
Prozesse, welche die Interaktion mehrerer Gewebe erfordern, u.a. vermutlich AT. Bezogen auf 
die vielen gewebespezifischen Veränderungen während der Transitphase, kann eine Erfassung 
der eigentlichen BCAA-Transporter und abbauenden Enzyme in den verschiedenen 
metabolischen Geweben peripartaler Milchkühe über potentiell regulierte Zielparameter 
innerhalb des BCAA-Stoffwechsels Auskunft geben und helfen den allgemeinen Beitrag der 
einzelnen Gewebe zum Stoffwechsel der BCAA abzuschätzen. 
Demnach waren die Ziele der vorliegenden Arbeit (1) die Beurteilung der potentiellen 
enzymatischen Kapazität von AT sowie Leber, Skelettmuskel und Euter im BCAA-
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Stoffwechsel von Kühen während der (späten Trächtigkeit und) frühen Laktation, (2) die 
Erfassung der zirkulierenden BCAA-Konzentration sowie der Gewebeexpression (und                  
-aktivität) der relevantesten BCAA-Transporter und -Enzyme in wichtigen metabolischen 
Geweben von Kühen während der späten Trächtigkeit und frühen Laktation und (3) die 
Untersuchung des Einflusses einer Überkonditionierung zum Zeitpunkt der Kalbung auf die 
zuvor genannten Parameter des systemischen und gewebebezogenen BCAA-Stoffwechsels bei 
Kühen währen der  späten Trächtigkeit und frühen Laktation. 
In der ersten Studie (Manuskript I) wurde die potentielle enzymatische Kapazität von AT 
(neben Leber, Muskel und Euter) im BCAA-Stoffwechsel von Milchkühen während der frühen 
Laktation erfasst. Die Hypothese war, dass die Frühlaktation, aufgrund von speziellen 
metabolischen Anpassungen, mit gewebespezifischen Veränderungen der Schlüsselenzyme des 
BCAA-Stoffwechsels verbunden ist und dass die BCAA-Enzyme im AT entscheidend zum 
Abbau beitragen. Hierfür wurden an den Tagen 1, 42 und 105 postpartum (p.p.) Gewebeproben 
(subkutanes und viszerales AT, Leber, M. semitendinosus und Euterparenchym) und Blut von 
25 geschlachteten primiparen Holsteinkühen entnommen. Die Serum-BCAA-Profile wurden 
analysiert und die mRNA- und Proteinexpression sowie die Aktivität der BCAA-Enzyme 
wurden in den verschiedenen Geweben erfasst, teilweise im Falle der branched-chain 
aminotransferase (BCAT) und vollständig für die branched-chain α-keto acid dehydrogenase 
(BCKDH). Die Gesamt-BCAA-Konzentration (und individuelle Isoleucin- und 
Valinkonzentration) war an Tag 1 p.p. am geringsten und stieg in Folge für die verbleibende 
Dauer des Versuches auf ein stetiges Level an. Die geringe BCAA-Konzentration um die 
Kalbung herum wurde dabei einerseits mit der zu dieser Zeit physiologisch reduzierten Futter- 
bzw. Proteinaufnahme und andererseits mit einem möglichen Anstieg von BCAA-enthaltenden 
und BCAA-verwendenden Immunparametern assoziiert. Demzufolge wird bei Kühen 
insbesondere eine Erhöhung von positiven Akute-Phase-Proteinen und Immunzellen kurz nach 
der Kalbung beobachtet. Zwischen den verschiedenen Geweben wurden ausgeprägte 
Unterschiede auf jeglichen molekularen Ebenen festgestellt. Die mRNA-Expression der 
mitochondrialen BCAT (BCAT2) war in beiden AT höher als in den anderen untersuchten 
Geweben, was zu der Annahme führt, dass AT von großer Bedeutung für den initialen Abbau 
der BCAA während der Frühlaktation bei Milchkühen sein könnte. Erstaunlicherweise tendierte 
Muskel meistens zu allgemein geringen mRNA-, Protein- und Aktivitätswerten der BCAA-
Enzyme. In diesem Fall könnte das eine eher nebensächliche Rolle des bovinen Muskelgewebes 
im BCAA-Katabolismus vermuten lassen. Eine hohe BCKDH-Expression und -Aktivität in der 
Leber, möglicherweise eine Gegenmaßnahme zu den dort meist reduzierten BCAA-Flüssen, 
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wurde mit einer erhöhten hepatischen oxidativen Kapazität für BCAA verbunden. Dies könnte 
u.a. dazu dienen, eine Hyperaminoazidämie und die Akkumulierung potentiell toxischer 
BCAA-Metabolite zu vermeiden. Trotz der erhöhten Proteinexpression, war die 
korrespondierende BCKDH-Aktivität im Euter reduziert. Es wurde daher angenommen, dass 
BCAA und deren Metabolite währen der frühen Laktation dort weniger oxidiert werden und 
stattdessen eher für die Milchproteinsynthese aufgespart werden.  
Innerhalb der zweiten Studie (Manuskript II) sollten die Veränderungen der zirkulierenden 
BCAA-Konzentrationen bei zum Zeitpunkt der Kalbung über- oder normalkonditionierten 
Milchkühen bestimmt werden und die Unterschiede der mRNA-Expression der relevantesten 
BCAA-Transporter sowie die mRNA- und Proteinexpression der BCAA-Schlüsselenzyme in 
AT, Muskel und Leber dieser Tiere während der späten Trächtigkeit und frühen Laktation 
identifiziert werden. Die Hypothese war, dass überkonditionierte Kühe, die eine erhöhte 
Gewebemobilisierung und vermutlich eine stärker verringerte Insulinsensitivität als Kühe mit 
normaler Körperkondition aufweisen, spezifische Veränderungen im BCAA-Stoffwechsel 
zeigen. Für den Versuch wurden 38 multipare Holsteinkühe eingesetzt, welche 15 Wochen 
antepartum (a.p.) entweder einer normalkonditionierten (NBCS; n = 19) oder einer 
überkonditionierten Gruppe (HBCS; n = 19) zugeteilt wurden. Die Gruppen erhielten jeweils 
unterschiedlich angepasste Fütterungen während der späten Laktation, um die angestrebten 
Ziele hinsichtlich des Body Condition Scores (BCS) und der Rückenfettdicke (RFD) (NBCS: 
BCS < 3.5 und RFD < 1.2 cm; HBCS: BCS > 3.75 und RFD > 1.4 cm) bis zum Zeitpunkt des 
Trockenstellens zu erreichen. An den Tagen 49 a.p., 3, 21 und 84 p.p. wurden Blut und 
Gewebebiopsien von subkutanem AT (scAT), M. semitendinosus und der Leber entnommen. 
Insgesamt waren die HBCS-Kühe während der Frühlaktation aufgrund einer stärker 
ausgeprägten und länger anhaltenden negativen Energiebilanz, einer erhöhten Lipolyse und 
vermutlich einer geringeren Insulinsensitivität stärker metabolisch belastet als die NBCS-Kühe. 
Bei der HBCS-Gruppe wurden ein Tiefstand der Gesamt-BCAA-Konzentration (und 
individueller Leucin- und Valinkonzentrationen) im Plasma an Tag 3 p.p. verzeichnet. Dies 
könnte zum einen an der generell geringeren Futteraufnahme dieser Gruppe liegen, zum 
anderen aber auch der Tatsache geschuldet sein, dass die HBCS-Kühe sich aufgrund des 
erhöhten metabolischen Stresses möglichweise eher in einem proinflammatorischen Zustand 
um die Kalbung herum befanden und somit mehr Aminosäuren für die Generierung von 
Immunparametern verwenden mussten. Die größten Unterschiede bei der Expression der 
BCAA-Transporter standen in Zusammenhang mit den verschiedenen Gewebearten. 
Verglichen mit den anderen Geweben konnten wir in scAT eine stetig erhöhte mRNA-
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Expression der BCAA-Transporter vorfinden, ungeachtet der unterschiedlichen 
Körperkondition oder der Zeit relativ zur Kalbung. Auch in dieser Studie wurde die höchste 
BCAT2 mRNA-Expression in AT detektiert (ohne Einfluss von BCS oder RFD). 
Zusammengefasst deutet dies darauf hin, dass bei Milchkühen (sc)AT, unabhängig von der 
Körperkondition, sowohl für die zelluläre BCAA-Aufnahme als auch deren Abbau von großer 
Bedeutung sein kann. Im Gegensatz hierzu exprimierte Leber (und teilweise Muskel) nur 
begrenzte Mengen an BCAA-Transportern und BCAT2, was auf eine dort geringere BCAA-
Aufnahme und Deaminierungskapazität schließen lässt. Ferner wurde beobachtet, dass die 
HBCS-Kühe eine höhere BCKDH E1α (BCKDHA) mRNA- und antepartum auch eine höhere 
BCKDHA-Proteinexpression in scAT aufwiesen als die NBCS-Kühe. Dies könnte 
insbesondere vor der Kalbung ein höheres Vermögen der HBCS-Tiere für den irreversiblen 
BCAA-Abbau im AT bedeuten. Allerdings wurde angenommen, dass die überkonditionierten 
Kühe während der späten Trächtigkeit mit Nährstoffen überversorgt waren und sich daher im 
Vergleich zu den normalkonditionierten Tieren eher in einer anabolen Situation befanden. Wie 
die geringere hepatische BCKDHA-Proteinexpression der HBCS-Tiere vor der Kalbung 
suggeriert, waren die überkonditionierten Kühe womöglich weniger auf die Oxidation der 
BCAA-Deaminierungsprodukte zur Energiegewinnung angewiesen und könnten die BCAA-
Metabolite stattdessen, über Verknüpfungen des Lipid- und BCAA-Stoffwechsels im AT, 
vermehrt zum Aufbau von weiterem Körperfett genutzt haben. 
Zusammenfassend zeigt die vorliegende Dissertation, dass der Stoffwechsel der BCAA ein 
komplexes und stark reguliertes System bei Milchkühen ist. Die Untersuchungen der 
gewebespezifischen Veränderungen der BCAA-Transporter und -Enzyme während des 
Übergangs von der späten Trächtigkeit zur frühen Laktation haben u.a. belegt, dass AT von 
signifikanter Bedeutung für die Aufnahme und den (initialen) Abbau der BCAA bei 
Milchkühen zu dieser Zeit sein kann. Bei überkonditionierten Kühen könnte ein erhöhter 
BCAA-Katabolismus im AT mit dem Lipidstoffwechsel verbunden sein. Dies gilt besonders 
für die späte Trächtigkeit, einem Zeitraum in dem die Tiere hauptsächlich noch Körperreserven 
aufbauen um die anstehende Laktation zu unterstützen. Jedoch sind weitere Studien 
erforderlich, um die genaue Mitwirkung des BCAA-Stoffwechsels an lipogenen und 
adipogenen Prozessen in Milchkühen quantitativ zu erfassen.  
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